COVID-19 Publications - Week 23 2021 1054 Publications

Update June 07 - June 13, 2021, Dr. Peter J. Lansberg MD, PhD

Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics

COVID-19 publications - Week 23 2021 1054 Publications

PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected]

Reliable on-line resources for Covid 19

WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap)

Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confrmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance

Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database COVID-19 prevention network Covid-Plex trial - (plasma exchange & convalescent plasma trial) The Covid-Plex trial is an investigator initiated, multicenter, parallel-group, open-label randomized clinical trial aiming to randomize patients with severe COVID-19 to standard care or standard care plus plasmapheresis and convalescent plasma.

If you are interested to participate Please contact Wladimir Szpirt, Nicholas Carlson Anders, or Perner Bo Feldt-Rasmussen. Depts. Of Intensive Care Therapy and Nephrology, Copenhagen University Hospital Rigshospitalet, Denmark

Covid-Plex trial

Mainstream Media New York Times - Corona update Fight Over Covid’s Origins Renews Debate on Risks of Lab Work Judge Blocks C.D.C. From Enforcing Virus Rules for Cruise Ships in Florida Moscow Sets Record for Daily Infections My Night in a Quarantine Hotel E.U. Recommends Lifting Nonessential Travel Ban High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S. Portugal orders Lisbon into a weekend lockdown as the Delta variant spreads. White House Announces $3 Billion for Antiviral Pills

Washington Post - Corona update Vaccination rates fall off, imperiling Biden’s July Fourth goal When anti-vaxxers want to come to your wedding Can I go on a group trip with un-vaccinated travelers? Watch out for these pandemic travel scams With airline altercations on the rise, a guide to best practices for bystanders Coronavirus herd immunity is within reach, but what happens if we fall short?

Guardian - Corona update Long Covid should be treated as disability, says TUC Under-18s ‘reservoirs’ for virus when all adults are jabbed, expert warns BBC tightens security after anti-vaxxer ‘death threats’ to staff UK pushes for fully vaccinated to be exempt from Covid self-isolation Third wave of Covid ‘definitely under way’ in UK, says expert

Key Articles

1. Use of aspirin in reduction of mortality of COVID-19 patients: A metanalysis. Int J Clin Pract 2021:e14515Srivastava R, Kumar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118111 Can aspirin be used as a safe prophylactic to reduce the risk of thromboembolic complications in COVID-19 patients? This meta-analysis evaluated ten appropriate studies (N=56 696) to examine the impact on mortality. Overall, an OR: 0.70 (0.63-0.77) indicated a benefit of aspirin use. After the exclusion of outliers, no effect was noted, 0.00 (-0.04 – 0.04). additional evidence is needed to validate the potential benefits of aspirin

2. Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review. Aging Clin. Exp. Res. 2021:1-11Raisi-Estabragh Z, Martineau AR, Curtis EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118024 This updated review on Vitamin D supplementation re-affirms the observed benefit observed in many small observational studies; however, no adequately powered randomized clinical trial has been published to confirm these effects. The authors recommend the use of 400 – 800 IU vitamin D supplements for those with vitamin D deficiency. Several large studies are in progress to elucidate the potential benefit of vitamin D in preventing COVID-19 complications

3. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Heart J Qual Care Clin Outcomes 2021; Harrison SL, Buckley BJR, Rivera-Caravaca JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107535 This umbrella review of systematic reviews confirms the overlapping pattern of cardiovascular (CV)- and COVID-19 risk factors. The majority of CV risk factors are modifiable. Improving these risk factors by lifestyle and appropriate medication can reduce the risks of COVID-19 related (fatal) complications that frequently are, in fact, cardiovascular complications.

4. Severe COVID-19 in Alzheimer's disease: APOE4's fault again? Alzheimers Res. Ther. 2021; 13:111Xiong N, Schiller MR, Li J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118974

5. The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis. Ann. Med. 2021; 53:874-884Wu KS, Lin PC, Chen YS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096808

6. Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19. Thromb Res 2021; 204:13-15Stanne TM, Pedersen A, Gisslén M, Jern C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102452

7. COVID-19 and Immunothrombosis: emerging understanding and clinical management. Br. J. Haematol. 2021; Shaw RJ, Bradbury C, Abrams ST et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114204

8. A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come? Virol J 2021; 18:120Shakaib B, Zohra T, Ikram A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098986

9. Is There any Alternative Receptor for SARS-CoV-2? Cell J 2021; 23:247- 250Shahriari Felordi M, Memarnejadian A, Najimi M, Vosough M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096226

10. Acute submassive pulmonary embolism after SARS-CoV-2 infection: a case report of reinfection or prolonged hypercoagulable state. Eur Heart J Case Rep 2021; 5:ytab103Pow T, Allen S, Brailovsky Y, Darki A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113773

11. History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis 2021; Panagides V, Vincent F, Weizman O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099379

12. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Open Heart 2021; 8Matli K, Farah R, Maalouf M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099529

13. Coronary heart disease and COVID-19: A meta-analysis. Med Clin (Engl Ed) 2021; 156:547-554Liang C, Zhang W, Li S, Qin G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109276

14. Myocarditis after SARS-CoV-2 Vaccination: A Vaccine-induced Reaction? Can J Cardiol 2021; D'Angelo T, Cattafi A, Carerj ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118375

15. Global REnal Involvement of CORonavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis of Incidence, Risk Factors, and Clinical Outcomes. Front Med (Lausanne) 2021; 8:678200Chan KW, Yu KY, Lee PW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113640

Basic Science (75 articles)

Biomarkers - Genetics (112 articles)

1. [The Contribution of SARS-CoV-2 Genomics to the Handling of the COVID-19 Pandemic in Portugal]. Acta Med Port 2021; Gomes JP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100356 2. The key role of the level of ACE2 gene expression in SARS-CoV-2 infection. Aging (Albany NY) 2021; 13Lecarpentier Y, Vallée A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115612 3. Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review. Aging Clin. Exp. Res. 2021:1-11Raisi-Estabragh Z, Martineau AR, Curtis EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118024 4. Severe COVID-19 in Alzheimer's disease: APOE4's fault again? Alzheimers Res. Ther. 2021; 13:111Xiong N, Schiller MR, Li J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118974 5. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. Am. J. Hum. Genet. 2021; Kosmicki JA, Horowitz JE, Banerjee N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115965 6. The presence of SARS-CoV-2 virus in semen samples of patients with COVID- 19 pneumonia. Andrologia 2021:e14145Saylam B, Uguz M, Yarpuzlu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115405 7. Absence of SARS-CoV-2 infection in the semen of men recovering from COVID-19 infection: An exploratory study and review of literature. Andrologia 2021:e14136Sharma AP, Sahoo S, Goyal K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115901 8. Combination of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Diagnosis. Ann Lab Med 2021; 41:568-576Aoki K, Takai K, Nagasawa T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108284 9. Biomarkers for Prognosis and Treatment Response in COVID-19 Patients. Ann Lab Med 2021; 41:540-548Bivona G, Agnello L, Ciaccio M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108281 10. Early Laboratory Preparedness of the Korea Disease Control and Prevention Agency and Response to Unknown Pneumonia Outbreak from Wuhan, China, in January 2020. Ann Lab Med 2021; 41:532-539Kim IH, Kang BH, Seo SH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108280 11. Validation of high-throughput, semiquantitative solid phase SARS coronavirus-2 serology assays in serum and dried blood spot matrices. Bioanalysis 2021; Maritz L, Woudberg NJ, Bennett AC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114884 12. IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid. Biomark. Insights 2021; 16:11772719211013363Donoso-Navarro E, Arribas Gómez I, Bernabeu-Andreu FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103886 13. Photonics of human saliva: potential optical methods for the screening of abnormal health conditions and infections. Biophys. Rev. 2021:1-27Lukose J, M SP, N M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093888 14. A single snapshot multiplex immunoassay platform utilizing dense test lines based on engineered beads. Biosens. Bioelectron. 2021; 190:113388Lee W, Kim H, Bae PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098362 15. Web-based, rapid and contactless management of ambulatory patients for SARS-CoV-2-testing. BMC Infect. Dis. 2021; 21:535Stemler J, Cornely OA, Noack- Schönborn T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098882 16. Comparison between RT-qPCR for SARS-CoV-2 and expanded triage in sputum of symptomatic and asymptomatic COVID-19 subjects in Ecuador. BMC Infect. Dis. 2021; 21:558Torres A, Fors M, Rivero T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118895 17. Containing pandemics through targeted testing of households. BMC Infect. Dis. 2021; 21:548Voigt A, Martyushenko N, Karlsen E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107917 18. A blood RNA transcriptome signature for COVID-19. BMC Med. Genomics 2021; 14:155Kwan PKW, Cross GB, Naftalin CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116667 19. Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020. BMC Public Health 2021; 21:1105Holden TM, Richardson RAK, Arevalo P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107947 20. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the frst wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland. BMJ Open 2021; 11:e051415Faller E, Wyse A, Barry R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103324 21. New Brazilian variant of the SARS-CoV-2 (P1) of COVID-19 in Alagoas state. Braz. J. Infect. Dis. 2021:101588da Silva JC, Félix VB, Leão S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102147 22. Single-cell multi-omics sequencing: application trends, COVID-19, data analysis issues and prospects. Brief. Bioinform. 2021; Huo L, Jiao Li J, Chen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111889 23. Detecting SARS-CoV-2 and its variant strains with a full genome tiling array. Brief. Bioinform. 2021; Jiang L, Guo Y, Yu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097003 24. A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays. Clin. Biochem. 2021; Poore B, Nerenz RD, Brodis D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34118242 25. Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID- 19 patients. Clin Chem Lab Med 2021; Lippi G, Henry BM, Favaloro EJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116589 26. Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program. Clin Infect Dis 2021; Stone M, Di Germanio C, Wright DJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111244 27. Comparison of renal histopathology and gene expression profles between severe COVID-19 and bacterial sepsis in critically ill patients. Crit Care 2021; 25:202Volbeda M, Jou-Valencia D, van den Heuvel MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112226 28. A Case of COVID-19 Re-Infection in a Liver Transplant Patient. Cureus 2021; 13:e14916Mohseni M, Albus M, Kaminski A, Harrison MF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113522 29. State of the art of colloidal particles and unique interfaces-based SARS-CoV-2 detection methods and COVID-19 diagnosis. Curr Opin Colloid Interface Sci 2021:101469Saatçi E, Natarajan S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093063 30. The roles of vitamin D in increasing the body's immunity and reducing injuries due to viral infections: With an emphasis on its possible role in SARS-CoV-2 (COVID-19). Curr. Pharm. Des. 2021; Aleebrahim-Dehkordi E, Deravi N, Yaghoobpoor S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102962 31. Bicentric evaluation of stabilizing sampling tubes for assessment of monocyte HLA-DR expression in clinical samples. Cytometry B Clin. Cytom. 2021; Hamada S, Jeannet R, Gossez M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117826 32. Detection of SARS-CoV-2 IgG antibodies in dried blood spots. Diagn. Microbiol. Infect. Dis. 2021; 101:115425Turgeon CT, Sanders KA, Granger D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116343 33. Food Insecurity and Affecting Factors in Households with Children During the Covid-19 Pandemic: A Cross-Sectional Study. Disaster Med Public Health Prep 2021:1-20Bulucu Büyüksoy GD, Çatıker A, Özdil K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096489 34. The promise of disease detection dogs in pandemic response: lessons learned from COVID-19. Disaster Med Public Health Prep 2021:1-19Otto CM, Sell TK, Veenema T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099088 35. Accuracy of four lateral fow immunoassays for anti SARS-CoV-2 antibodies: a head-to-head comparative study. EBioMedicine 2021; 68:103414Jones HE, Mulchandani R, Taylor-Phillips S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34098341 36. COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral fow assay: A national systematic evaluation of sensitivity and specifcity for mass-testing. EClinicalMedicine 2021:100924Peto T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34101770 37. Ethics Guidance for Environmental Scientists Engaged in Surveillance of Wastewater for SARS-CoV-2. Environ. Sci. Technol. 2021; Hrudey SE, Silva DS, Shelley J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101444 38. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests. Epidemiol Infect 2021; 149:e140De Marco Verissimo C, O'Brien C, López Corrales J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099081 39. Gastroenteritis and cardiogenic shock in a healthcare worker: a case report of COVID-19 myocarditis confrmed with serology. Eur Heart J Case Rep 2021; 5:ytab013Sivalokanathan S, Foley M, Cole G, Youngstein T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104859 40. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Eur J Clin Microbiol Infect Dis 2021:1-15Huber T, Steininger P, Irrgang P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109500 41. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review. Eur. J. Med. Res. 2021; 26:51SeyedAlinaghi S, Mirzapour P, Dadras O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103090 42. The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in April 2021. Euro Surveill 2021; 26Roquebert B, Trombert-Paolantoni S, Haim-Boukobza S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114541 43. Vitamin D attenuates COVID-19 complications via modulation of proinfammatory cytokines, antiviral proteins, and autophagy. Expert Rev. Anti Infect. Ther. 2021; Gilani SJ, Bin-Jumah M, Nadeem MS, Kazmi I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112047 44. Human Tear Fluid Analysis for Clinical Applications: Progress and Prospects. Expert Rev Mol Diagn 2021; Adigal SS, Rizvi A, Rayaroth NV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115952 45. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity. Faseb j 2021; 35:e21713Suresh V, Mohanty V, Avula K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105201 46. Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data. Front Genet 2021; 12:636441Sardar R, Sharma A, Gupta D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093642 47. Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay. Front. Immunol. 2021; 12:688436Brand I, Gilberg L, Bruger J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093595 48. False Negative Mitigation in Group Testing for COVID-19 Screening. Front Med (Lausanne) 2021; 8:661277Alizad-Rahvar AR, Vafadar S, Totonchi M, Sadeghi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095171 49. Dynamic Changes in Coagulation Function in Patients With Pneumonia Under Admission and Non-admission Treatment. Front Med (Lausanne) 2021; 8:626384Xu J, Zhang Y, Li Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109187 50. Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study. Front Mol Biosci 2021; 8:671923Beeckmans S, Van Driessche E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109214 51. Can Vitamin D Defciency Increase the Susceptibility to COVID-19? Front. Physiol. 2021; 12:630956Maha Q, Talal M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093219 52. Profling COVID-19 Genetic Research: A Data-Driven Study Utilizing Intelligent Bibliometrics. Front Res Metr Anal 2021; 6:683212Wu M, Zhang Y, Grosser M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109284 53. Laboratory tests for the detection of SARS-CoV-2 infection: basic principles and examples. Ger. Med. Sci. 2021; 19:Doc06Alkharsah KR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108851 54. Increased procoagulant platelet levels are predictive of death in COVID-19. Geroscience 2021:1-11Khattab MH, Prodan CI, Vincent AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109507 55. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut Microbes 2021; 13:1- 15Newsome RC, Gauthier J, Hernandez MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100340 56. Using SNSs for early detection of disease outbreak in developing countries: evidence from COVID-19 pandemic in Nigeria. Heliyon 2021; 7:e07184Adebisi T, Aregbesola A, Asamu F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099986 57. Ephrin-A1 and the sheddase ADAM12 are upregulated in COVID-19. Heliyon 2021; 7:e07200Mendoza R, Saha N, Momeni A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095559 58. Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2. Infect Dis Ther 2021:1- 15Zheng F, Chen R, Yao R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34110618 59. Role of vitamins and minerals as immunity boosters in COVID-19. Infammopharmacology 2021:1-16Kumar P, Kumar M, Bedi O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110533 60. Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity. Int Immunopharmacol 2021; 98:107825Cuesta-Llavona E, Gómez J, Albaiceta GM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116286 61. Comparison of Rapid Antibody Test and Thorax Computed Tomography Results in Patients who Underwent RT-PCR with the Pre-Diagnosis of COVID- 19. Int J Clin Pract 2021:e14524Kızıloglu I, Sener A, Siliv N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120388 62. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Int J Clin Pract 2021:e14462Lu Q, Zhu Z, Tan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107113 63. SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama. Int J Infect Dis 2021; Díaz Y, Ortiz A, Weeden A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107326 64. Repositive RT-PCR test in discharged COVID-19 patients during medical isolation observation. Int. J. Med. Sci. 2021; 18:2545-2550Huang K, Liu W, Zhou J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104085 65. Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain. iScience 2021:102681Wu C, Qavi AJ, Hachim A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095780 66. The incidence of anosmia in patients with laboratory-confrmed COVID 19 infection in India: An observational study. J. Anaesthesiol. Clin. Pharmacol. 2021; 37:51-56Kumar V, Singla S, Gupta N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103823 67. Dynamics of COVID-19 Lockdown on Blood Indices and Its Impact on Individuals' Immunological Health Status: A Cohort Study in Madinah, Saudi Arabia. J. Blood Med. 2021; 12:395-402Suliman BA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104026 68. Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study. J. Clin. Endocrinol. Metab. 2021; Faulds ER, Boutsicaris A, Sumner L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100545 69. Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control Study. J. Clin. Med. Res. 2021; 13:258-267Acharya R, Poudel D, Bowers R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104277 70. Trends in COVID-19 Testing and Positivity Rates from a Mobile Testing Program in the Phoenix Metropolitan Area. J. Community Health 2021:1-5Lau CSM, Johns J, Merlene S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34115310 71. Correct Execution of the Nasopharyngeal Swab: A Fundamental Method to Improve Diagnosis of SARS-CoV-2 Infection. J Dr Nurs Pract 2021; Spinato G, Fabbris C, Menegaldo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108199 72. Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department. J. Emerg. Med. 2021; Stauning MA, Altintas I, Kallemose T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092446 73. Healthcare workers acquired COVID-19 disease from patients? An investigation by phylogenomics. J Hosp Infect 2021; Chun-Wai Wong R, Lee MK, Kit-Hang Siu G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098050 74. A multiregional evaluation of Ct values in SARS-CoV-2 VOC-20DEC-01 variant. J Infect Dis 2021; Hill KJ, Dewar R, Templeton K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097743 75. Proper assignation of reactivation in a COVID-19 recurrence initially interpreted as a reinfection. J Infect Dis 2021; Pérez Lago L, Martínez Lozano H, Pajares Díaz JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107025 76. Evaluation of three commercial SARS-CoV-2 serology assays in a tertiary care hospital in the United Arab Emirates. J Infect Public Health 2021; 14:898- 902Alatoom A, Atef S, AbdelWareth L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34119842 77. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID- 19 patients. J Infect Public Health 2021; 14:845-851Chen Y, Li P, Ding Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118734 78. Large variations in disease severity, death and ICU admission of 2993 patients infected with SARS-CoV-2: The potential impact of genetic vulnerability. J Infect Public Health 2021; 14:886-891Farajallah HM, AlSuwaidi SK, AlSuwaidi SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118740 79. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio and Their Role as Predictors of Disease Severity of Coronavirus Disease 2019 (COVID- 19). J Lab Physicians 2021; 13:58-63Jain R, Gopal A, Pathak BK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103879 80. Archived dengue serum samples produced false-positive results in SARS- CoV-2 lateral fow-based rapid antibody tests. J. Med. Microbiol. 2021; 70Nath H, Mallick A, Roy S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110279 81. In-hospital Mortality in SARS-CoV-2 stratifed by serum 25-Hydroxy-Vitamin D levels: A Retrospective Study. J Med Virol 2021; Al-Jarallah M, Rajan R, Dashti R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101207 82. Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19. J Nephrol 2021:1-12Vogel MJ, Mustroph J, Staudner ST et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34110585 83. SARS-CoV-2 in asymptomatic pregnant women in South Brazil: RT-PCR and serological detection. J. Perinat. Med. 2021; Chiste JA, Furuie IN, Nogueira MB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107573 84. 7-ketocholesterol: effects on viral infections and hypothetical contribution in COVID-19. J. Steroid Biochem. Mol. Biol. 2021; 212:105939Ghzaiel I, Sassi K, Zarrouk A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118414 85. Seroprevalence of COVID-19 and associated factors in a medical institution in Pakistan. J Taibah Univ Med Sci 2021; Naiyar I, Anjum AF, Khalid AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093105 86. Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19. J. Thromb. Thrombolysis 2021:1-8Mennuni MG, Rolla R, Grisaf L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110529 87. SARS-CoV2 spike protein gene variants with N501T and G142D mutation- dominated infections in mink in the United States. J. Vet. Diagn. Invest. 2021:10406387211023481Cai HY, Cai A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109885 88. Immuno-fbrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2. JCI Insight 2021; Chun HJ, Coutavas E, Pine AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111030 89. Reduced retinal vessel density in COVID-19 patients and elevated D-dimer levels during the acute phase of the infection. Med Clin (Engl Ed) 2021; 156:541- 546Guemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109275 90. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus. Microbiol Spectr 2021:e0001021Steenwyk JL, Mead ME, de Castro PA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106569 91. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection. Mol. Cell 2021; Kamel W, Noerenberg M, Cerikan B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118193 92. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19). Nutrition 2021; 90:111308Eroğlu İ, Eroğlu B, Güven GS. http://www.ncbi.nlm.nih.gov/pubmed/? term=34111831 93. Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients. Open Forum Infect Dis 2021; 8:ofab195Antar AAR, Yu T, Pisanic N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095338 94. Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community. Open Forum Infect Dis 2021; 8:ofaa531Appa A, Takahashi S, Rodriguez-Barraquer I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109255 95. Yield of Severe Acute Respiratory Syndrome Coronavirus 2 Lower Respiratory Tract Testing After a Negative Nasopharyngeal Test Among Hospitalized Persons Under Investigation for Coronavirus Disease 2019. Open Forum Infect Dis 2021; 8:ofab257Egbuonu K, Hyle EP, Hurtado RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113690 96. Use of Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Analysis of Serum Peptidome to Classify and Predict Coronavirus Disease 2019 Severity. Open Forum Infect Dis 2021; 8:ofab222Gomila RM, Martorell G, Fraile-Ribot PA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109258 97. Persistent Symptoms and Association With Infammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients. Open Forum Infect Dis 2021; 8:ofab156Ong SWX, Fong SW, Young BE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095336 98. High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients With COVID-19. Open Forum Infect Dis 2021; 8:ofaa551Pandey U, Yee R, Shen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095334 99. Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center. Open Forum Infect Dis 2021; 8:ofab049Spinicci M, Vellere I, Graziani L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109256 100. SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020. Pathology 2021; Craigie A, McGregor R, Whitcombe AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119335 101. Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets. Platelets 2021:1-9Violi F, Cammisotto V, Pignatelli P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097572 102. Universal COVID-19 testing and a three-space triage protocol is associated with a nine-fold decrease in possible nosocomial infections in an inpatient psychiatric facility. Psychiatry Res 2021; 302:114036Brody BD, Shi Z, Shaffer C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098157 103. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology 2021; 131:105295Kappelmann N, Dantzer R, Khandaker GM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119855 104. Comparative analysis of viral infection outcomes in human seminal fuid from prior viral epidemics and Sars-CoV-2 may offer trends for viral sexual transmissibility and long-term reproductive health implications. Reprod Health 2021; 18:123Pike JFW, Polley EL, Pritchett DY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112171 105. Low Anti-Mullerian Hormone Levels Are Associated with the Severity of Anxiety Experienced by Healthcare Professionals During the COVID-19 Pandemic. Reprod. Sci. 2021:1-6Yeğin GF, Desdicioğlu R, Seçen E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101147 106. An Intelligent Graphene-Based Biosensing Device for Cytokine Storm Syndrome Biomarkers Detection in Human Biofuids. Small 2021:e2101508Hao Z, Luo Y, Huang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110682 107. Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure 2021; Cerutti G, Rapp M, Guo Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111408 108. Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19. Thromb Res 2021; 204:13- 15Stanne TM, Pedersen A, Gisslén M, Jern C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102452 109. Positive Direct Antiglobulin Test in COVID-19 patients: decision-making process. Transfus. Clin. Biol. 2021; Cabo J, Brochier A, Saussoy P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111506 110. Role of ABO blood system in COVID-19: Findings from a southern Italian study. Transfus. Med. 2021; Negro P, Congedo M, Zizza A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114287 111. Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19. Viral Immunol 2021; Avendaño-Félix M, Ochoa-Ramírez LA, Ramos-Payán R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115949 112. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study. Virol J 2021; 18:126Yin SW, Zhou Z, Wang JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118952

Children (44 articles)

1. The Perfect Storm: Rapid Progression of Diabetic Ketoacidosis in Pediatric Diabetes in the Setting of COVID-19. AACE Clin Case Rep 2021; Modarelli R, Balikcioglu PG, Hendrix G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104714 2. Addressing pediatric mental health using telehealth during COVID-19 and beyond: A narrative review. Acad. Pediatr. 2021; Cunningham NR, Ely SL, Garcia BNB, Bowden J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118499 3. Multisystem infammatory syndrome in children with COVID-19. Am J Emerg Med 2021; 49:148-152Gottlieb M, Bridwell R, Ravera J, Long B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116467 4. Forecast modeling to identify changes in pediatric emergency department utilization during the COVID-19 pandemic. Am J Emerg Med 2021; 49:142- 147Ramgopal S, Pelletier JH, Rakkar J, Horvat CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111834 5. Clinical, laboratory, and chest CT features of severe versus non-severe pediatric patients with COVID-19 infection among different age groups. BMC Infect. Dis. 2021; 21:560Hoseinyazdi M, Esmaeilian S, Jahankhah R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118894 6. COVID-19 related multisystem infammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar. BMC Pediatr. 2021; 21:267Hasan MR, Al Zubaidi K, Diab K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103044 7. Immune responses and therapeutic challenges in paediatric patients with new- onset acute myeloid leukaemia and concomitant COVID-19. Br. J. Haematol. 2021; Patel PA, Lapp SA, Grubbs G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096051 8. Calculating the impact of COVID-19 pandemic on child abuse and neglect in the U.S. Child Abuse Negl. 2021; 118:105136Nguyen LH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098378 9. Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea. Circulation 2021; Kang JM, Kim YE, Huh K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092115 10. Vaccines and Disease Relapses in Children with Nephrotic Syndrome. Clin J Am Soc Nephrol 2021; 16:937-938Angeletti A, Bruschi M, Bianchin S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117084 11. Obesity as a Risk Factor for Severe Illness From COVID-19 in the Pediatric Population. Cureus 2021; 13:e14825Agarwal A, Karim F, Fernandez Bowman A, Antonetti CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094778 12. Food Insecurity and Affecting Factors in Households with Children During the Covid-19 Pandemic: A Cross-Sectional Study. Disaster Med Public Health Prep 2021:1-20Bulucu Büyüksoy GD, Çatıker A, Özdil K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096489 13. "Doing What I can, but I got no Magic Wand:" A Snapshot of Early Childhood Educator Experiences and Efforts to Ensure Quality During the COVID-19 Pandemic. Early Child Educ J 2021:1-12Crawford A, Vaughn KA, Guttentag CL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092993 14. The Implications of COVID-19 for Early Childhood Education in Ethiopia: Perspectives from Parents and Caregivers. Early Child Educ J 2021:1-13Kim JH, Araya M, Hailu BH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092994 15. Initial Development of a National Survey on Remote Learning in Early Childhood During COVID-19: Establishing Content Validity and Reporting Successes and Barriers. Early Child Educ J 2021:1-13McKenna M, Soto-Boykin X, Cheng K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092995 16. Rethinking Home-School Partnerships: Lessons Learned from Latinx Parents of Young Children During the COVID-19 Era. Early Child Educ J 2021:1- 12Soltero-González L, Gillanders C. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092996 17. Preschoolers' Approaches to Learning and Family-school Connections During COVID-19: An Empirical Study Based on a Wuhan Sample. Early Child Educ J 2021:1-11Tan F, Gong X, Zhang X, Zhang R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092992 18. Pediatric Pulmonary Function Testing in COVID-19 Pandemic and Beyond. A Position Statement From the Hellenic Pediatric Respiratory Society. Front Pediatr 2021; 9:673322Fouzas S, Gidaris D, Karantaglis N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095031 19. Problematic Use of Internet-Related Activities and Perceived Weight Stigma in Schoolchildren: A Longitudinal Study Across Different Epidemic Periods of COVID-19 in China. Front Psychiatry 2021; 12:675839Fung XCC, Siu AMH, Potenza MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108898 20. COVID-19 among Minority Children in Detroit, Michigan during the Early National Surge of the Pandemic. Glob Pediatr Health 2021; 8:2333794x211022710Ang JY, Kannikeswaran N, Parker K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104706 21. The Effect of Using Rome IV Criteria on the Prevalence of Functional Abdominal Pain Disorders and Functional Constipation among Children of the Western Region of Saudi Arabia. Glob Pediatr Health 2021; 8:2333794x211022265Khayat A, Algethami G, Baik S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104704 22. Algorithm for the Diagnosis and Management of the Multisystem Infammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease (COVID- 19). Int J Clin Pract 2021:e14471Emeksiz S, Çelikel Acar B, Kibar AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107136 23. Multisystem Infammatory Syndrome in Children (MISC): a systematic review. Int J Clin Pract 2021:e14450Guimarães D, Pissarra R, Reis-Melo A, Guimarães H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105843 24. An overview on the COVID-19 complications in pediatric population: A pandemic dilemma. Int J Clin Pract 2021:e14494Seth S, Rashid F, Khera K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115913 25. Does Covid-19 in Children Have a Milder Course than Infuenza? Int J Clin Pract 2021:e14466Yılmaz K, Şen V, Aktar F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34107134 26. Telemedicine experiences at a pediatric endocrinology clinic during the COVID-19 pandemic. Ir. J. Med. Sci. 2021:1-6Denkboy Ongen Y, Eren E, Sahin KC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100191 27. Telephone consultations to manage paediatric outpatient clinics during the COVID-19 pandemic: a service evaluation. Ir. J. Med. Sci. 2021:1-7Edwards LM, Parry M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100192 28. Kawasaki like illness due to COVID-19: a review of the literature. J Infect Dev Ctries 2021; 15:630-638Fang Y, Aravamudan VM, Sridharan GK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106885 29. Voluntary COVID-19 vaccination of children: a social responsibility. J. Med. Ethics 2021; Brusa M, Barilan YM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34117126 30. In brief: Pfzer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old. Med. Lett. Drugs Ther. 2021; 63:81. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101717 31. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvasc. Res. 2021; 138:104196Çakmak F, Demirbuga A, Demirkol D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097919 32. What does the “corona” situation do to the sleep of our children? Monatsschr. Kinderheilkd. 2021; 169:496-497Kerbl R. 33. Multisystem Infammatory Syndrome in Children and COVID-19 Infections. NASN Sch. Nurse 2021:1942602x211021136Bultas MW, Fuller K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098792 34. [Experiences of families of autistic children during a period of lockdown: Exploratory study]. Neuropsychiatr. Enfance Adolesc. 2021; Chamak B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092836 35. High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients With COVID-19. Open Forum Infect Dis 2021; 8:ofaa551Pandey U, Yee R, Shen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095334 36. Socio-demographic disparities in the eating behaviour of Malaysian children during the COVID-19 lockdown. Osong Public Health Res Perspect 2021; Joseph Louis SP, Tyug TS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102050 37. COVID-19 pneumonia in a child with Sotos syndrome. Pediatr. Int. 2021; Ito T, Kudo E, Yamazaki T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101950 38. Post SARS-CoV-2 infection reactive arthritis: a brief report of two pediatric cases. Pediatr. Rheumatol. Online J. 2021; 19:89Sinaei R, Pezeshki S, Parvaresh S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118941 39. The impact of the COVID-19 pandemic on positive airway pressure usage in children with sleep-disordered breathing. Sleep Breath 2021:1-8Sunkonkit K, Selvadurai S, Voutsas G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34105105 40. The impact of the COVID-19 pandemic on nighttime room entries and sleep disruptions for pediatric patients. Sleep Med. 2021; 84:76-81Riehm JM, Arora VM, Tatineni S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119840 41. Telehealth in Pediatric Surgical Subspecialties: Rapid Adoption in the Setting of COVID-19. Telemed J E Health 2021; Schmidtberg LC, Grindle C, Hersh DS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101508 42. Multisystemic infammatory syndrome in children associated with COVID-19: a single center experience in Turkey. Turk Arch Pediatr 2021; 56:192-199Başar EZ, Sönmez HE, Öncel S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104908 43. Is arterial switch operation possible with neonatology-focused intensive care unit modality. Turk Gogus Kalp Damar Cerrahisi Derg 2021; 29:136-142Doyurgan O, Özdemir F, Akdeniz O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104506 44. Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada. Vaccine 2021; Piché-Renaud PP, Ji C, Farrar DS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108076

Clinical Features (34 articles)

1. Clinical, laboratory, and chest CT features of severe versus non-severe pediatric patients with COVID-19 infection among different age groups. BMC Infect. Dis. 2021; 21:560Hoseinyazdi M, Esmaeilian S, Jahankhah R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118894 2. Recovery from COVID-19-related olfactory disorders and quality of life: insights from an observational online study. Chem. Senses 2021; Ferdenzi C, Bousquet C, Aguera PE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097726 3. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021; Peghin M, Palese A, Venturini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111579 4. Cutaneous manifestations related to the COVID-19 pandemic: a review article. Cutan. Ocul. Toxicol. 2021; 40:168-174Molaee H, Allahyari F, Emadi SN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097555 5. Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data. Front Genet 2021; 12:636441Sardar R, Sharma A, Gupta D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093642 6. SARS-CoV-2-Specifc Antibody Prevalence and Symptoms in a Local Austrian Population. Front Med (Lausanne) 2021; 8:632942Ladage D, Höglinger Y, Ladage D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109189 7. Clinical Characteristics of COVID-19-Infected Cancer Patients in Pakistan: Differences Between Survivors and Non-Survivors. Front. Oncol. 2021; 11:655634Asghar K, Abu Bakar M, Akram MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094950 8. Examination of the effects of COVID 19 on corneal endothelium. Graefes Arch Clin Exp Ophthalmol 2021:1-6Erdem S, Karahan M, Ava S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097111 9. Incidence of Anosmia among Covid 19 patients in India. Indian J Otolaryngol Head Neck Surg 2021:1-10Aanand P, Angral S, Varshney S, Raj R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099977 10. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol 2021; Boscolo-Rizzo P, Guida F, Polesel J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109765 11. Assessment of patient recognition of coronavirus disease 2019 (COVID-19)- associated olfactory loss and recovery: a longitudinal study. Int Forum Allergy Rhinol 2021; Prajapati DP, Shahrvini B, Said M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096193 12. Relationship Between Chest Computed Tomography Findings and Clinical Conditions of Coronavirus Disease (COVID-19): A Multicentre Experience. Int J Clin Pract 2021:e14459Yılmaz Demirci N, Uğraş Dikmen A, Taşçı C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105857 13. Does Covid-19 in Children Have a Milder Course than Infuenza? Int J Clin Pract 2021:e14466Yılmaz K, Şen V, Aktar F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34107134 14. Epidemiology and Outcomes of COVID-19 in Home Dialysis Patients Compared with In-Center Dialysis Patients. J Am Soc Nephrol 2021; Hsu CM, Weiner DE, Aweh G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108232 15. The incidence of anosmia in patients with laboratory-confrmed COVID 19 infection in India: An observational study. J. Anaesthesiol. Clin. Pharmacol. 2021; 37:51-56Kumar V, Singla S, Gupta N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103823 16. An observed association between conjunctivitis and severity of COVID-19. J Infect 2021; Loffredo L, Oliva A, Paraninf A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118275 17. The unusual course of a migraine attack during COVID-19 infection - Case studies of three patients. J Infect Public Health 2021; 14:903-905Waliszewska- Prosół M, Budrewicz S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119843 18. Clinical Features of Olfactory Dysfunction in COVID-19 Patients. J Korean Med Sci 2021; 36:e161Seo MY, Choi WS, Lee SH. http://www.ncbi.nlm.nih.gov/pubmed/? term=34100564 19. Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico. J Med Virol 2021; Rodríguez- Vidales EP, Garza-Carrillo D, Pérez-Trujillo JJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101203 20. SARS-CoV-2 in asymptomatic pregnant women in South Brazil: RT-PCR and serological detection. J. Perinat. Med. 2021; Chiste JA, Furuie IN, Nogueira MB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107573 21. Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19. J. Thromb. Thrombolysis 2021:1-8Mennuni MG, Rolla R, Grisaf L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110529 22. Comparison of COVID-19 versus infuenza on the incidence, features, and recovery from acute kidney injury in hospitalized United States Veterans. Kidney Int 2021; Birkelo BC, Parr SK, Perkins AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111501 23. Reduced retinal vessel density in COVID-19 patients and elevated D-dimer levels during the acute phase of the infection. Med Clin (Engl Ed) 2021; 156:541- 546Guemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109275 24. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome. Neurol. Neurochir. Pol. 2021; Przytuła F, Błądek S, Sławek J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096013 25. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19). Nutrition 2021; 90:111308Eroğlu İ, Eroğlu B, Güven GS. http://www.ncbi.nlm.nih.gov/pubmed/? term=34111831 26. Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients. Open Forum Infect Dis 2021; 8:ofab195Antar AAR, Yu T, Pisanic N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095338 27. Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center. Open Forum Infect Dis 2021; 8:ofab049Spinicci M, Vellere I, Graziani L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109256 28. Epidemiological, imaging, laboratory, and clinical characteristics and factors related to mortality in patients with COVID-19: a single-center study. Osong Public Health Res Perspect 2021; Azarkar Z, Salehiniya H, Kazemi T, Abbaszadeh H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102047 29. Clinical and epidemiological characteristics and outcomes of patients hospitalized for COVID-19 in Douala, Cameroon. Pan Afr. Med. J. 2021; 38:246Mekolo D, Bokalli FA, Chi FM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104294 30. Long COVID presenting with intermittent fever after COVID-19 pneumonia. Radiol Case Rep 2021; Arita Y, Yamamoto S, Nagata M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104285 31. Comparative analysis of viral infection outcomes in human seminal fuid from prior viral epidemics and Sars-CoV-2 may offer trends for viral sexual transmissibility and long-term reproductive health implications. Reprod Health 2021; 18:123Pike JFW, Polley EL, Pritchett DY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112171 32. Incidence of pneumomediastinum in COVID-19: A single-center comparison between 1st and 2nd wave. Respir Investig 2021; Tacconi F, Rogliani P, Leonardis F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108126 33. Upper respiratory tract and otolaryngological manifestations of coronavirus disease 2019 (COVID-19): A systemic review. SAGE Open Med 2021; 9:20503121211016965Al-Swiahb JN, Motiwala MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094558 34. Epidemiological and clinical characteristics of the frst 500 confrmed COVID- 19 inpatients in a tertiary infectious disease referral hospital in Manila, Philippines. Trop Med Health 2021; 49:48Agrupis KA, Smith C, Suzuki S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118992

CNS (23 articles)

1. Infammatory Response Leads to Neuronal Death in Human Post-Mortem Cerebral Cortex in Patients with COVID-19. ACS Chem Neurosci 2021; 12:2143- 2150Boroujeni ME, Simani L, Bluyssen HAR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100287 2. Severe COVID-19 in Alzheimer's disease: APOE4's fault again? Alzheimers Res. Ther. 2021; 13:111Xiong N, Schiller MR, Li J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118974 3. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinfammation in dementia-like cognitive impairment. Alzheimers Res. Ther. 2021; 13:110Zhou Y, Xu J, Hou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108016 4. Neurological manifestations and neuroimaging fndings in patients with SARS-CoV2-a systematic review. Egypt J Neurol Psychiatr Neurosurg 2021; 57:68Mohan N, Fayyaz MA, Del Rio C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093004 5. SARS-CoV-2 associated Miller-Fisher syndrome or polyneuritis cranialis. Environ. Sci. Pollut. Res. Int. 2021:1-3Finsterer J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117541 6. Persistent visual dysfunction following PRES due to COVID-19: Case series and literature review. Eur. J. Neurol. 2021; Hixon AM, Thaker AA, Pelak VS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115917 7. Case Report: Bilateral Palsy of the Vocal Cords After COVID-19 Infection. Front. Neurol. 2021; 12:619545Jungbauer F, Hülse R, Lu F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093389 8. Alteration of Autonomic Nervous System Is Associated With Severity and Outcomes in Patients With COVID-19. Front. Physiol. 2021; 12:630038Pan Y, Yu Z, Yuan Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093217 9. SARS-CoV-2 associated or post partum Guillain Barre syndrome? J. Clin. Neurosci. 2021; Finsterer J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116899 10. Guillain-Barré Syndrome after Novel Coronavirus Disease 2019. J. Emerg. Med. 2021; Yakoby J, Litvak I, Yu E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103203 11. Diffuse functional brain disconnection syndrome in critically ill patients with COVID-19. J Infect Public Health 2021; 14:906-909Iacovazzo C, Vargas M, Tedeschi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119844 12. Neurological complications in COVID-19 - a diagnostic challenge. J. Med. Life 2021; 14:216-224Vacaras V, Frunze S, Cordos AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104245 13. COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2. J. Neuroimaging 2021; Lewis A, Jain R, Frontera J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105198 14. Dimensions of SARS-CoV-2 associated Guillain-Barré syndrome. J. Neuroimmunol. 2021; 357:577626Finsterer J, Ghosh R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116278 15. MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or infammatory myelitis? J. Neurovirol. 2021:1-6Abrams RMC, Safavi F, Tuhrim S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101085 16. COVID-19 leukoencephalopathy with subacute magnetic resonance imaging fndings of vasculitis and demyelination. J. Neurovirol. 2021:1-6Vahedi A, Apap Mangion S, Silber E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101087 17. The interplay of stress and electrocortical reactivity to reward in the prospective prediction of depression symptoms during COVID-19. J. Psychiatr. Res. 2021; 140:124-131Feurer C, Granros M, Calentino AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111702 18. Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction. Mol. Neurobiol. 2021:1-13Kaundal RK, Kalvala AK, Kumar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110602 19. The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurol Sci 2021:1-7Moghadasi AN, Mirmosayyeb O, Barzegar M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34100130 20. SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis. Neurologia (Engl Ed) 2021; Piñar Morales R, Ramírez Rivas MA, Barrero Hernández FJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103271 21. ?Mini-review:_Guillain Barrè syndrome and myelitis associated with SARS- CoV-2 infection_? Neurosci. Lett. 2021:136040Canavero I, Ravaglia S, Valentino F, Micieli G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118307 22. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology 2021; 131:105295Kappelmann N, Dantzer R, Khandaker GM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119855 23. Acute Necrotic Hemorrhagic Leukoencephalitis related to COVID-19: a report of two cases. Radiol Case Rep 2021; Alqahtani A, Alaklabi A, Kristjansson S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104284

Coagulation (48 articles)

1. Protocol for percutaneous tracheostomy and prevention of COVID-19 transmission. Am. J. Otolaryngol. 2021; 42:103090Avalos N, Grego K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098456 2. Anticoagulation in the obese patient with COVID-19-associated venous thromboembolism. BMJ Case Rep. 2021; 14McCormick JP, Connaughton J, McDonnell N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116998 3. Rectus sheath and retroperitoneal haematomas in patients with Coronavirus 2019 infection. Br. J. Haematol. 2021; Hazenberg P, Lechareas S, Vasquez Rios M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096041 4. COVID-19 and Immunothrombosis: emerging understanding and clinical management. Br. J. Haematol. 2021; Shaw RJ, Bradbury C, Abrams ST et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114204 5. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? Cardiovasc. Drugs Ther. 2021:1-14Castro P, Palomo M, Moreno-Castaño AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097193 6. Pulmonary Vein Thrombosis in COVID-19. Chest 2021; 159:e361-e364Goddard SA, Tran DQ, Chan MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099150 7. Massive Pulmonary Embolism and Deep Vein Thrombosis in COVID-19 Pneumonia: Two Case Reports. Cureus 2021; 13:e14833Chopra S, Kaur J, Kaur M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104583 8. Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration. Cureus 2021; 13:e14853Idogun PO, Ward MC, Teklie Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113494 9. Rectus Sheath Hematoma Due to Low Molecular Weight Heparin in a COVID- 19 Patient in Turkey. Cureus 2021; 13:e14870Kalayci T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104600 10. Splenic Infarct Due to a Patent Foramen Ovale and Paradoxical Emboli Post- COVID-19 Infection: A Case Study. Cureus 2021; 13:e14887Norton EJ, Sheikh N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109076 11. Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in COVID-19 pandemic: a systematic review. Egypt J Neurol Psychiatr Neurosurg 2021; 57:67Kurnianto A, Tugasworo D, Andhitara Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093003 12. Unexpected acute pulmonary embolism in an old COVID-19 patient with warfarin overdose: a case report. Eur Heart J Case Rep 2021; 5:ytab206Coutrot M, Delrue M, Joly BS, Siguret V. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104863 13. Acute submassive pulmonary embolism after SARS-CoV-2 infection: a case report of reinfection or prolonged hypercoagulable state. Eur Heart J Case Rep 2021; 5:ytab103Pow T, Allen S, Brailovsky Y, Darki A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113773 14. Bi-atrial thrombosis in a patient with SARS-CoV-2 infection: a case report. Eur Heart J Case Rep 2020; 4:1-5Torres R, Gul F, Azmaiparashvili Z, Patarroyo-Aponte G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104858 15. Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Rev Vaccines 2021:1-6Esba LCA, Al Jeraisy M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092166 16. Clinical Signifcance of Plasma D-Dimer in COVID-19 Mortality. Front Med (Lausanne) 2021; 8:638097Li Y, Deng Y, Ye L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113629 17. Dynamic Changes in Coagulation Function in Patients With Pneumonia Under Admission and Non-admission Treatment. Front Med (Lausanne) 2021; 8:626384Xu J, Zhang Y, Li Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109187 18. Increased procoagulant platelet levels are predictive of death in COVID-19. Geroscience 2021:1-11Khattab MH, Prodan CI, Vincent AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109507 19. US Ventilator Allocation and Patient Triage Policies in Anticipation of the COVID-19 Surge. Health Secur 2021; Chelen JSC, White DB, Zaza S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107775 20. The Effect Of Chronic DOAC Treatment On Clinical Outcomes Of Hospitalized Patients With COVID-19. Int J Clin Pract 2021:e14467Aslan B, Akyüz A, Işık F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107130 21. Use of aspirin in reduction of mortality of COVID-19 patients: A metanalysis. Int J Clin Pract 2021:e14515Srivastava R, Kumar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118111 22. Association between risk of VTE and mortality in patients with COVID-19. Int J Infect Dis 2021; Chen S, Zheng T, Wang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107325 23. Staged acute mesenteric and peripheral ischemia treatment in COVID-19 patient: Case report. Int. J. Surg. Case Rep. 2021; 84:106105Dinoto E, Ferlito F, La Marca MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119938 24. Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality? Intern Emerg Med 2021:1-3Pasin F, Calabrese A, Pelagatti L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100214 25. Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study. J. Clin. Endocrinol. Metab. 2021; Faulds ER, Boutsicaris A, Sumner L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100545 26. Intracerebral hemorrhage in COVID-19: A narrative review. J. Clin. Neurosci. 2021; 89:271-278Margos NP, Meintanopoulos AS, Filioglou D, Ellul J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119280 27. Successful treatment of acute spleno-porto-mesenteric vein thrombosis after ChAdOx1 nCoV-19 vaccine. A case report. J Crit Care 2021; 65:72-75Umbrello M, Brena N, Vercelli R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111682 28. What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web-survey helps us understand where the doubts lie. J Glob Antimicrob Resist 2021; Colaneri M, Valsecchi P, Vecchia M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118478 29. Is venous thromboembolism a predictable marker in older patients with COVID-19 infection? A single-center observational study. J Infect Dev Ctries 2021; 15:639-345De Giorgi A, Contini C, Greco S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106886 30. Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J. Stroke Cerebrovasc. Dis. 2021; 30:105906Dias L, Soares-Dos-Reis R, Meira J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111775 31. Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19. J. Thromb. Thrombolysis 2021:1-8Mennuni MG, Rolla R, Grisaf L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110529 32. Protocol for a Nationwide Internet-based Health Survey of Workers During the COVID-19 Pandemic in 2020. J uoeh 2021; 43:217-225Fujino Y, Ishimaru T, Eguchi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092766 33. Late mesenteric ischemia after Sars-Cov-2 infection: case report. J Vasc Bras 2021; 20:e20200105de Macedo VSO, Moreira GB, de Albuquerque ACF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093678 34. Reduced retinal vessel density in COVID-19 patients and elevated D-dimer levels during the acute phase of the infection. Med Clin (Engl Ed) 2021; 156:541- 546Guemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109275 35. Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia? Med. Hypotheses 2021; 152:110621El Hasbani G, Taher AT. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116360 36. The frst known case of vaccine-induced thrombotic thrombocytopenia in Australia. Med. J. Aust. 2021; Hocking J, Chunilal SD, Chen VM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117641 37. Prevention of venous thromboembolism in COVID-19 outpatients. MMW- Fortschritte der Medizin 2021; 163:56-57Darius H, Grothues J, Haas S et al. 38. Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation. Mol. Cell. Biochem. 2021:1-11Pérez- Campos Mayoral L, Hernández-Huerta MT, Papy-García D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110554 39. High frequency of endoluminal thrombus in patients with ischaemic stroke following SARS-CoV-2 infection. Neurologia 2021; Gómez-Porro P, Cabal-Paz B, Valenzuela-Chamorro S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103174 40. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologia (Engl Ed) 2021. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112621 41. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Open Heart 2021; 8Matli K, Farah R, Maalouf M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099529 42. Aggressive Thromboprophylaxis Improves Clinical Process and Decreases the Need of Intensive Care Unit in Covid-19. Pak J Med Sci 2021; 37:668- 674Ugur M, Adiyeke E, Recep E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104145 43. Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets. Platelets 2021:1-9Violi F, Cammisotto V, Pignatelli P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097572 44. Acute Necrotic Hemorrhagic Leukoencephalitis related to COVID-19: a report of two cases. Radiol Case Rep 2021; Alqahtani A, Alaklabi A, Kristjansson S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104284 45. Hemorrhage and venous thromboembolism in critically ill patients with COVID-19. SAGE Open Med 2021; 9:20503121211020167Qiu C, Li T, Wei G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104439 46. Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment. SAGE Open Med Case Rep 2021; 9:2050313x211016991Sottilotta G, Mangano C, Basile R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104443 47. Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19. Thromb Res 2021; 204:13- 15Stanne TM, Pedersen A, Gisslén M, Jern C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102452 48. Increased pulmonary embolism in patients with COVID-19: a case series and literature review. Trop Dis Travel Med Vaccines 2021; 7:16Hesam-Shariati S, Fatehi P, Abouzaripour M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34118995

Complications (78 articles)

1. COVID-19 morbidity and severity in patients with age-related macular degeneration: a Korean nationwide cohort study. Am. J. Ophthalmol. 2021:11881Yang JM, Moon SY, Lee JY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34102151 2. Early vs. late tracheostomy in ventilated COVID-19 patients - A retrospective study. Am. J. Otolaryngol. 2021; 42:103102Livneh N, Mansour J, Kassif Lerner R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120008 3. Preparing Intensive Care Unit in Resource-Constraint Setting Amid COVID-19 Pandemic: Our Experience and Review. Anesth Essays Res 2020; 14:366- 369Kajal K, Naik BN, Singh A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092843 4. Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study. Ann Intensive Care 2021; 11:92Ferreira JC, Ho YL, Besen B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097145 5. Unusual source of recurrent Corynebacterium bacteraemia in an immunocompromised patient. BMJ Case Rep. 2021; 14Bakhsh ARA, Lewis KE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116997 6. COVID-19-associated Staphylococcus aureus cavitating pneumonia. BMJ Case Rep. 2021; 14Chandran S, Avari M, Cherian BP, Suarez C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117003 7. Lobar expression of SARS-CoV-2 pneumonia. BMJ Case Rep. 2021; 14Mendes Pedro D, Cunha M, Marques T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34112635 8. 'Assisted self-proning' in a case of severe COVID-19 pneumonitis. BMJ Mil Health 2021; Pitts W, Cais S, Simon E, Hunt D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103382 9. Rectus sheath and retroperitoneal haematomas in patients with Coronavirus 2019 infection. Br. J. Haematol. 2021; Hazenberg P, Lechareas S, Vasquez Rios M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096041 10. COVID-19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system. Cancer 2021; Fu C, Stoeckle JH, Masri L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096048 11. Characteristics and outcomes of cancer patients with covid-19 at a safety-net hospital. Cancer Treat Res Commun 2021; 28:100418Ozer M, Goksu SY, Mahdi M, Gandhi N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118790 12. COVID-19 infection with delayed presentation of infective endocarditis of the prosthetic pulmonary valve. Cardiol. Young 2021:1-3Chimoriya R, Awasthy N, Kumar G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092265 13. Laryngotracheal Complications in Intubated COVID-19 Patients. Clin. Med. Insights Case Rep. 2021; 14:11795476211020590Sandu K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104030 14. Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis. Crit Care 2021; 25:197De Pascale G, De Maio F, Carelli S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099016 15. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients. Crit Care 2021; 25:199Li Bassi G, Suen JY, Dalton HJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108029 16. COVID-19 Associated Spontaneous Pneumothorax and Pneumopericardium: A Case Report. Cureus 2021; 13:e14861Bistre J, Douedi S, Alshami A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113499 17. Massive Pulmonary Embolism and Deep Vein Thrombosis in COVID-19 Pneumonia: Two Case Reports. Cureus 2021; 13:e14833Chopra S, Kaur J, Kaur M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104583 18. Rectus Sheath Hematoma Due to Low Molecular Weight Heparin in a COVID- 19 Patient in Turkey. Cureus 2021; 13:e14870Kalayci T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104600 19. The usefulness of Shock Index and Modifed Shock Index in predicting outcome of COVID-19 patients. Disaster Med Public Health Prep 2021:1-16Kurt E, Bahadirli S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099089 20. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves' disease. Endocrine 2021:1-12Murugan AK, Alzahrani AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106438 21. Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors. Endocrinol Metab (Seoul) 2021; Lui DTW, Lee CH, Chow WS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107601 22. Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax. Epidemiol Infect 2021; 149:e137Guven BB, Erturk T, Kompe Ö, Ersoy A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099076 23. Unexpected acute pulmonary embolism in an old COVID-19 patient with warfarin overdose: a case report. Eur Heart J Case Rep 2021; 5:ytab206Coutrot M, Delrue M, Joly BS, Siguret V. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104863 24. Platypnoea-orthodeoxia syndrome after percutaneous treatment of ruptured sinus Valsalva complicated by SARS-Cov-2 pneumonia: a case report. Eur Heart J Case Rep 2021; 5:ytab176Jenab Y, Hosseinsabet A, Vaskelyte L, Hosseini K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109294 25. Bi-atrial thrombosis in a patient with SARS-CoV-2 infection: a case report. Eur Heart J Case Rep 2020; 4:1-5Torres R, Gul F, Azmaiparashvili Z, Patarroyo-Aponte G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104858 26. Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021. Euro Surveill 2021; 26Buil JB, van Zanten ARH, Bentvelsen RG et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34114540 27. Clinical Characteristics of COVID-19-Infected Cancer Patients in Pakistan: Differences Between Survivors and Non-Survivors. Front. Oncol. 2021; 11:655634Asghar K, Abu Bakar M, Akram MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094950 28. Features of Cytokine Storm Identifed by Distinguishing Clinical Manifestations in COVID-19. Front Public Health 2021; 9:671788Shen WX, Luo RC, Wang JQ, Chen ZS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109148 29. Does COVID-19 pneumonia signify secondary organizing pneumonia?: A narrative review comparing the similarities between these two distinct entities. Heart Lung 2021; 50:667-674Chong WH, Saha BK, Chopra A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098237 30. High-fow Nasal Cannula therapy: A feasible treatment for vulnerable elderly COVID-19 patients in the wards. Heart Lung 2021; 50:654-659van Steenkiste J, van Herwerden MC, Weller D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34098235 31. Post covid 19 pulmonary fbrosis. Is it real threat? Indian J. Tuberc. 2021; 68:330-333Rai DK, Sharma P, Kumar R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099197 32. An overview on the COVID-19 complications in pediatric population: A pandemic dilemma. Int J Clin Pract 2021:e14494Seth S, Rashid F, Khera K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115913 33. Chemokines and Eicosanoids Fuel the Hyperinfammation Within the Lungs of Patients with Severe COVID-19. J Allergy Clin Immunol 2021; Zaid Y, Doré É, Dubuc I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111453 34. COVID-19 and short and medium-term outcomes in liver transplant patients: A spanish single-center case series. J. Clin. Exp. Hepatol. 2021; Tejedor-Tejada J, Fuentes-Valenzuela E, Alonso-Martin C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092967 35. Guillain-Barré Syndrome after Novel Coronavirus Disease 2019. J. Emerg. Med. 2021; Yakoby J, Litvak I, Yu E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103203 36. Thyroid dysfunction in COVID-19 patients. J. Endocrinol. Invest. 2021:1-5Baldelli R, Nicastri E, Petrosillo N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34101132 37. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021; 9Goldman JD, Robinson PC, Uldrick TS, Ljungman P. http://www.ncbi.nlm.nih.gov/pubmed/? term=34117116 38. Is venous thromboembolism a predictable marker in older patients with COVID-19 infection? A single-center observational study. J Infect Dev Ctries 2021; 15:639-345De Giorgi A, Contini C, Greco S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106886 39. Co-infection of COVID-19 and recurrent malaria. J Infect Dev Ctries 2021; 15:625-629Pusparani A, Henrina J, Cahyadi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106884 40. Diffuse functional brain disconnection syndrome in critically ill patients with COVID-19. J Infect Public Health 2021; 14:906-909Iacovazzo C, Vargas M, Tedeschi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119844 41. Closed-Loop Versus Conventional Mechanical Ventilation in COVID-19 ARDS. J. Intensive Care Med. 2021:8850666211024139Wendel Garcia PD, Hofmaenner DA, Brugger SD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098803 42. Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai. J Microbiol Immunol Infect 2021; Miao Q, Ma Y, Ling Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103263 43. Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter study. J. Thorac. Cardiovasc. Surg. 2021; Saeed O, Tatooles AJ, Farooq M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112505 44. Immuno-fbrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2. JCI Insight 2021; Chun HJ, Coutavas E, Pine AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111030 45. A tale of two diseases: Sarcoidosis, COVID-19 and new therapeutic options with dual RAS inhibition and tetanus-diphtheria vaccine. Med. Hypotheses 2021; 152:110619Ozbalci D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102600 46. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus. Microbiol Spectr 2021:e0001021Steenwyk JL, Mead ME, de Castro PA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106569 47. Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation. Mol. Cell. Biochem. 2021:1-11Pérez- Campos Mayoral L, Hernández-Huerta MT, Papy-García D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110554 48. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicenter study from Iran. Mycoses 2021; Pakdel F, Ahmadikia K, Salehi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096653 49. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome. Neurol. Neurochir. Pol. 2021; Przytuła F, Błądek S, Sławek J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096013 50. Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care- Associated Infections. Open Forum Infect Dis 2021; 8:ofab201Kubin CJ, McConville TH, Dietz D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099978 51. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Open Heart 2021; 8Matli K, Farah R, Maalouf M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099529 52. Aneurysm of right sinus of valsalva revealed by COVID-19 infection. Pan Afr. Med. J. 2021; 38:260Rasras H, Bazid Z. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104308 53. COVID-19 pneumonia in a child with Sotos syndrome. Pediatr. Int. 2021; Ito T, Kudo E, Yamazaki T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101950 54. Post SARS-CoV-2 infection reactive arthritis: a brief report of two pediatric cases. Pediatr. Rheumatol. Online J. 2021; 19:89Sinaei R, Pezeshki S, Parvaresh S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118941 55. Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets. Platelets 2021:1-9Violi F, Cammisotto V, Pignatelli P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097572 56. Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgrad. Med. J. 2021; Banerjee M, Pal R, Bhadada SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103372 57. Cardiac index is associated with oxygenation in COVID-19 acute respiratory distress syndrome. Pulm Circ 2021; 11:20458940211019626Poor HD, Rurak K, Howell D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104425 58. Acute Necrotic Hemorrhagic Leukoencephalitis related to COVID-19: a report of two cases. Radiol Case Rep 2021; Alqahtani A, Alaklabi A, Kristjansson S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104284 59. Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure. Respir. Med. 2021; 185:106477Damiani M, Gandini L, Landi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102594 60. Possible role of COVID-19 in the relapse of Klein-Levin Syndrome. Respir Med Case Rep 2021; 33:101445Nasrullah A, Javed A, Ashraf O, Malik K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094848 61. Individualized ventilatory management in patients with COVID-19-associated acute respiratory distress syndrome. Respir Med Case Rep 2021; 33:101433Taenaka H, Yoshida T, Hashimoto H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094847 62. Endotracheal granulation after tracheostomy in acute respiratory distress syndrome from COVID-19. Respirol Case Rep 2021; 9:e00787Matsumoto H, Hanada S, Yamamoto K, Takaya H. http://www.ncbi.nlm.nih.gov/pubmed/? term=34094572 63. Successful endobronchial occlusion in empyema with broncho-pleural fstula secondary to COVID-19 pneumonia: a case report and literature review. Respirol Case Rep 2021; 9:e00785Nakano T, Kawada M, Minami K, Kaneda H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094570 64. Post-COVID-19 exacerbation of fbrodysplasia ossifcans progressiva with multiple fare-ups and extensive heterotopic ossifcation in a 45-year-old female patient. Rheumatol. Int. 2021:1-7Grgurevic L, Novak R, Hrkac S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110466 65. Hemorrhage and venous thromboembolism in critically ill patients with COVID-19. SAGE Open Med 2021; 9:20503121211020167Qiu C, Li T, Wei G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104439 66. [Continuous deep sedation until death for COVID-19 patients]. Soins 2021; 66:30-33Amar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103130 67. [Palliative care and COVID-19, a creative challenge]. Soins 2021; 66:37- 38Amouroux-Gorsse V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103132 68. [Infuence of COVID-19 on issues relating to end of life and the support of patients]. Soins 2021; 66:26-29Aubry R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103129 69. [When care means being present for the other]. Soins 2021; 66:39-40Benduduh K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103133 70. [Student nurses faced with the palliative care approach]. Soins 2021; 66:51Hérisson B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103138 71. [Supporting end-of-life at home during a pandemic]. Soins 2021; 66:49- 50Lecointre B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103137 72. [Impacts of the health crisis on palliative care]. Soins 2021; 66:22-25Lefaucheur AS, Hirsch G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103128 73. [Identifed palliative care beds in the time of COVID-19]. Soins 2021; 66:44- 45Parot-Monpetit A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103135 74. Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease. Ther. Clin. Risk Manag. 2021; 17:553-561Tu C, Wang G, Geng Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103920 75. COVID-19 and Mucormycosis Syndemic: Double Health Threat to a Collapsing Healthcare System in India. Trop Med Int Health 2021; Christopher NRI, Mehedi Hasan M, Goyal S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117677 76. Follow-up strategy with long-term veno-venous extracorporeal membrane oxygenation support for complicated severe acute respiratory distress related to COVID-19 and recovery of the lungs. Turk Gogus Kalp Damar Cerrahisi Derg 2021; 29:252-258Kırali K, Erkılınç A, Erdal Taşçı A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104520 77. Liver injury in COVID-19: clinical features and treatment management. Virol J 2021; 18:121Yu D, Du Q, Yan S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34108015 78. Assessment of nitric oxide (NO) potential to mitigate COVID-19 severity. Virusdisease 2021:1-6Srivastava S, Garg I, Hembrom AA, Kumar B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099981

Cured – Recovered (23 articles)

1. Long-term consequences in critically ill COVID-19 patients: a prospective cohort study. Acta Anaesthesiol. Scand. 2021; Schandl A, Hedman A, Lyngå P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097753 2. Absence of SARS-CoV-2 infection in the semen of men recovering from COVID-19 infection: An exploratory study and review of literature. Andrologia 2021:e14136Sharma AP, Sahoo S, Goyal K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115901 3. Antibody persistency and trend post-SARS-CoV-2 infection at eight months. Ann. Ig. 2021; Dehgani-Mobaraki P, Kamber Zaidi A, Porreca A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113953 4. Practical strategies for delivering airway training in the COVID-19 era. Br J Anaesth 2021; Hickman J, McNarry AF, Kelly FE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092382 5. Recovery from COVID-19-related olfactory disorders and quality of life: insights from an observational online study. Chem. Senses 2021; Ferdenzi C, Bousquet C, Aguera PE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097726 6. Early Rehabilitation Feasibility in a COVID-19 Intensive Care Unit. Chest 2021; Stutz MR, Leonhard AG, Ward CM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34116067 7. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. Chin. Med. 2021; 16:44An X, Duan L, Zhang YH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099015 8. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021; Peghin M, Palese A, Venturini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111579 9. A Case of COVID-19 Re-Infection in a Liver Transplant Patient. Cureus 2021; 13:e14916Mohseni M, Albus M, Kaminski A, Harrison MF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113522 10. Post-COVID-19 Fatigue: A Case of Infectious Hypothyroidism. Cureus 2021; 13:e14815Whiting A, Reyes JVM, Ahmad S, Lieber J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094769 11. Acute submassive pulmonary embolism after SARS-CoV-2 infection: a case report of reinfection or prolonged hypercoagulable state. Eur Heart J Case Rep 2021; 5:ytab103Pow T, Allen S, Brailovsky Y, Darki A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113773 12. Post covid 19 pulmonary fbrosis. Is it real threat? Indian J. Tuberc. 2021; 68:330-333Rai DK, Sharma P, Kumar R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099197 13. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol 2021; Boscolo-Rizzo P, Guida F, Polesel J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109765 14. SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama. Int J Infect Dis 2021; Díaz Y, Ortiz A, Weeden A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107326 15. Repositive RT-PCR test in discharged COVID-19 patients during medical isolation observation. Int. J. Med. Sci. 2021; 18:2545-2550Huang K, Liu W, Zhou J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104085 16. Rehabilitation in adult post-COVID-19 patients in post-acute care with Therapeutic Exercise. J Frailty Aging 2021; 10:297-300Udina C, Ars J, Morandi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105716 17. Thirty-Day Post-Discharge Outcomes Following COVID-19 Infection. J Gen Intern Med 2021:1-8Kingery JR, Bf Martin P, Baer BR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100231 18. Proper assignation of reactivation in a COVID-19 recurrence initially interpreted as a reinfection. J Infect Dis 2021; Pérez Lago L, Martínez Lozano H, Pajares Díaz JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107025 19. Cardio-Pulmonary Sequelae in Recovered COVID-19 Patients: Considerations for Primary Care. J. Prim. Care Community Health 2021; 12:21501327211023726Sarfraz Z, Sarfraz A, Barrios A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096390 20. Persistent dyspnea after COVID-19: Suggestions for follow-up care. MMW- Fortschritte der Medizin 2021; 163:52-55Kolditz M, Beyer-Westendorf J, von Bonin S, Koschel DS. 21. Persistent Symptoms and Association With Infammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients. Open Forum Infect Dis 2021; 8:ofab156Ong SWX, Fong SW, Young BE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095336 22. Long COVID presenting with intermittent fever after COVID-19 pneumonia. Radiol Case Rep 2021; Arita Y, Yamamoto S, Nagata M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104285 23. Post-COVID-19 exacerbation of fbrodysplasia ossifcans progressiva with multiple fare-ups and extensive heterotopic ossifcation in a 45-year-old female patient. Rheumatol. Int. 2021:1-7Grgurevic L, Novak R, Hrkac S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110466

Cardiovascular disease (69 articles)

1. Ischemic Stroke: An Underestimated Complication of COVID-19. Aging Dis 2021; 12:691-704Cao W, Zhang C, Wang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094634 2. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinfammation in dementia-like cognitive impairment. Alzheimers Res. Ther. 2021; 13:110Zhou Y, Xu J, Hou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108016 3. Understanding the role of left and right ventricular strain assessment in patients hospitalized with COVID-19. Am Heart J Plus 2021:100018Park J, Kim Y, Pereira J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095889 4. Cardiovascular Complications Related to COVID-19 Disease. Anesth Essays Res 2020; 14:359-365Alsatli RA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092842 5. The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis. Ann. Med. 2021; 53:874-884Wu KS, Lin PC, Chen YS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096808 6. History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis 2021; Panagides V, Vincent F, Weizman O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099379 7. Coronavirus disease vaccination in heart failure: No time to waste. Arch Cardiovasc Dis 2021; Roncalli J, Roubille F, Lamblin N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099378 8. Subacute effusive-constrictive pericarditis in a patient with COVID-19. BMJ Case Rep. 2021; 14Diaconu R, Popescu L, Voicu A, Donoiu I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116993 9. Anticoagulation in the obese patient with COVID-19-associated venous thromboembolism. BMJ Case Rep. 2021; 14McCormick JP, Connaughton J, McDonnell N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116998 10. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br. J. Clin. Pharmacol. 2021; Asiimwe IG, Pushpakom S, Turner RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101232 11. SARS-CoV-2 infection with pneumonia and stroke. Brain Hemorrhages 2021; Hassan M, Syed F, Mustafa F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34095787 12. Myocarditis after SARS-CoV-2 Vaccination: A Vaccine-induced Reaction? Can J Cardiol 2021; D'Angelo T, Cattaf A, Carerj ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118375 13. COVID-19 infection with delayed presentation of infective endocarditis of the prosthetic pulmonary valve. Cardiol. Young 2021:1-3Chimoriya R, Awasthy N, Kumar G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092265 14. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? Cardiovasc. Drugs Ther. 2021:1-14Castro P, Palomo M, Moreno-Castaño AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097193 15. Progress in cardiac research - from rebooting cardiac regeneration to a complete cell atlas of the heart. Cardiovasc Res 2021; Davidson SM, Padró T, Bollini S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114614 16. COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 2021; Pesce M, Agostoni P, Bøtker HE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117887 17. Pulmonary Vein Thrombosis in COVID-19. Chest 2021; 159:e361-e364Goddard SA, Tran DQ, Chan MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099150 18. Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea. Circulation 2021; Kang JM, Kim YE, Huh K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092115 19. Mechanisms of myocardial injury in COVID-19. Clin Chem 2021; Bularga A, Chapman AR, Mills NL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117871 20. Massive Pulmonary Embolism and Deep Vein Thrombosis in COVID-19 Pneumonia: Two Case Reports. Cureus 2021; 13:e14833Chopra S, Kaur J, Kaur M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104583 21. Rectus Sheath Hematoma Due to Low Molecular Weight Heparin in a COVID- 19 Patient in Turkey. Cureus 2021; 13:e14870Kalayci T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104600 22. Coronavirus Disease 2019 Infection as a Risk Factor for Infective Endocarditis. Cureus 2021; 13:e14813Kumanayaka D, Mutyala M, Reddy DV, Slim J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094767 23. Splenic Infarct Due to a Patent Foramen Ovale and Paradoxical Emboli Post- COVID-19 Infection: A Case Study. Cureus 2021; 13:e14887Norton EJ, Sheikh N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109076 24. Cardio-oncology Training in the COVID-19 Era. Curr. Treat. Options Oncol. 2021; 22:58Feldman S, Liu J, Steingart R, Gupta D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34097148 25. Heart rate variability moderates the effects of COVID-19-related stress and family adversity on emotional problems in adolescents: Testing models of differential susceptibility and diathesis stress. Dev. Psychopathol. 2021:1- 12Miller JG, Chahal R, Kirshenbaum JS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099071 26. Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in COVID-19 pandemic: a systematic review. Egypt J Neurol Psychiatr Neurosurg 2021; 57:67Kurnianto A, Tugasworo D, Andhitara Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093003 27. Contrast echocardiography facilitates appropriate management of hospitalized patients with coronavirus disease 2019 (COVID-19) and suspected right ventricular masses: case series. Eur Heart J Case Rep 2021; 5:ytaa575Botrous C, Bioh G, Patel A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104860 28. Impella 5.0 support before, during, and after surgical ventriculoplasty following acute myocardial infarction in the COVID-19 era: a case report. Eur Heart J Case Rep 2021; 5:ytab037Briani M, Torracca L, Crescenzi G, Barbone A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104861 29. Acute submassive pulmonary embolism after SARS-CoV-2 infection: a case report of reinfection or prolonged hypercoagulable state. Eur Heart J Case Rep 2021; 5:ytab103Pow T, Allen S, Brailovsky Y, Darki A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113773 30. Multimodality cardiac imaging for management of a cardiac mass in the era of COVID-19: a case report. Eur Heart J Case Rep 2021; 5:ytab062Ranjan P, LaRocca G, Sanz J, Croft L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104862 31. Gastroenteritis and cardiogenic shock in a healthcare worker: a case report of COVID-19 myocarditis confrmed with serology. Eur Heart J Case Rep 2021; 5:ytab013Sivalokanathan S, Foley M, Cole G, Youngstein T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104859 32. Bi-atrial thrombosis in a patient with SARS-CoV-2 infection: a case report. Eur Heart J Case Rep 2020; 4:1-5Torres R, Gul F, Azmaiparashvili Z, Patarroyo-Aponte G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104858 33. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Heart J Qual Care Clin Outcomes 2021; Harrison SL, Buckley BJR, Rivera-Caravaca JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107535 34. Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Rev Vaccines 2021:1-6Esba LCA, Al Jeraisy M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092166 35. Utility of Non-invasive Cardiac Imaging Assessment in Coronavirus Disease 2019. Front Cardiovasc Med 2021; 8:663864Hothi SS, Jiang J, Steeds RP, Moody WE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095253 36. Chronic Total Occlusion Percutaneous Coronary Intervention during the COVID-19 pandemic: Insights from the PROGRESS-CTO Registry. Hellenic J. Cardiol. 2021; Vemmou E, Alaswad K, Khatri JJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098128 37. Association between risk of VTE and mortality in patients with COVID-19. Int J Infect Dis 2021; Chen S, Zheng T, Wang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107325 38. Staged acute mesenteric and peripheral ischemia treatment in COVID-19 patient: Case report. Int. J. Surg. Case Rep. 2021; 84:106105Dinoto E, Ferlito F, La Marca MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119938 39. Chronic Cardio-Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID-19: A Multicenter, Retrospective, and Real-World Study. J Am Heart Assoc 2021:e018451Chen Q, Wang L, Li C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096317 40. Association of Kidney Disease With Outcomes in COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. J Am Heart Assoc 2021; 10:e020910Rao A, Ranka S, Ayers C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107743 41. T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study. J. Cardiovasc. Magn. Reson. 2021; 23:68Galea N, Marchitelli L, Pambianchi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107985 42. Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study. J. Cardiovasc. Magn. Reson. 2021; 23:77Gorecka M, McCann GP, Berry C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34112195 43. Intracerebral hemorrhage in COVID-19: A narrative review. J. Clin. Neurosci. 2021; 89:271-278Margos NP, Meintanopoulos AS, Filioglou D, Ellul J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119280 44. Successful treatment of acute spleno-porto-mesenteric vein thrombosis after ChAdOx1 nCoV-19 vaccine. A case report. J Crit Care 2021; 65:72-75Umbrello M, Brena N, Vercelli R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111682 45. Is venous thromboembolism a predictable marker in older patients with COVID-19 infection? A single-center observational study. J Infect Dev Ctries 2021; 15:639-345De Giorgi A, Contini C, Greco S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106886 46. Kawasaki like illness due to COVID-19: a review of the literature. J Infect Dev Ctries 2021; 15:630-638Fang Y, Aravamudan VM, Sridharan GK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106885 47. Evaluation of three commercial SARS-CoV-2 serology assays in a tertiary care hospital in the United Arab Emirates. J Infect Public Health 2021; 14:898- 902Alatoom A, Atef S, AbdelWareth L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34119842 48. MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or infammatory myelitis? J. Neurovirol. 2021:1-6Abrams RMC, Safavi F, Tuhrim S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101085 49. COVID-19 leukoencephalopathy with subacute magnetic resonance imaging fndings of vasculitis and demyelination. J. Neurovirol. 2021:1-6Vahedi A, Apap Mangion S, Silber E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101087 50. Cardio-Pulmonary Sequelae in Recovered COVID-19 Patients: Considerations for Primary Care. J. Prim. Care Community Health 2021; 12:21501327211023726Sarfraz Z, Sarfraz A, Barrios A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096390 51. Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J. Stroke Cerebrovasc. Dis. 2021; 30:105906Dias L, Soares-Dos-Reis R, Meira J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111775 52. Racial Disparities in Ischemic Stroke Among Patients with COVID-19 in the United States. J. Stroke Cerebrovasc. Dis. 2021; 30:105877Lekoubou A, Pelton M, Ba DM, Ssentongo P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102552 53. Late mesenteric ischemia after Sars-Cov-2 infection: case report. J Vasc Bras 2021; 20:e20200105de Macedo VSO, Moreira GB, de Albuquerque ACF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093678 54. Cardiovascular Complications Are Uncommon in Healthcare Workers With Mild or Asymptomatic COVID-19 Infection. JACC Cardiovasc. Imaging 2021; Berry C, Mangion K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119431 55. Coronary heart disease and COVID-19: A meta-analysis. Med Clin (Engl Ed) 2021; 156:547-554Liang C, Zhang W, Li S, Qin G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109276 56. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvasc. Res. 2021; 138:104196Çakmak F, Demirbuga A, Demirkol D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097919 57. Prevention of venous thromboembolism in COVID-19 outpatients. MMW- Fortschritte der Medizin 2021; 163:56-57Darius H, Grothues J, Haas S et al. 58. High frequency of endoluminal thrombus in patients with ischaemic stroke following SARS-CoV-2 infection. Neurologia 2021; Gómez-Porro P, Cabal-Paz B, Valenzuela-Chamorro S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103174 59. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologia (Engl Ed) 2021. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112621 60. Three-month functional prognosis of patients hospitalised due to acute ischaemic stroke in Aragon: regional analysis of the impact of COVID-19. Neurologia (Engl Ed) 2021; Tejada Meza H, Lambea Gil Á, Villar Yus C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099423 61. The cardiovascular complications in COVID-19: Focus on acute cardiac injury. Pak J Med Sci 2021; 37:908-912Saeed S, Rajani R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104187 62. Therapeutic targets of natural products for the management of cardiovascular symptoms of coronavirus disease 2019. Phytother. Res. 2021; Mohammadi Pour P, Farzaei MH, Soleiman Dehkordi E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34110678 63. Cardiac index is associated with oxygenation in COVID-19 acute respiratory distress syndrome. Pulm Circ 2021; 11:20458940211019626Poor HD, Rurak K, Howell D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104425 64. ANCA-associated vasculitis after COVID-19. Rheumatol. Int. 2021:1-7Izci Duran T, Turkmen E, Dilek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100115 65. Hemorrhage and venous thromboembolism in critically ill patients with COVID-19. SAGE Open Med 2021; 9:20503121211020167Qiu C, Li T, Wei G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104439 66. Evidence of a Blood Pressure Reduction During the COVID-19 Pandemic and Associated Lockdown Period: Insights from e-Health Data. Telemed J E Health 2021; Girerd N, Meune C, Duarte K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34101507 67. Cough from a cardiologic perspective. Ther. Umsch. 2021; 78:181-186Pavlicek- Bahlo M, Hunziker L. 68. Increased pulmonary embolism in patients with COVID-19: a case series and literature review. Trop Dis Travel Med Vaccines 2021; 7:16Hesam-Shariati S, Fatehi P, Abouzaripour M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34118995 69. Myocarditis following COVID-19 mRNA vaccination. Vaccine 2021; Abu Mouch S, Roguin A, Hellou E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092429

Diagnosis (4 articles)

1. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests. Epidemiol Infect 2021; 149:e140De Marco Verissimo C, O'Brien C, López Corrales J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099081 2. Pay attention to doctor-patient dialogues: Multi-modal knowledge graph attention image-text embedding for COVID-19 diagnosis. Inf Fusion 2021; 75:168-185Zheng W, Yan L, Gou C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093095 3. SARS-CoV-2 diagnosis: a single-centre experience. J. Med. Life 2021; 14:257- 261Maruntelu I, Caragea AM, Tizu M, Constantinescu I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104250 4. Simultaneous presence of the "bullseye" and "reversed halo" sign at CT of COVID-19 pneumonia: A case report. Radiol Case Rep 2021; Giannakis A, Móré D, Mangold DL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099964

DM-MS-Obesity (20 articles)

1. The Perfect Storm: Rapid Progression of Diabetic Ketoacidosis in Pediatric Diabetes in the Setting of COVID-19. AACE Clin Case Rep 2021; Modarelli R, Balikcioglu PG, Hendrix G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104714 2. Anticoagulation in the obese patient with COVID-19-associated venous thromboembolism. BMJ Case Rep. 2021; 14McCormick JP, Connaughton J, McDonnell N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116998 3. Perioperative challenges in managing a morbidly obese patient with COVID-19 undergoing an elective tracheostomy. BMJ Case Rep. 2021; 14Teah KM, Tsen SSY, Fong KK, Yeap TB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103307 4. Exploring support needs of people living with diabetes during the coronavirus COVID-19 pandemic: insights from a UK survey. BMJ Open Diabetes Res Care 2021; 9Sauchelli S, Bradley J, England C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099440 5. JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations. Cardiovasc Endocrinol Metab 2021; 10:80-88Menshawey R, Menshawey E, Alserr AHK, Abdelmassih AF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109302 6. Obesity as a Risk Factor for Severe Illness From COVID-19 in the Pediatric Population. Cureus 2021; 13:e14825Agarwal A, Karim F, Fernandez Bowman A, Antonetti CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094778 7. Effect of COVID-19-Associated Lockdown on Patients With Diabetic Retinopathy. Cureus 2021; 13:e14831Chatziralli I, Dimitriou E, Kazantzis D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094782 8. Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran. Diabetol. Metab. Syndr. 2021; 13:63Abdoli S, Silveira M, Doosti-Irani M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116721 9. Predictors of severe COVID-19 disease in patients with diabetes: a multicenter review. Endocr. Pract. 2021; Kristan MM, Kim YK, Nelson T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102308 10. Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives. Expert Rev. Endocrinol. Metab. 2021:1-9Rajpal A, Sayyed Kassem L, Aron DC. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096441 11. A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients. Front. Pharmacol. 2021; 12:666348Bousquet-Mélou A, Lespine A, Sutra JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093195 12. Problematic Use of Internet-Related Activities and Perceived Weight Stigma in Schoolchildren: A Longitudinal Study Across Different Epidemic Periods of COVID-19 in China. Front Psychiatry 2021; 12:675839Fung XCC, Siu AMH, Potenza MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108898 13. Diabetes and susceptibility to infections: implication for COVID-19. Immunology 2021; van Niekerk G, van der Merwe M, Engelbrecht AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115881 14. Chronic Cardio-Metabolic Disease Increases the Risk of Worse Outcomes Among Hospitalized Patients With COVID-19: A Multicenter, Retrospective, and Real-World Study. J Am Heart Assoc 2021:e018451Chen Q, Wang L, Li C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096317 15. Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study. J. Clin. Endocrinol. Metab. 2021; Faulds ER, Boutsicaris A, Sumner L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100545 16. Preadmission predictors of severe COVID-19 in patients with diabetes mellitus. J. Diabetes Complications 2021:107967Shukla AP, Tchang BG, Lam T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099384 17. Diabetes and COVID-19: The Past, The Present, and The Future. Metabolism 2021; 121:154814Pranata R, Henrina J, Raffaello WM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119537 18. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicenter study from Iran. Mycoses 2021; Pakdel F, Ahmadikia K, Salehi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096653 19. Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients. Open Forum Infect Dis 2021; 8:ofab195Antar AAR, Yu T, Pisanic N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095338 20. Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgrad. Med. J. 2021; Banerjee M, Pal R, Bhadada SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103372

Education and training and science (62 articles)

1. Simulated Patient Environment: A Training Tool for Healthcare Professionals in COVID-19 Era. Adv Med Educ Pract 2021; 12:579-585M VB, Arumugam MK, Debnath DJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104036 2. The Confict of Public Health Law and Civil Liberties The Role of Research Data and First Amendment Law. Am. J. Med. 2021; Harris CE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097887 3. Changes in sociocultural attitudes towards appearance, body image, eating attitudes and behaviours, physical activity, and quality of life in students before and during COVID-19 lockdown. Appetite 2021; 166:105452Baceviciene M, Jankauskiene R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107292 4. Innovations in education of the medical molecular biology curriculum during the COVID-19 pandemic in China. Biochem Mol Biol Educ 2021; Xie C, Huang C, Yang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111317 5. Deep Insight: Convolutional Neural Network and its Applications for COVID-19 Prognosis. Biomed. Signal Process. Control 2021:102814Khanday NY, Sof SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093724 6. Current knowledge of COVID-19: advances, challenges and future perspectives. Biosaf Health 2021; Wu Y, Peng Z, Yan Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104880 7. An analysis of school absences in England during the COVID-19 pandemic. BMC Med 2021; 19:137Southall E, Holmes A, Hill EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092228 8. Distance education during COVID 19: an Italian survey on the university teachers' perspectives and their emotional conditions. BMC Med. Educ. 2021; 21:335Casacchia M, Cifone MG, Giusti L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107926 9. Interns' perspectives on impacts of the COVID-19 pandemic on the medical school to residency transition. BMC Med. Educ. 2021; 21:330Winn AS, Weaver MD, O'Donnell KA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098966 10. Impact of COVID-19 on the mental health of US college students. BMC Psychol 2021; 9:95Lee J, Solomon M, Stead T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103081 11. Progress in cardiac research - from rebooting cardiac regeneration to a complete cell atlas of the heart. Cardiovasc Res 2021; Davidson SM, Padró T, Bollini S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114614 12. Nothing About Us Without Us - Towards Genuine Inclusion of Disabled Scientists and Science Students Post Pandemic. Chemistry (Easton) 2021; Sarju JP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101912 13. Knowledge, attitudes and practices of patients with chronic illnesses during the COVID-19 pandemic: A cross-sectional survey from Pakistan. Chronic Illn 2021:17423953211023961Mahmood MM, Rehman J, Arif B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107795 14. Making Meaning of Integrated Care during a Pandemic: Learning from Older Adults. Clin. Gerontol. 2021:1-17Beasley EA, Scott TL, Pachana NA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100336 15. Assessing school-based policy actions for COVID-19: An agent-based analysis of incremental infection risk. Comput. Biol. Med. 2021; 134:104518Zafarnejad R, Griffn PM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34102403 16. Cardio-oncology Training in the COVID-19 Era. Curr. Treat. Options Oncol. 2021; 22:58Feldman S, Liu J, Steingart R, Gupta D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34097148 17. COVID-19 Pandemic: Knowledge, Attitude And Perception Of Medical Students Towards The Novel Coronavirus Disease. Disaster Med Public Health Prep 2021:1-23Emara HE, Alhindi AA, Orebi HA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096491 18. "Doing What I can, but I got no Magic Wand:" A Snapshot of Early Childhood Educator Experiences and Efforts to Ensure Quality During the COVID-19 Pandemic. Early Child Educ J 2021:1-12Crawford A, Vaughn KA, Guttentag CL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092993 19. The Implications of COVID-19 for Early Childhood Education in Ethiopia: Perspectives from Parents and Caregivers. Early Child Educ J 2021:1-13Kim JH, Araya M, Hailu BH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092994 20. Initial Development of a National Survey on Remote Learning in Early Childhood During COVID-19: Establishing Content Validity and Reporting Successes and Barriers. Early Child Educ J 2021:1-13McKenna M, Soto-Boykin X, Cheng K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092995 21. Rethinking Home-School Partnerships: Lessons Learned from Latinx Parents of Young Children During the COVID-19 Era. Early Child Educ J 2021:1- 12Soltero-González L, Gillanders C. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092996 22. Preschoolers' Approaches to Learning and Family-school Connections During COVID-19: An Empirical Study Based on a Wuhan Sample. Early Child Educ J 2021:1-11Tan F, Gong X, Zhang X, Zhang R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092992 23. Academic and emotional effects of online learning during the COVID-19 pandemic on engineering students. Educ Inf Technol (Dordr) 2021:1-28Baltà- Salvador R, Olmedo-Torre N, Peña M, Renta-Davids AI. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108843 24. Adoption of online proctored examinations by university students during COVID-19: Innovation diffusion study. Educ Inf Technol (Dordr) 2021:1-20Raman R, B S, G V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093065 25. The survey about live broadcast teaching in Chinese middle schools during the COVID-19 Pandemic. Educ Inf Technol (Dordr) 2021:1-15Yu L, Lan M, Xie M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108845 26. EMJ COVID-19 monthly top fve. Emerg Med J 2021; Callanan R, Deasy C, Slowey J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103381 27. Challenges of higher education related to e-learning in developing countries during COVID-19 spread: a review of the perspectives of students, instructors, policymakers, and ICT experts. Environ. Sci. Pollut. Res. Int. 2021:1-7Zarei S, Mohammadi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100207 28. Anxiety and Social Support as Predictors of Student Academic Motivation During the COVID-19. Front. Psychol. 2021; 12:644338Camacho A, Correia N, Zaccoletti S, Daniel JR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108910 29. Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework. Front Public Health 2021; 9:638605Nymark P, Sachana M, Leite SB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095051 30. Profling COVID-19 Genetic Research: A Data-Driven Study Utilizing Intelligent Bibliometrics. Front Res Metr Anal 2021; 6:683212Wu M, Zhang Y, Grosser M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109284 31. Anxiety and depression among Kosovar university students during the initial phase of outbreak and lockdown of COVID-19 pandemic. Health Psychol Behav Med 2021; 9:239-250Arënliu A, Bërxulli D, Perolli-Shehu B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104559 32. E-Mentoring Female Underrepresented Public Health Student Researchers: Supporting a More Diverse Postpandemic Workforce. Health Secur 2021; Mahayosnand PP, Zanders L, Sabra ZM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34097467 33. Knowledge, Attitudes, and Practices Regarding COVID-19 prevention among Vietnamese Healthcare Workers in 2020. Health Serv Insights 2021; 14:11786329211019225Tien TQ, Tuyet-Hanh TT, Linh TNQ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103939 34. The role of ethics in science: a systematic literature review from the frst wave of COVID-19. Health Technol (Berl) 2021:1-9Maccaro A, Piaggio D, Pagliara S, Pecchia L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104626 35. The COVID-19 pandemic impact on pediatric surgery residency programs. Heliyon 2021; 7:e07199Gunadi, Balela N, Kalim AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095598 36. Psychological impacts of COVID-19 and satisfaction from online classes: disturbance in daily routine and prevalence of depression, stress, and anxiety among students of Pakistan. Heliyon 2021; 7:e07030Khawar MB, Abbasi MH, Hussain S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095563 37. The Challenge of Dental Education After COVID-19 Pandemic - Present and Future Innovation Study Design. Inquiry 2021; 58:469580211018293Clemente MP, Moreira A, Pinto JC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105420 38. Undergraduate nursing students' resilience, challenges, and supports during corona virus pandemic. Int. J. Ment. Health Nurs. 2021; Hamadeh Kerbage S, Garvey L, Willetts G, Olasoji M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109714 39. International nurse education leaders' experiences of responding to the COVID-19 pandemic: A qualitative study. J. Adv. Nurs. 2021; Ion R, Craswell A, Hughes L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105829 40. Association between perceived stress and depression among medical students during the outbreak of COVID-19: The mediating role of insomnia. J. Affect. Disord. 2021; 292:89-94Liu Z, Liu R, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107425 41. COVID-19 pandemic and its impact on peer review speed of anesthesiology journals: An observational study. J. Anaesthesiol. Clin. Pharmacol. 2021; 37:57- 62Behera BK, Radhakrishnan RV, Mohanty CR, Bellapukonda S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103824 42. Variations in Medical Students' Educational Preferences, Attitudes and Volunteerism during the COVID-19 Global Pandemic. J. Community Health 2021:1-9Appelbaum NP, Misra SM, Welch J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106370 43. Moving Medical Students into Shared Housing During the COVID-19 Pandemic. J Med Educ Curric Dev 2021; 8:23821205211018702Ludwig AB, Meholli MM, Baum SG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104790 44. Knowledge, attitude and practice towards COVID-19 among individuals with associated comorbidities. J. Med. Life 2021; 14:225-237Saeed S, Awasthi AA, Nandi D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104246 45. Knowledge and Perceptions of COVID-19 Among Health Care Professionals, Medical Students, and Dental Students in the GCC Region: A Cross-Sectional Correlational Study. J Multidiscip Healthc 2021; 14:1223-1232Abdulwahab M, Kamal M, AlAli AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103924 46. Time to reopen schools: COVID-19, health disparity and education. J Public Health (Oxf) 2021; Kahambing JGS. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109378 47. Exploration of Immersive Virtual Reality in Teaching Veterinary Orthopedics. J. Vet. Med. Educ. 2021:e20210009McCaw K, West A, Duncan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102095 48. Development of a Coronavirus Disease 2019 (COVID-19) Application Ontology for the Accrual to Clinical Trials (ACT) network. JAMIA Open 2021; 4:ooab036Visweswaran S, Samayamuthu MJ, Morris M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113801 49. Building Primary-School Children's Resilience through a Web-Based Interactive Learning Environment: Quasi-Experimental Pre-Post Study. JMIR Pediatr Parent 2021; 4:e27958Nicolaidou I, Stavrou E, Leonidou G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106080 50. Dual attention multiple instance learning with unsupervised complementary loss for COVID-19 screening. Med. Image Anal. 2021; 72:102105Chikontwe P, Luna M, Kang M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102477 51. Development of a Virtual Journal Club in Anatomy: a Responsive Pandemic Pedagogy. Med Sci Educ 2021:1-8Keet KA, Baatjes KJ, Venter RG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094692 52. Exploring the STEP-uP to practice: A survey of UK Lead Midwives for Education views of the STudent midwife Extended Practice Placement during the frst wave of the COVID-19 pandemic. Midwifery 2021; 101:103048Cooke A, Hancock A, White H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111806 53. Building bridges and capacity for Black, Indigenous, and scholars of color in the era of COVID-19 and Black Lives Matter. Nurs. Outlook 2021; Crooks N, Smith A, Lofton S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092370 54. Mental Disorders of Bangladeshi Students During the COVID-19 Pandemic: A Systematic Review. Psychol. Res. Behav. Manag. 2021; 14:645-654Al Mamun F, Hosen I, Misti JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104010 55. Anticipated impact of stem cell and other cellular medicine clinical trials for COVID-19. Regen. Med. 2021; Kim M, Knoepfer PS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114493 56. Dental Professional's Knowledge, Preventive Awareness and Attitude Towards COVID-19 in Saudi Arabia: A Cross-Sectional Survey. Risk Manag. Healthc. Policy 2021; 14:2277-2288Alwazzan RA, Baseer MA, OM AL, Ingle NA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104018 57. [Doing, planning, "planning-doing:" a case of municipal pragmatism in collaboration with a university during the COVID-19 pandemic]. Salud Colect 2021; 17:e3341Slomp Junior H, Coelho KSC, Barros DM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105329 58. [Student nurses faced with the palliative care approach]. Soins 2021; 66:51Hérisson B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103138 59. Effects of the COVID-19 crisis on survey feldwork: Experience and lessons from two major supplements to the U.S. Panel Study of Income Dynamics. Surv Res Methods 2020; 14:241-245Sastry N, McGonagle K, Fomby P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093884 60. Developments in work-related upper limb disorders (WRULD) amongst Dutch university students from 2004 to 2014. Work 2021; Dekker MC, Egmond RV, Molenbroek JFM, Vink P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092687 61. Higher education students' behaviour and mental health during Covid-19 lockdown: a pilot study. Z Gesundh Wiss 2021:1-7Mishra L, Kumar NP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094814 62. Annual meeting of the German Society for Rheumatology going virtual— successfully defying the pandemic. Z. Rheumatol. 2021; 80:399-407Richter JG, Chehab G, Knitza J et al.

Elderly (18 articles)

Epidemiology (89 articles)

1. Understanding the cycles of COVID-19 incidence: Principal Component Analysis and interaction of biological and socio-economic factors. Ann Med Surg (Lond) 2021; 66:102437Duarte P, Riveros-Perez E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094532 2. COVID-19 and sunlight: Impact on SARS-CoV-2 transmissibility, morbidity, and mortality. Ann Med Surg (Lond) 2021; 66:102419Sharun K, Tiwari R, Dhama K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094531 3. Infection vulnerability stratifcation risk modelling of COVID-19 data: a deterministic SEIR epidemic model analysis. Ann Oper Res 2021:1-27Kumar A, Choi TM, Wamba SF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103780 4. Status evaluation of provinces affected by COVID-19: A qualitative assessment using fuzzy system. Appl Soft Comput 2021; 109:107540Ghosh B, Biswas A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093096 5. Forecasting the spread of COVID-19 using LSTM network. BMC Bioinformatics 2021; 22:316Kumar S, Sharma R, Tsunoda T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112086 6. The role of SARC-F scale in predicting progression risk of COVID-19 in elderly patients: a prospective cohort study in Wuhan. BMC Geriatr. 2021; 21:355Ma Y, He M, Hou LS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112103 7. Pathogenesis-based preexposure prophylaxis associated with a low risk of SARS-CoV-2 infection in healthcare workers at a designated COVID-19 hospital: a pilot study. BMC Infect. Dis. 2021; 21:536Dubina MV, Gomonova VV, Taraskina AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098889 8. The African Network for Improved Diagnostics, Epidemiology and Management of common infectious Agents. BMC Infect. Dis. 2021; 21:539Schubert G, Achi V, Ahuka S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34098893 9. Containing pandemics through targeted testing of households. BMC Infect. Dis. 2021; 21:548Voigt A, Martyushenko N, Karlsen E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107917 10. Predicting the incidence of COVID-19 using data mining. BMC Public Health 2021; 21:1087Ahouz F, Golabpour A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34098928 11. Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020. BMC Public Health 2021; 21:1105Holden TM, Richardson RAK, Arevalo P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107947 12. COVID-19 and non-communicable diseases in the Eastern Mediterranean Region: the need for a syndemics approach to data reporting and healthcare delivery. BMJ Glob Health 2021; 6Nassereddine G, Habli S, Slama S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103327 13. The secondary transmission pattern of COVID-19 based on contact tracing in Rwanda. BMJ Glob Health 2021; 6Semakula M, Niragire F, Umutoni A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103325 14. Designing COVID-19 mortality predictions to advance clinical outcomes: Evidence from the Department of Veterans Affairs. BMJ Health Care Inform 2021; 28Makridis CA, Strebel T, Marconi V, Alterovitz G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108143 15. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the frst wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland. BMJ Open 2021; 11:e051415Faller E, Wyse A, Barry R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103324 16. SARS-CoV-2 seroprevalence in students and teachers: a longitudinal study from May to October 2020 in German secondary schools. BMJ Open 2021; 11:e049876Kirsten C, Unrath M, Lück C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34112645 17. New Brazilian variant of the SARS-CoV-2 (P1) of COVID-19 in Alagoas state. Braz. J. Infect. Dis. 2021:101588da Silva JC, Félix VB, Leão S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102147 18. Modeling and controlling the spread of epidemic with various social and economic scenarios. Chaos Solitons Fractals 2021; 148:111046Gandzha IS, Kliushnichenko OV, Lukyanets SP. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103789 19. Nonlinear control of infection spread based on a deterministic SEIR model. Chaos Solitons Fractals 2021; 149:111051Piccirillo V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108820 20. Study on the mathematical modelling of COVID-19 with Caputo-Fabrizio operator. Chaos Solitons Fractals 2021:111121Rahman MU, Ahmad S, Matoog RT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108819 21. Reporting of Infectious Diseases in the United States During the COVID-19 Pandemic. Clin Infect Dis 2021; Crane MA, Popovic A, Panaparambil R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097015 22. Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program. Clin Infect Dis 2021; Stone M, Di Germanio C, Wright DJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111244 23. Assessing school-based policy actions for COVID-19: An agent-based analysis of incremental infection risk. Comput. Biol. Med. 2021; 134:104518Zafarnejad R, Griffn PM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34102403 24. Case numbers beyond contact tracing capacity are endangering the containment of COVID-19. Deutsches Arzteblatt International 2020; 117:790- 791Linden M, Dehning J, Mohr SB et al. 25. A Bibliometric Analysis of Covid-19 and the Association with the Number of Total Cases. Disaster Med Public Health Prep 2021:1-24Pasin O, Pasin T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100348 26. Study of SEIR epidemic model and scenario analysis of COVID-19 pandemic. Ecol Genet Genom 2021; 19:100087Paul S, Mahata A, Ghosh U, Roy B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095599 27. Did Covid-19 hit harder in peripheral areas? The case of Italian municipalities. Econ. Hum. Biol. 2021; 42:101018Armillei F, Filippucci F, Fletcher T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098432 28. [First importations of SARS-CoV-2 P.1 and P.2 variants from Brazil to Spain and early community transmission]. Enferm. Infecc. Microbiol. Clin. 2021; Campoy PJS, Buenestado-Serrano S, Pérez-Lago L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099945 29. Reductions of migrant population reduces the number of COVID-19 epidemic: a case study in China. Environ. Sci. Pollut. Res. Int. 2021:1-11Han L, Jia J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114147 30. Ethics Guidance for Environmental Scientists Engaged in Surveillance of Wastewater for SARS-CoV-2. Environ. Sci. Technol. 2021; Hrudey SE, Silva DS, Shelley J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101444 31. The land of the Lotus-eaters in the COVID-19 epidemic. Eur J Cardiothorac Surg 2021; Bertolaccini L, Spaggiari L. http://www.ncbi.nlm.nih.gov/pubmed/? term=34118151 32. Different approaches to quantify years of life lost from COVID-19. Eur. J. Epidemiol. 2021:1-9Ferenci T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114188 33. The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states. Eur. J. Epidemiol. 2021:1-12Pozo-Martin F, Weishaar H, Cristea F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114189 34. The SARS-CoV-2 B.1.351 lineage (VOC β) is outgrowing the B.1.1.7 lineage (VOC α) in some French regions in April 2021. Euro Surveill 2021; 26Roquebert B, Trombert-Paolantoni S, Haim-Boukobza S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114541 35. Challenges Caused by Imported Cases Abroad for the Prevention and Control of COVID-19 in China. Front Med (Lausanne) 2021; 8:573726Zhu J, Zhang Q, Jia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095156 36. Epidemiology Characteristics of COVID-19 Infection Amongst Primary Health Care Workers in Qatar: March-October 2020. Front Public Health 2021; 9:679254Al-Kuwari MG, AbdulMalik MA, Al-Nuaimi AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095077 37. Pragmatic Use of Planetary Health and Nature-Based Solutions for Future Pandemics Using COVID-19 Case Scenario. Front Public Health 2021; 9:620120Boriani E, Aragrande M, Canali M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095046 38. The Long-Term Presence of SARS-CoV-2 on Cold-Chain Food Packaging Surfaces Indicates a New COVID-19 Winter Outbreak: A Mini Review. Front Public Health 2021; 9:650493Chi Y, Wang Q, Chen G, Zheng S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095057 39. COVID-19 among Minority Children in Detroit, Michigan during the Early National Surge of the Pandemic. Glob Pediatr Health 2021; 8:2333794x211022710Ang JY, Kannikeswaran N, Parker K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104706 40. Using SNSs for early detection of disease outbreak in developing countries: evidence from COVID-19 pandemic in Nigeria. Heliyon 2021; 7:e07184Adebisi T, Aregbesola A, Asamu F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099986 41. Imagination and remembrance: what role should historical epidemiology play in a world bewitched by mathematical modelling of COVID-19 and other epidemics? Hist Philos Life Sci 2021; 43:81Heriot GS, Jamrozik E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100155 42. Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area - a population-based registry study. Infect Dis (Lond) 2021:1-11Forsblom E, Silén S, Kortela E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100692 43. Health Sentinel: A mobile crowdsourcing platform for self-reported surveys provides early detection of COVID-19 clusters in San Luis Potosí, Mexico. Int. J. Med. Inform. 2021; 153:104508Ruiz-Correa S, López-Revilla R, Díaz-Barriga F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098316 44. A Cross-Sectional Analysis of Demographic and Behavioral Risk Factors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Among a Sample of U.S. College Students. J. Adolesc. Health 2021; Kianersi S, Ludema C, Macy JT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112598 45. Epidemiology and Outcomes of COVID-19 in Home Dialysis Patients Compared with In-Center Dialysis Patients. J Am Soc Nephrol 2021; Hsu CM, Weiner DE, Aweh G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108232 46. Addressing the global surge of COVID-19 cases: Insights from diagnostics, improved treatment strategies, vaccine development and application. J Clin Transl Res 2021; 7:127-139Adedokun KA, Olarinmoye AO, Olayemi LO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104816 47. Probabilistic forecasts of COVID-19 deaths with the progression rate from pneumonia to ARDS: An open-data-based global study. J Formos Med Assoc 2021; Chang WJ, Chen YC, Hsu CY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34116895 48. Estimating global burden of COVID-19 with disability-adjusted life years and value of statistical life metrics. J Formos Med Assoc 2021; Fan CY, Fann JC, Yang MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119392 49. Preparedness for containing COVID-19 outbreak in mass religious gathering with non-pharmaceutical interventions (NPIs). J Formos Med Assoc 2021; Hsu CY, Chen YM, Su CW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119393 50. Continental transmission of emerging COVID-19 on the 38° north latitude. J Formos Med Assoc 2021; Ku MS, Huang LM, Chiu SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112588 51. Healthcare workers acquired COVID-19 disease from patients? An investigation by phylogenomics. J Hosp Infect 2021; Chun-Wai Wong R, Lee MK, Kit-Hang Siu G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098050 52. Risk factors for SARS-CoV-2 transmission in non-household clusters. J Infect 2021; Noh JY, Song JY, Hyun HJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34116074 53. Trends of Epidemiological and Demographic Indicators of COVID-19 in India. J Infect Dev Ctries 2021; 15:618-624Gupta MK, Bhardwaj P, Goel AD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106883 54. Epidemiology of COVID-19 in Indonesia: common source and propagated source as a cause for outbreaks. J Infect Dev Ctries 2021; 15:646-652Hikmawati I, Setiyabudi R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106887 55. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia. J Infect Public Health 2021; 14:832-838Alharbi NK, Alghnam S, Algaissi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118732 56. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID- 19 patients. J Infect Public Health 2021; 14:845-851Chen Y, Li P, Ding Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118734 57. Nonlinear dynamics for the spread of pathogenesis of COVID-19 pandemic. J Infect Public Health 2021; 14:817-831Sharma SK, Bangia A, Alshehri M, Bhardwaj R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118731 58. COVID-19 prevalence forecasting using Autoregressive Integrated Moving Average (ARIMA) and Artifcial Neural Networks (ANN): Case of Turkey. J Infect Public Health 2021; 14:811-816Toğa G, Atalay B, Toksari MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118730 59. Demographic and territorial characteristics of COVID-19 cases and excess mortality in the European Union during the frst wave. J Popul Res (Canberra) 2021:1-24Goujon A, Natale F, Ghio D, Conte A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093083 60. Closed but Not Protected: Excess Deaths Among the Amish and Mennonites During the COVID-19 Pandemic. J Relig Health 2021:1-15Stein RE, Corcoran KE, Colyer CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117598 61. Seroprevalence of COVID-19 and associated factors in a medical institution in Pakistan. J Taibah Univ Med Sci 2021; Naiyar I, Anjum AF, Khalid AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093105 62. SARS-CoV2 spike protein gene variants with N501T and G142D mutation- dominated infections in mink in the United States. J. Vet. Diagn. Invest. 2021:10406387211023481Cai HY, Cai A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109885 63. Associations with COVID-19 Symptoms, Prevention Interest, and Testing Among Sexual and Gender Minority Adults in a Diverse National Sample. LGBT Health 2021; Phillips G, 2nd, Xu J, Ruprecht MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115955 64. COVID-19 outbreak in India: an SEIR model-based analysis. Nonlinear Dyn 2021:1-25Saikia D, Bora K, Bora MP. http://www.ncbi.nlm.nih.gov/pubmed/? term=34108815 65. RLIM: a recursive and latent infection model for the prediction of US COVID-19 infections and turning points. Nonlinear Dyn 2021:1-14Yu X, Lu L, Shen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092919 66. Coastal vulnerability analysis to support strategies for tackling COVID-19 infection. Ocean Coast Manag 2021; 211:105731Armenio E, Mossa M, Petrillo AF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092937 67. Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community. Open Forum Infect Dis 2021; 8:ofaa531Appa A, Takahashi S, Rodriguez-Barraquer I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109255 68. Epidemiological, imaging, laboratory, and clinical characteristics and factors related to mortality in patients with COVID-19: a single-center study. Osong Public Health Res Perspect 2021; Azarkar Z, Salehiniya H, Kazemi T, Abbaszadeh H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102047 69. A spatial analysis of the association between social vulnerability and the cumulative number of confrmed deaths from COVID-19 in United States counties through November 14, 2020. Osong Public Health Res Perspect 2021; Sung B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102048 70. Clinical and epidemiological characteristics and outcomes of patients hospitalized for COVID-19 in Douala, Cameroon. Pan Afr. Med. J. 2021; 38:246Mekolo D, Bokalli FA, Chi FM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104294 71. SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020. Pathology 2021; Craigie A, McGregor R, Whitcombe AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119335 72. [COVID-19: critical appraisal of the evidence]. An Pediatr (Barc) 2021; Rodríguez PG, Agapito BP, Rodríguez MSA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099961 73. What factors underlie attitudes regarding protective mask use during the COVID-19 pandemic? Pers. Individ. Dif. 2021; 181:111038Mallinas SR, Maner JK, Ashby Plant E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092834 74. Resurgence of COVID-19 in India: time for introspection. Postgrad. Med. J. 2021; Pal R, Yadav U. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103376 75. COVID-19 in India: Who are we leaving behind? Prog Disaster Sci 2021; 10:100163Raju E, Dutta A, Ayeb-Karlsson S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34095809 76. Perceptions of the COVID-19 pandemic in Japan with respect to cultural, information, disaster and social issues. Prog Disaster Sci 2021; 10:100158Suppasri A, Kitamura M, Tsukuda H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095808 77. Universal COVID-19 testing and a three-space triage protocol is associated with a nine-fold decrease in possible nosocomial infections in an inpatient psychiatric facility. Psychiatry Res 2021; 302:114036Brody BD, Shi Z, Shaffer C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098157 78. SARS-CoV-2 contact tracing among disadvantaged populations during epidemic intervals should be a priority strategy: results from a pilot experiment in Barcelona. Public Health 2021; 195:132-134Vallès X, Roure S, Valerio L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111802 79. The application of K-means clustering for province clustering in Indonesia of the risk of the COVID-19 pandemic based on COVID-19 data. Qual Quant 2021:1-9Abdullah D, Susilo S, Ahmar AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103768 80. SARS-CoV‑2 incidental fndings among Hamburg deaths: an epidemiological monitoring during the dynamic infection event in spring 2020. Rechtsmedizin 2021; Klein A, Langenwalder F, Heinrich F et al. 81. Steady state Kalman flter design for cases and deaths prediction of Covid-19 in Greece. Results Phys 2021; 26:104391Assimakis N, Adam M, Ktena A, Manasis C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104629 82. Controlling of pandemic COVID-19 using optimal control theory. Results Phys 2021; 26:104311Seddighi Chaharborj S, Seddighi Chaharborj S, Hassanzadeh Asl J, Phang PS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094820 83. Time-variant reliability-based prediction of COVID-19 spread using extended SEIVR model and Monte Carlo sampling. Results Phys 2021; 26:104364Shadabfar M, Mahsuli M, Sioofy Khoojine A, Hosseini VR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094819 84. Are Epidemiological Estimates Able to Describe the Ability of Health Systems to Cope with COVID-19 Epidemic? Risk Manag. Healthc. Policy 2021; 14:2221- 2229Castaldi S, Luconi E, Rivieccio BA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104013 85. Risk and resilience of vulnerable families in Hong Kong under the impact of COVID-19: an ecological resilience perspective. Soc. Psychiatry Psychiatr. Epidemiol. 2021:1-12Zhuang X, Lau YY, Chan WMH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100978 86. Variation and correlation between ultraviolet index and tropospheric ozone during COVID-19 lockdown over megacities of India. Stoch. Environ. Res. Risk Assess. 2021:1-19Bera B, Bhattacharjee S, Shit PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093082 87. Indoors ventilation in times of confnement by SARS-CoV-2 epidemic: A comparative approach between Spain and Italy. Sustain Cities Soc 2021; 72:103051Lepore E, Aguilera Benito P, Piña Ramírez C, Viccione G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099968 88. Infuence of Transportation Network on Transmission Heterogeneity of COVID- 19 in China. Transp Res Part C Emerg Technol 2021; 129:103231Lu J, Lin A, Jiang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092940 89. Racial equity in the fght against COVID-19: a qualitative study examining the importance of collecting race-based data in the Canadian context. Trop Dis Travel Med Vaccines 2021; 7:15Ahmed R, Jamal O, Ishak W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112261

Gastro-enterology (17 articles)

1. [Management of cholelithiasis in times of COVID-19. A challenge for the system]. Cir Esp 2021; Mikel P, Irene O, Maria BJ, Benedetto I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092800 2. A Case of COVID-19 Re-Infection in a Liver Transplant Patient. Cureus 2021; 13:e14916Mohseni M, Albus M, Kaminski A, Harrison MF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113522 3. COVID-19 Pandemic Increased Anxiety Among Patients with Infammatory Bowel Disease: A Patient Survey in a Tertiary Referral Center. Dig. Dis. Sci. 2021:1-6Stone ML, Feng M, Forster EM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34115232 4. Gastroenteritis and cardiogenic shock in a healthcare worker: a case report of COVID-19 myocarditis confrmed with serology. Eur Heart J Case Rep 2021; 5:ytab013Sivalokanathan S, Foley M, Cole G, Youngstein T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104859 5. The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19. Front Mol Biosci 2021; 8:666054Li H, Li J, Xiao W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109213 6. The Heterogenous Effect of COVID-19 on Liver Transplantation Activity and Waitlist Mortality in the United States. Front Surg 2021; 8:669129Yuan Q, Haque O, Coe TM, Markmann JF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095209 7. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut Microbes 2021; 13:1- 15Newsome RC, Gauthier J, Hernandez MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100340 8. Diagnosis of Suspected Small Bowel Bleeding by Capsule Endoscopy in Patients with COVID-19. Intern Med 2021; Li L, Yang L, Li J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092734 9. Autoimmune hepatitis following sars-cov-2 VACCINE: MAY not be a casualty. J Hepatol 2021; Rocco A, Sgamato C, Compare D, Nardone G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116081 10. An examination of gastrointestinal absorption using the acetaminophen absorption test in critically ill patients with COVID-19: A retrospective cohort study. Nutr. Clin. Pract. 2021; Southren DL, Nardone AD, Haastrup AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101267 11. SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19. Open Forum Infect Dis 2021; 8:ofab205Wong GL, Yip TC, Wong VW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099979 12. [SARS-CoV-2 infection and COVID‒19 in Gaucher disease: indications for vaccination]. Orv. Hetil. 2021; 162:938-942Maródi L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120104 13. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation. Saudi J. Gastroenterol. 2021; Alqahtani SA, Barry M, Memish Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100388 14. Investigation of droplets released during digestive endoscopy using a high- speed camera (with video): a pilot study. Surg. Endosc. 2021:1-5Lee DS, Jeong JB, Kim JW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115216 15. Prevalence of COVID-19 in patients with autoimmune liver disease in Europe: A patient-oriented online survey. United European Gastroenterol J 2021; Zecher BF, Buescher G, Willemse J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34105883 16. Liver injury in COVID-19: clinical features and treatment management. Virol J 2021; 18:121Yu D, Du Q, Yan S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34108015 17. COVID-19 in normal, diseased and transplanted liver. World J. Gastroenterol. 2021; 27:2576-2585Signorello A, Lenci I, Milana M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092976

Guidelines (6 articles)

1. Validation Checklist for Massive Vaccination Cente. Ann. Ig. 2021; Capolongo S, Brambilla A, Girardi A, Signorelli C. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113951 2. Pediatric Pulmonary Function Testing in COVID-19 Pandemic and Beyond. A Position Statement From the Hellenic Pediatric Respiratory Society. Front Pediatr 2021; 9:673322Fouzas S, Gidaris D, Karantaglis N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095031 3. Mental Health and Psychosocial Support During COVID-19: A Review of Health Guidelines in Sub-Saharan Africa. Front Psychiatry 2021; 12:571342Molebatsi K, Musindo O, Ntlantsana V, Wambua GN. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093251 4. Emerging Science, Personal Protective Equipment Guidance, and Resource Scarcity: Inaction and Inequity for Workers in Essential Industries. Health Secur 2021; Lowe AE, Dineen KK, Herstein JJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107779 5. Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe. Risk Manag. Healthc. Policy 2021; 14:2421-2433Kniepeiss D, Jantscher L, Al-Sharafy S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113196 6. Perceptions of the Health Care Workers about the Guideline Implemented for Safe Surgical Practice during COVID-19 Pandemic in a University Teaching Hospital. Surg J (N Y) 2021; 7:e73-e82Iyer S, Subramaniam S, Thankappan K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104719

Imaging (36 articles)

1. CT angiography of abdomen and pelvis in critically ill COVID-19 patients: imaging fndings and correlation with the CT chest score. Abdom Radiol (NY) 2021:1-11Vadvala HV, Shan A, Fishman EK, Gawande RS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115186 2. Clinical, laboratory, and chest CT features of severe versus non-severe pediatric patients with COVID-19 infection among different age groups. BMC Infect. Dis. 2021; 21:560Hoseinyazdi M, Esmaeilian S, Jahankhah R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118894 3. Remote screening of diabetic retinopathy using ultra-widefeld retinal imaging. Diabetes Res Clin Pract 2021:108902Kato A, Fujishima K, Takami K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102247 4. Neurological manifestations and neuroimaging fndings in patients with SARS-CoV2-a systematic review. Egypt J Neurol Psychiatr Neurosurg 2021; 57:68Mohan N, Fayyaz MA, Del Rio C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093004 5. Contrast echocardiography facilitates appropriate management of hospitalized patients with coronavirus disease 2019 (COVID-19) and suspected right ventricular masses: case series. Eur Heart J Case Rep 2021; 5:ytaa575Botrous C, Bioh G, Patel A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104860 6. Multimodality cardiac imaging for management of a cardiac mass in the era of COVID-19: a case report. Eur Heart J Case Rep 2021; 5:ytab062Ranjan P, LaRocca G, Sanz J, Croft L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104862 7. Chest radiograph characteristics in COVID-19 infection and their association with survival. Eur J Radiol Open 2021; 8:100360Colman J, Zamfr G, Sheehan F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095358 8. COVID-FACT: A Fully-Automated Capsule Network-Based Framework for Identifcation of COVID-19 Cases from Chest CT Scans. Front Artif Intell 2021; 4:598932Heidarian S, Afshar P, Enshaei N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113843 9. Utility of Non-invasive Cardiac Imaging Assessment in Coronavirus Disease 2019. Front Cardiovasc Med 2021; 8:663864Hothi SS, Jiang J, Steeds RP, Moody WE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095253 10. Lung Ultrasound Score as a Predictor of Mortality in Patients With COVID-19. Front Cardiovasc Med 2021; 8:633539Sun Z, Zhang Z, Liu J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113658 11. Autonomous Robotic Point-of-Care Ultrasound Imaging for Monitoring of COVID-19-Induced Pulmonary Diseases. Front Robot AI 2021; 8:645756Al-Zogbi L, Singh V, Teixeira B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113656 12. Lung ultrasound score as a tool to monitor disease progression and detect ventilator-associated pneumonia during COVID-19-associated ARDS. Heart Lung 2021; 50:700-705Dargent A, Chatelain E, Si-Mohamed S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107394 13. COVID-19 pulmonary consolidations detection in chest X-ray using progressive resizing and transfer learning techniques. Heliyon 2021; 7:e07211Bhatt A, Ganatra A, Kotecha K. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109279 14. Why is it important to report early possible COVID-19 PET/CT fndings in cancer patients? Explaining with a case series. Indian J. Cancer 2021; 58:248- 258Tekin D, Budak E, Yoldas B, Budak A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34100412 15. CT appearances, patterns of progression, and follow-up of COVID-19: evaluation on thin-section CT. Insights Imaging 2021; 12:73Guan CS, Lv ZB, Li JJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110540 16. Algorithm for the Diagnosis and Management of the Multisystem Infammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease (COVID- 19). Int J Clin Pract 2021:e14471Emeksiz S, Çelikel Acar B, Kibar AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107136 17. Comparison of Rapid Antibody Test and Thorax Computed Tomography Results in Patients who Underwent RT-PCR with the Pre-Diagnosis of COVID- 19. Int J Clin Pract 2021:e14524Kızıloglu I, Sener A, Siliv N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120388 18. Relationship Between Chest Computed Tomography Findings and Clinical Conditions of Coronavirus Disease (COVID-19): A Multicentre Experience. Int J Clin Pract 2021:e14459Yılmaz Demirci N, Uğraş Dikmen A, Taşçı C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105857 19. Subpleural Curvilinear Shadows Associated with COVID-19. Intern Med 2021; Fujita J, Nakamura H, Miyagi K, Tateyama M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092732 20. T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study. J. Cardiovasc. Magn. Reson. 2021; 23:68Galea N, Marchitelli L, Pambianchi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107985 21. Modifed lung ultrasound scoring system to evaluate the feasibility of pregnant women with COVID-19 pneumonia. J Matern Fetal Neonatal Med 2021:1-6Zhang Y, Lyu G, Kang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096434 22. Deep Learning on Chest X-ray Images to Detect and Evaluate Pneumonia Cases at the Era of COVID-19. J Med Syst 2021; 45:75Hammoudi K, Benhabiles H, Melkemi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101042 23. COVID-19 leukoencephalopathy with subacute magnetic resonance imaging fndings of vasculitis and demyelination. J. Neurovirol. 2021:1-6Vahedi A, Apap Mangion S, Silber E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101087 24. Reduced retinal vessel density in COVID-19 patients and elevated D-dimer levels during the acute phase of the infection. Med Clin (Engl Ed) 2021; 156:541- 546Guemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109275 25. COVID-19 Diagnosis on CT Scan Images Using a Generative Adversarial Network and Concatenated Feature Pyramid Network with an Attention Mechanism. Med. Phys. 2021; Li Z, Zhang J, Li B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117783 26. Truncating a densely connected convolutional neural network with partial layer freezing and feature fusion for diagnosing COVID-19 from chest X-rays. MethodsX 2021; 8:101408Montalbo FJP. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109106 27. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvasc. Res. 2021; 138:104196Çakmak F, Demirbuga A, Demirkol D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097919 28. Epidemiological, imaging, laboratory, and clinical characteristics and factors related to mortality in patients with COVID-19: a single-center study. Osong Public Health Res Perspect 2021; Azarkar Z, Salehiniya H, Kazemi T, Abbaszadeh H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102047 29. Characteristics of chest high resolution computed tomography images of COVID-19: A retrospective study of 46 patients. Pak J Med Sci 2021; 37:840- 845Lu Y, Zhou J, Mo Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104175 30. Lung Segmentation and Automatic Detection of COVID-19 Using Radiomic Features from Chest CT Images. Pattern Recognit 2021:108071Zhao C, Xu Y, He Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092815 31. [CME Sonography 98: Chest Ultrasound]. Praxis (Bern 1994) 2021; 110:453- 459Bürge T, Tuma J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107766 32. [COVID-19 and Pulmonary Ultrasound: An Innovative Approach to the Disease in the GP's Offce]. Praxis (Bern 1994) 2021; 110:431-437Griffa A, Rezzonico S, Giongo A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107760 33. [POCUS - Thoracic Sonography in Times of Corona: What Sonographing Family Physicians Should Examine]. Praxis (Bern 1994) 2021; 110:439-448Horn R, Mathis G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107764 34. [Strong Increase in Lung Ultrasound Due to COVID-19]. Praxis (Bern 1994) 2021; 110:427-430Mathis G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107759 35. Are Lung Ultrasound Findings in COVID-19 Pneumonia Typical or Specifc? Praxis (Bern 1994) 2021; 110:421-425Volpicelli G, Cardinale L, Fraccalini T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107756 36. Simultaneous presence of the "bullseye" and "reversed halo" sign at CT of COVID-19 pneumonia: A case report. Radiol Case Rep 2021; Giannakis A, Móré D, Mangold DL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099964

Immune response (56 articles)

1. Can We Protect Those We Care for in A Pandemic? - Prevalence of Neutralizing Antibodies against SARS-CoV-2 in Nursing Homes. Aging Dis 2021; 12:710-717Willschke H, Wochele-Thoma T, Atanasov AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094636 2. Multisystem infammatory syndrome in children with COVID-19. Am J Emerg Med 2021; 49:148-152Gottlieb M, Bridwell R, Ravera J, Long B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116467 3. Antibody persistency and trend post-SARS-CoV-2 infection at eight months. Ann. Ig. 2021; Dehgani-Mobaraki P, Kamber Zaidi A, Porreca A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113953 4. Combination of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Diagnosis. Ann Lab Med 2021; 41:568-576Aoki K, Takai K, Nagasawa T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108284 5. Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic infammatory conditions and immunosuppressive therapy in a monocentric cohort'. Ann. Rheum. Dis. 2021; Veenstra J, Wang J, McKinnon-Maksimowicz K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112654 6. Autoimmunity and COVID-19 - The microbiotal connection. Autoimmun Rev 2021:102865Katz-Agranov N, Zandman-Goddard G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118455 7. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers. BMC Infect. Dis. 2021; 21:544Jackson-Thompson BM, Goguet E, Laing ED et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107889 8. COVID-19 related multisystem infammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar. BMC Pediatr. 2021; 21:267Hasan MR, Al Zubaidi K, Diab K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103044 9. Immune responses and therapeutic challenges in paediatric patients with new- onset acute myeloid leukaemia and concomitant COVID-19. Br. J. Haematol. 2021; Patel PA, Lapp SA, Grubbs G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096051 10. COVID-19 and Immunothrombosis: emerging understanding and clinical management. Br. J. Haematol. 2021; Shaw RJ, Bradbury C, Abrams ST et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114204 11. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? Cardiovasc. Drugs Ther. 2021:1-14Castro P, Palomo M, Moreno-Castaño AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097193 12. Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea. Circulation 2021; Kang JM, Kim YE, Huh K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092115 13. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the Era of vaccination: A systematic review and meta-analysis. Clin Microbiol Infect 2021; Kayı İ, Madran B, Keske Ş et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116205 14. Accuracy of four lateral fow immunoassays for anti SARS-CoV-2 antibodies: a head-to-head comparative study. EBioMedicine 2021; 68:103414Jones HE, Mulchandani R, Taylor-Phillips S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34098341 15. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity. EBioMedicine 2021; 68:103410Nielsen SS, Vibholm LK, Monrad I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098342 16. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine. EClinicalMedicine 2021:100928Pellini R, Venuti A, Pimpinelli F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109307 17. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis 2021; 27Schwarz T, Tober-Lau P, Hillus D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102097 18. Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors. Endocrinol Metab (Seoul) 2021; Lui DTW, Lee CH, Chow WS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107601 19. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections. Eur J Clin Microbiol Infect Dis 2021:1-15Huber T, Steininger P, Irrgang P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109500 20. SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility. F S Rep 2021; Morris RS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095871 21. Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay. Front. Immunol. 2021; 12:688436Brand I, Gilberg L, Bruger J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093595 22. A Virus-Specifc Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19. Front. Immunol. 2021; 12:674279Yeo JG, Leong JY, Tay SH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113347 23. SARS-CoV-2-Specifc Antibody Prevalence and Symptoms in a Local Austrian Population. Front Med (Lausanne) 2021; 8:632942Ladage D, Höglinger Y, Ladage D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109189 24. Features of Cytokine Storm Identifed by Distinguishing Clinical Manifestations in COVID-19. Front Public Health 2021; 9:671788Shen WX, Luo RC, Wang JQ, Chen ZS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109148 25. The pivotal roles of the host immune response in the fne-tuning the infection and the development of the vaccines for SARS-CoV-2. Hum Vaccin Immunother 2021:1-13Alturaiki W, Mubarak A, Al Jurayyan A, Hemida MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114940 26. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 infammasome activation and pulmonary infammation. Immunity 2021; Xian H, Liu Y, Rundberg Nilsson A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34115964 27. Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2. Infect Dis Ther 2021:1- 15Zheng F, Chen R, Yao R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34110618 28. Algorithm for the Diagnosis and Management of the Multisystem Infammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease (COVID- 19). Int J Clin Pract 2021:e14471Emeksiz S, Çelikel Acar B, Kibar AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107136 29. Multisystem Infammatory Syndrome in Children (MISC): a systematic review. Int J Clin Pract 2021:e14450Guimarães D, Pissarra R, Reis-Melo A, Guimarães H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105843 30. Chemokines and Eicosanoids Fuel the Hyperinfammation Within the Lungs of Patients with Severe COVID-19. J Allergy Clin Immunol 2021; Zaid Y, Doré É, Dubuc I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111453 31. Dynamics of COVID-19 Lockdown on Blood Indices and Its Impact on Individuals' Immunological Health Status: A Cohort Study in Madinah, Saudi Arabia. J. Blood Med. 2021; 12:395-402Suliman BA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104026 32. COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico. J. Clin. Immunol. 2021:1-16Castano-Jaramillo LM, Yamazaki-Nakashimada MA, O'Farrill-Romanillos PM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114122 33. Infammation at the Crossroads: the Combined Effects of COVID-19, Ageing, and Air Pollution. J Frailty Aging 2021; 10:281-285Martin PJ, Billet S, Landkocz Y, Fougère B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105713 34. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021; 9Goldman JD, Robinson PC, Uldrick TS, Ljungman P. http://www.ncbi.nlm.nih.gov/pubmed/? term=34117116 35. Kawasaki like illness due to COVID-19: a review of the literature. J Infect Dev Ctries 2021; 15:630-638Fang Y, Aravamudan VM, Sridharan GK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106885 36. Heterologous immunization with Covishield and Pfzer vaccines against SARS-CoV-2 elicits a robust humoral immune response. J Infect Dev Ctries 2021; 15:653-656Ostadgavahi AT, Booth R, Sisson G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106888 37. COVID-19 mRNA vaccination generates greater IgG levels in women compared to men. J Infect Dis 2021; Demonbreun AR, Sancilio A, Velez ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117873 38. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID- 19 patients. J Infect Public Health 2021; 14:845-851Chen Y, Li P, Ding Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118734 39. Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico. J Med Virol 2021; Rodríguez- Vidales EP, Garza-Carrillo D, Pérez-Trujillo JJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101203 40. Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation. Mol. Cell. Biochem. 2021:1-11Pérez- Campos Mayoral L, Hernández-Huerta MT, Papy-García D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110554 41. An Impaired Infammatory and Innate Immune Response in COVID-19. Mol. Cells 2021; Park SH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098591 42. Multisystem Infammatory Syndrome in Children and COVID-19 Infections. NASN Sch. Nurse 2021:1942602x211021136Bultas MW, Fuller K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098792 43. Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients. Open Forum Infect Dis 2021; 8:ofab195Antar AAR, Yu T, Pisanic N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095338 44. Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community. Open Forum Infect Dis 2021; 8:ofaa531Appa A, Takahashi S, Rodriguez-Barraquer I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109255 45. SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020. Pathology 2021; Craigie A, McGregor R, Whitcombe AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119335 46. HIF-1α is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes. Proc Natl Acad Sci U S A 2021; 118Peng T, Du SY, Son M, Diamond B. http://www.ncbi.nlm.nih.gov/pubmed/? term=34108245 47. ANCA-associated vasculitis after COVID-19. Rheumatol. Int. 2021:1-7Izci Duran T, Turkmen E, Dilek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100115 48. Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune- mediated diseases: a controlled study among hospital workers and elderly. Rheumatol. Int. 2021:1-12Seyahi E, Bakhdiyarli G, Oztas M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109466 49. Serologic response to SARS-CoV-2 in an African population. Sci Afr 2021; 12:e00802Fai KN, Corine TM, Bebell LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095639 50. Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure 2021; Cerutti G, Rapp M, Guo Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111408 51. Author response to: Correspondence to humoral immune response to COVID- 19 mRNA vaccine in patients with multiple sclerosis treated with high-effcacy disease-modifying therapies. Ther. Adv. Neurol. Disord. 2021; 14:17562864211020082Achiron A, Mandel M, Dreyer-Alster S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104221 52. Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-effcacy disease-modifying therapies. Ther. Adv. Neurol. Disord. 2021; 14:17562864211019567Piquet AL, Corboy JR, Vollmer TL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104219 53. Multisystemic infammatory syndrome in children associated with COVID-19: a single center experience in Turkey. Turk Arch Pediatr 2021; 56:192-199Başar EZ, Sönmez HE, Öncel S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104908 54. Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19. Viral Immunol 2021; Avendaño-Félix M, Ochoa-Ramírez LA, Ramos-Payán R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115949 55. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study. Virol J 2021; 18:126Yin SW, Zhou Z, Wang JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118952 56. Immune system and COVID-19 by sex differences and age. Womens Health (Lond) 2021; 17:17455065211022262Ciarambino T, Para O, Giordano M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096383 Management miscellaneous diseases (61 articles)

1. Characterizing the Impact of COVID-19 on Pre-Exposure Prophylaxis (PrEP) Care. AIDS Behav. 2021:1-4Rogers BG, Tao J, Maynard M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114166 2. Forecast modeling to identify changes in pediatric emergency department utilization during the COVID-19 pandemic. Am J Emerg Med 2021; 49:142- 147Ramgopal S, Pelletier JH, Rakkar J, Horvat CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111834 3. COVID-19 morbidity and severity in patients with age-related macular degeneration: a Korean nationwide cohort study. Am. J. Ophthalmol. 2021:11881Yang JM, Moon SY, Lee JY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34102151 4. Spontaneous regression of oesophageal squamous cell carcinoma. BMJ Case Rep. 2021; 14Khan H, Casey P, Hayes S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099447 5. Nosocomial SARS-CoV-2 transmission in a neonatal unit in Botswana: chronic overcrowding meets a novel pathogen. BMJ Case Rep. 2021; 14Nakstad B, Kaang T, Gezmu AM, Strysko J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099450 6. Perioperative challenges in managing a morbidly obese patient with COVID-19 undergoing an elective tracheostomy. BMJ Case Rep. 2021; 14Teah KM, Tsen SSY, Fong KK, Yeap TB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103307 7. National survey on the treatment of acute appendicitis in Spain during the initial period of the COVID-19 pandemic. Cir Esp (Engl Ed) 2021; 99:450- 456Prieto M, Ielpo B, Jiménez Fuertes M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092540 8. The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection. Clin Infect Dis 2021; Zhang AW, Morjaria S, Kaltsas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111237 9. One Hundred Twenty-Day Mortality Rates for Hip Fracture Patients with COVID-19 Infection. Clin. Orthop. Surg. 2021; 13:135-143Oputa TJ, Dupley L, Bourne JT. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094003 10. Emergency presentations of head and neck cancer: our experience in the wake of the Covid-19 pandemic. Clin. Otolaryngol. 2021; Wilkie MD, Gaskell P, Hall B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097807 11. Changing trend in the management of head neck cancers during the COVID-19 pandemic. Eur Arch Otorhinolaryngol 2021:1-8Pradhan P, Preetam C, Parida PK, Samal DK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120204 12. Impella 5.0 support before, during, and after surgical ventriculoplasty following acute myocardial infarction in the COVID-19 era: a case report. Eur Heart J Case Rep 2021; 5:ytab037Briani M, Torracca L, Crescenzi G, Barbone A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104861 13. Impact of COVID-19 pandemic on plastic surgery activities and residency programs in a tertiary referral centre in Iran. Eur. J. Plast. Surg. 2021:1- 7Kalantar-Hormozi A, Habibzadeh Z, Yavari M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103788 14. Management of breast cancer patients during the peak of the COVID 19 pandemic. Eur. J. Surg. Oncol. 2021; Montagna E, Bellerba F, Sangalli C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116901 15. The Impact of COVID-19 Interventions on Infuenza and Mycobacterium Tuberculosis Infection. Front Public Health 2021; 9:672568Geng Y, Li G, Zhang L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095074 16. Impact of COVID-19 Pandemic on Pre-Treatment Delays, Detection, and Clinical Characteristics of Tuberculosis Patients in Ningxia Hui Autonomous Region, China. Front Public Health 2021; 9:644536Wang X, He W, Lei J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095053 17. Upper Limb Home-Based Robotic Rehabilitation During COVID-19 Outbreak. Front Robot AI 2021; 8:612834Manjunatha H, Pareek S, Jujjavarapu SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109220 18. Case Report: COVID-19 Pneumonia Following Left Pneumonectomy for Lung Cancer Complicated by Empyema and Bronchopleural Fistula. Front Surg 2021; 8:679757Testori A, Giudici VM, Alloisio M, Cioff U. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095211 19. Intussusception and COVID19, Successful Mechanic Reduction, Case Report. Glob Pediatr Health 2021; 8:2333794x211019693Guerrón N, Figueroa LM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104695 20. The Effect of Using Rome IV Criteria on the Prevalence of Functional Abdominal Pain Disorders and Functional Constipation among Children of the Western Region of Saudi Arabia. Glob Pediatr Health 2021; 8:2333794x211022265Khayat A, Algethami G, Baik S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104704 21. Reduction in Sporadic Norovirus Infections Following the Start of the COVID- 19 Pandemic, 2019-2020, Philadelphia. Infect Dis Ther 2021:1-6Nachamkin I, Richard-Greenblatt M, Yu M, Bui H. http://www.ncbi.nlm.nih.gov/pubmed/? term=34120315 22. Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-center experience from Turkey. Int J Clin Pract 2021:e14442Batıbay S, Koçak Ulucaköy R, Özdemir B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105856 23. Impact of the COVID-19 pandemic on HIV care in Guatemala. Int J Infect Dis 2021; Medina N, Alastruey-Izquierdo A, Bonilla O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119676 24. Middle ear effusion prevalence at time of tympanostomy before and during COVID-19 pandemic. Int J Pediatr Otorhinolaryngol 2021; 147:110785Nguyen DK, Jueng J, Maul TM, Wei JL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116322 25. The impact of physical restriction measures imposed during the two waves of COVID-19 on chlamydia and gonorrhea diagnoses in Belgium. Results of an sexually transmitted infection clinic. Int. J. STD AIDS 2021:9564624211013289De Baetselier I, Apers L, Platteau T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096386 26. The impact of the SARS-CoV-2 pandemic on referral characteristics in a national tertiary spinal injuries unit. Ir. J. Med. Sci. 2021:1-6O'Halloran L, Ahern DP, McDonnell JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115306 27. Evaluation of Postoperative Complication with Medically Necessary, Time- Sensitive Scoring System During Acute COVID-19 Pandemic: A Prospective Observational Study. J Am Coll Surg 2021; Dinçer MB, Güler MM, Kaan Gök AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111533 28. Letter to the editor regarding "The impact of COVID-19 on neurosurgical head trauma referrals and admission at a tertiary neurosurgical centre". J. Clin. Neurosci. 2021; Pérez-García V, Amaris-Pérez A, Escobar-Pacheco C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119381 29. Continuation and Discontinuation Rates of Biologics in Dermatology Patients During COVID-19 Pandemic. J. Cutan. Med. Surg. 2021:12034754211024125Cohen SR, Kahn JS, Gao DX et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107794 30. Cigarette Smoking and Risk Perceptions During the COVID-19 Pandemic Reported by Recently Hospitalized Participants in a Smoking Cessation Trial. J Gen Intern Med 2021:1-8Rigotti NA, Chang Y, Regan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100230 31. Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross- sectional study. J. Headache Pain 2021; 22:53Suzuki K, Takeshima T, Igarashi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098873 32. How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient's perception: Study on 600 patients on biologic therapy. J Infect Public Health 2021; 14:878-882Bernardini N, Skroza N, Spagnoli A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118738 33. Closed-Loop Versus Conventional Mechanical Ventilation in COVID-19 ARDS. J. Intensive Care Med. 2021:8850666211024139Wendel Garcia PD, Hofmaenner DA, Brugger SD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098803 34. Orthodontic treatment in times of Covid-19. J. Med. Life 2021; 14:205- 209Morosan H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104243 35. Global survey on disruption and mitigation of neurological services during COVID-19: the perspective of global international neurological patients and scientifc associations. J. Neurol. 2021:1-13Triki CC, Leonardi M, Mallouli SZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117527 36. Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey. J. Neurooncol. 2021:1-7Schäfer N, Bumes E, Eberle F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115248 37. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. J. Subst. Abuse Treat. 2021; 131:108449Brothers S, Viera A, Heimer R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34098303 38. The new services that opioid treatment programs have adopted in response to COVID-19. J. Subst. Abuse Treat. 2021; 130:108393Cantor J, Laurito A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118694 39. The impact of COVID-19 on opioid treatment program (OTP) services: Where do we go from here? J. Subst. Abuse Treat. 2021; 131:108394Tracy K, Wachtel L, Friedman T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098292 40. Assessing the quality of life of head and neck healthcare workers during the COVID-19 pandemic-A self-reported global cross-sectional questionnaire study by the International Federation of Head and Neck Oncologic Societies. J. Surg. Oncol. 2021; Singh A, Garg A, Mandlik D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109640 41. COVID-19 and Ophthalmology: A Never Ending Story? Klin. Monbl. Augenheilkd. 2021; 238:554Cursiefen C, Heiligenhaus A. 42. Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia? Med. Hypotheses 2021; 152:110621El Hasbani G, Taher AT. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116360 43. A Patient-Focused Survey to Assess the Effects of the COVID-19 Pandemic and Social Guidelines on People with Muscular Dystrophy. Muscle Nerve 2021; Eichinger K, Lewis L, Dilek N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34105174 44. Changes in motor function in Duchenne muscular dystrophy patients after travel restrictions due to COVID-19. Muscle Nerve 2021; Nishizawa H, Nakamura A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105182 45. Initial assessment of framework for delivery of elective orthopaedic surgery in the United Kingdom following the COVID-19 pandemic. Musculoskelet. Surg. 2021:1-6Sharkey S, Narang K, Pacheco RJ, Anthony C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109553 46. Emergent Admissions to the Epilepsy Monitoring Unit in the Setting of COVID- 19 Pandemic-related, State-mandated Restrictions: Clinical Decision Making and Outcomes. Neurodiagn J 2021:1-9Zepeda R, Lee Y, Agostini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110971 47. Challenges for malaria surveillance during the COVID-19 emergency response in Nampula, Mozambique, January - May 2020. Pan Afr. Med. J. 2021; 38:254Afai G, Banze AR, Candrinho B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104302 48. The impact of COVID-19 on the tuberculosis control activities in Addis Ababa. Pan Afr. Med. J. 2021; 38:243Beyene NW, Sitotaw AL, Tegegn B, Bobosha K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104291 49. Patients' perceptions of orthodontic treatment experiences during COVID-19: a cross-sectional study. Prog. Orthod. 2021; 22:17Arqub SA, Voldman R, Ahmida A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101037 50. [Hymenoptera venom allergy: Management of venom extracts shortage or sanitary crisis (Covid-19 pandemic).]. Rev Fr Allergol (2009) 2021; Chatain C, Birnbaum J, Van der Brempt X. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099963 51. Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe. Risk Manag. Healthc. Policy 2021; 14:2421-2433Kniepeiss D, Jantscher L, Al-Sharafy S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113196 52. The impact of the COVID-19 pandemic on positive airway pressure usage in children with sleep-disordered breathing. Sleep Breath 2021:1-8Sunkonkit K, Selvadurai S, Voutsas G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34105105 53. Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan. SN Compr Clin Med 2021:1-5Ul Mustafa Z, Salman M, Aldeyab M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095752 54. Open Appendicectomy under Spinal Anesthesia-A Valuable Alternative during COVID-19. Surg J (N Y) 2021; 7:e69-e72Mai DVC, Sagar A, Claydon O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104718 55. The Impact of COVID-19 Disease on Urology Practice. Surg J (N Y) 2021; 7:e83- e91Moussa M, Chakra MA, Papatsoris AG, Dellis A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104720 56. IMPACT of COVID-19 on hip fracture services: A global survey by the International Multicentre Project Auditing COVID-19 in Trauma & Orthopaedics. Surgeon 2021; Hall AJ, Clement ND, MacLullich AMJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103268 57. Evidence of a Blood Pressure Reduction During the COVID-19 Pandemic and Associated Lockdown Period: Insights from e-Health Data. Telemed J E Health 2021; Girerd N, Meune C, Duarte K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34101507 58. Is arterial switch operation possible with neonatology-focused intensive care unit modality. Turk Gogus Kalp Damar Cerrahisi Derg 2021; 29:136-142Doyurgan O, Özdemir F, Akdeniz O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104506 59. EFFECT OF CORONAVIRUS PANDEMIC ON ORGAN DONATION AND TRANSPLANTATION IN TURKEY. Turk J Med Sci 2021; Torun EG, Uysal Yazici M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118807 60. Adenotonsillectomy in high risk patients: Hematologic abnormalities and COVID-19 considerations. World J Otorhinolaryngol Head Neck Surg 2021; Ruiz R, Dedhia K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094629 61. Annual meeting of the German Society for Rheumatology going virtual— successfully defying the pandemic. Z. Rheumatol. 2021; 80:399-407Richter JG, Chehab G, Knitza J et al.

Management (83 articles)

1. Can We Protect Those We Care for in A Pandemic? - Prevalence of Neutralizing Antibodies against SARS-CoV-2 in Nursing Homes. Aging Dis 2021; 12:710-717Willschke H, Wochele-Thoma T, Atanasov AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094636 2. Responding to disaster: Form and function of a pharmacy incident command structure. Am. J. Health Syst. Pharm. 2021; Murray RL, Boothe K, Lazarre M, Miller L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100860 3. Protocol for percutaneous tracheostomy and prevention of COVID-19 transmission. Am. J. Otolaryngol. 2021; 42:103090Avalos N, Grego K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098456 4. Early vs. late tracheostomy in ventilated COVID-19 patients - A retrospective study. Am. J. Otolaryngol. 2021; 42:103102Livneh N, Mansour J, Kassif Lerner R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120008 5. Preparing Intensive Care Unit in Resource-Constraint Setting Amid COVID-19 Pandemic: Our Experience and Review. Anesth Essays Res 2020; 14:366- 369Kajal K, Naik BN, Singh A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092843 6. Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study. Ann Intensive Care 2021; 11:92Ferreira JC, Ho YL, Besen B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097145 7. Biomarkers for Prognosis and Treatment Response in COVID-19 Patients. Ann Lab Med 2021; 41:540-548Bivona G, Agnello L, Ciaccio M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108281 8. The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis. Ann. Med. 2021; 53:874-884Wu KS, Lin PC, Chen YS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096808 9. Community end-of-life care during COVID-19: Findings of a UK primary care survey. BJGP Open 2021; Mitchell S, Oliver P, Gardiner C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117014 10. Anticoagulation in the obese patient with COVID-19-associated venous thromboembolism. BMJ Case Rep. 2021; 14McCormick JP, Connaughton J, McDonnell N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116998 11. 'Assisted self-proning' in a case of severe COVID-19 pneumonitis. BMJ Mil Health 2021; Pitts W, Cais S, Simon E, Hunt D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103382 12. Practical strategies for delivering airway training in the COVID-19 era. Br J Anaesth 2021; Hickman J, McNarry AF, Kelly FE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092382 13. Immune responses and therapeutic challenges in paediatric patients with new- onset acute myeloid leukaemia and concomitant COVID-19. Br. J. Haematol. 2021; Patel PA, Lapp SA, Grubbs G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096051 14. The 'loneliness pandemic': implications for gerontological nursing. Br J Nurs 2021; 30:652-655Laranjeira C. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109813 15. [The COVID-19 battle at CHU Zhongnan and Leishenshan hospital: a summary of the global mobilization in China and refections on the Wuhan experience]. Bull. Acad. Natl. Med. 2021; Xinghuan W, Brugère-Picoux J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092794 16. Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea. Circulation 2021; Kang JM, Kim YE, Huh K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092115 17. Laryngotracheal Complications in Intubated COVID-19 Patients. Clin. Med. Insights Case Rep. 2021; 14:11795476211020590Sandu K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104030 18. One Hundred Twenty-Day Mortality Rates for Hip Fracture Patients with COVID-19 Infection. Clin. Orthop. Surg. 2021; 13:135-143Oputa TJ, Dupley L, Bourne JT. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094003 19. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients. Crit Care 2021; 25:199Li Bassi G, Suen JY, Dalton HJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108029 20. HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies. Curr. HIV/AIDS Rep. 2021:1-10Gravett RM, Marrazzo JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105091 21. Infuence of COVID-19 shutdown on the workload of a university eye clinic. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2021; Framme C, Gottschling J, Buley P et al. 22. Self-Medication in COVID-19 Pandemic: The survival of the fttest. Disaster Med Public Health Prep 2021:1-19Rafq K, Nesar S, Anser H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099083 23. The infuence of selection bias on identifying an association between allergy medication use and SARS-CoV-2 infection. EClinicalMedicine 2021:100936Thompson LA, Gurka MJ, Filipp SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104879 24. Vitamin D attenuates COVID-19 complications via modulation of proinfammatory cytokines, antiviral proteins, and autophagy. Expert Rev. Anti Infect. Ther. 2021; Gilani SJ, Bin-Jumah M, Nadeem MS, Kazmi I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112047 25. Knowledge, Attitudes, and Practices of Urban Residents Toward COVID-19 in Shaanxi During the Post-lockdown Period. Front Public Health 2021; 9:659797Xu N, Zhang Y, Zhang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095063 26. End of Life Decision-Making Challenges in a Latino Patient with COVID-19: Facing Barriers. Gerontol Geriatr Med 2021; 7:23337214211021726Huayanay I, Pantoja C, Chang C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104688 27. Preventing a Post-Pandemic Double Burden of Disease in the COVID-19 Pandemic. Glob Adv Health Med 2021; 10:21649561211010137Chan AHY, Horne R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104575 28. Potential Role of Vitamins and Zinc on Acute Respiratory Infections Including Covid-19. Glob Pediatr Health 2021; 8:2333794x211021739Murni IK, Prawirohartono EP, Triasih R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104701 29. US Ventilator Allocation and Patient Triage Policies in Anticipation of the COVID-19 Surge. Health Secur 2021; Chelen JSC, White DB, Zaza S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107775 30. High-fow Nasal Cannula therapy: A feasible treatment for vulnerable elderly COVID-19 patients in the wards. Heart Lung 2021; 50:654-659van Steenkiste J, van Herwerden MC, Weller D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34098235 31. Appropriate use of antimicrobial therapy for COVID-19 co-infection. Immunotherapy 2021; Lai CC, Yu WL. http://www.ncbi.nlm.nih.gov/pubmed/? term=34114473 32. Impact of Infammatory Response Modifers on the Incidence of Hospital- Acquired Infections in Patients with COVID-19. Infect Dis Ther 2021:1-12Meira F, Moreno-García E, Linares L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34115314 33. Role of vitamins and minerals as immunity boosters in COVID-19. Infammopharmacology 2021:1-16Kumar P, Kumar M, Bedi O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110533 34. Decision support tool for hospital resource allocation during the COVID-19 pandemic. Inform Med Unlocked 2021; 24:100618Brüggemann S, Chan T, Wardi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095453 35. The Effect Of Chronic DOAC Treatment On Clinical Outcomes Of Hospitalized Patients With COVID-19. Int J Clin Pract 2021:e14467Aslan B, Akyüz A, Işık F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107130 36. Use of aspirin in reduction of mortality of COVID-19 patients: A metanalysis. Int J Clin Pract 2021:e14515Srivastava R, Kumar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118111 37. After Action Reviews of COVID-19 response: Case study of a large tertiary care hospital in Italy. Int. J. Health Plann. Manage. 2021; Sebastiano S, Eleonora B, Camilla Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096091 38. After Action Reviews of COVID-19 response: Case study of a large tertiary care hospital in Italy. Int. J. Health Plann. Manage. 2021; Sorbello S, Bossi E, Zandalasini C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096091 39. COVID Challenges and Adaptations Among Home-Based Primary Care Practices: Lessons for an Ongoing Pandemic From a National Survey. J. Am. Med. Dir. Assoc. 2021; Ritchie CS, Gallopyn N, Sheehan O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111388 40. Rehabilitation in adult post-COVID-19 patients in post-acute care with Therapeutic Exercise. J Frailty Aging 2021; 10:297-300Udina C, Ars J, Morandi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105716 41. What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web-survey helps us understand where the doubts lie. J Glob Antimicrob Resist 2021; Colaneri M, Valsecchi P, Vecchia M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118478 42. Acceleration of differentiated service delivery for HIV treatment in sub- Saharan Africa during COVID-19. J Int AIDS Soc 2021; 24:e25704Grimsrud A, Wilkinson L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105884 43. Closed-Loop Versus Conventional Mechanical Ventilation in COVID-19 ARDS. J. Intensive Care Med. 2021:8850666211024139Wendel Garcia PD, Hofmaenner DA, Brugger SD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098803 44. Rapid Intensive Care Unit Onboarding in Response to a Pandemic. J Med Educ Curric Dev 2021; 8:23821205211020741Alroumi F, Cota D, Chinea J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104792 45. Missed nursing care during the COVID-19 pandemic: a comparative observational study. J. Nurs. Manag. 2021; von Vogelsang AC, Göransson KE, Falk AC, Nymark C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097799 46. Innovation in a Crisis: Lessons Learned from the Rapid Development of an End-of-Life Palliative Care Unit during the COVID-19 Pandemic. J. Palliat. Med. 2021; Drutchas A, Kavanaugh A, Cina K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096800 47. Ethical challenges in management of critically ill pregnant patients with coronavirus disease 2019 (COVID-19). J. Perinat. Med. 2021; Gulersen M, Rochelson B, Bornstein E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34116587 48. A cross-sectional survey on community pharmacists readiness to fght COVID-19 in a developing country: knowledge, attitude, and practice in Lebanon. J Pharm Policy Pract 2021; 14:51Zeenny RM, Dimassi A, Sacre H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116719 49. Palliative Opioids May Be a Bridge to Care for Rural Long-Term Care Facility Residents with Severe COVID-19 Symptoms. J. Prim. Care Community Health 2021; 12:21501327211023706Crocetti E, Assadzandi S, Pilkerton CS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109858 50. A dignifed death: management of dead bodies during COVID-19. J Public Health (Oxf) 2021; Corpuz JCG. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096608 51. Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: A retrospective multicenter study. J. Thorac. Cardiovasc. Surg. 2021; Saeed O, Tatooles AJ, Farooq M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112505 52. A tale of two diseases: Sarcoidosis, COVID-19 and new therapeutic options with dual RAS inhibition and tetanus-diphtheria vaccine. Med. Hypotheses 2021; 152:110619Ozbalci D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102600 53. Management of COVID-19 mass casualty incidents in nursing and retirement homes. Medizinische Klinik - Intensivmedizin und Notfallmedizin 2021; Schreiber W, Wolf P, Bigalke N et al. 54. SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment. Microbiome 2021; 9:132Marotz C, Belda-Ferre P, Ali F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103074 55. Prevention of venous thromboembolism in COVID-19 outpatients. MMW- Fortschritte der Medizin 2021; 163:56-57Darius H, Grothues J, Haas S et al. 56. Persistent dyspnea after COVID-19: Suggestions for follow-up care. MMW- Fortschritte der Medizin 2021; 163:52-55Kolditz M, Beyer-Westendorf J, von Bonin S, Koschel DS. 57. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Open Heart 2021; 8Matli K, Farah R, Maalouf M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099529 58. Aggressive Thromboprophylaxis Improves Clinical Process and Decreases the Need of Intensive Care Unit in Covid-19. Pak J Med Sci 2021; 37:668- 674Ugur M, Adiyeke E, Recep E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104145 59. Anforderungen, Ressourcen und Arbeitsengagement Pfegender während der zweiten Welle der COVID-19-Pandemie. Pfege 2021:1-10Dürr L, Forster A, Bartsch CE, Koob C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114894 60. Inter- und intraprofessionelle Zusammenarbeit in Krisensituationen auf der Intensivstation am Beispiel von COVID-19. Pfege 2021:1-12Fröhlich MR, Rettke H, Conca A, Boden K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109801 61. The Unique Challenges Facing Rural Providers in the COVID-19 Pandemic. Popul Health Manag 2021; 24:304-306Segel JE, Ross HI, Edwards JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115960 62. Integrating Behavioral Health and Serious Illness Care in a Post-COVID-19 Environment. Psychiatr. Serv. 2021:appips202000903Shalev D, Spaeth-Rublee B, Cheung S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106738 63. Individualized ventilatory management in patients with COVID-19-associated acute respiratory distress syndrome. Respir Med Case Rep 2021; 33:101433Taenaka H, Yoshida T, Hashimoto H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094847 64. Endotracheal granulation after tracheostomy in acute respiratory distress syndrome from COVID-19. Respirol Case Rep 2021; 9:e00787Matsumoto H, Hanada S, Yamamoto K, Takaya H. http://www.ncbi.nlm.nih.gov/pubmed/? term=34094572 65. Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment. SAGE Open Med Case Rep 2021; 9:2050313x211016991Sottilotta G, Mangano C, Basile R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104443 66. [Continuous deep sedation until death for COVID-19 patients]. Soins 2021; 66:30-33Amar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103130 67. [Palliative care and COVID-19, a creative challenge]. Soins 2021; 66:37- 38Amouroux-Gorsse V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103132 68. [Infuence of COVID-19 on issues relating to end of life and the support of patients]. Soins 2021; 66:26-29Aubry R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103129 69. [When care means being present for the other]. Soins 2021; 66:39-40Benduduh K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103133 70. [Reinventing proximity with the patient while maintaining social distancing]. Soins 2021; 66:34-36Farota-Romejko I. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103131 71. [Student nurses faced with the palliative care approach]. Soins 2021; 66:51Hérisson B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103138 72. [COVID-19 in care homes, a new organisation required]. Soins 2021; 66:41- 43Lacour F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103134 73. [Prisoners, caregivers and volunteers faced with COVID-19]. Soins 2021; 66:54- 56Le Pelley Fontenya P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103141 74. [Supporting end-of-life at home during a pandemic]. Soins 2021; 66:49- 50Lecointre B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103137 75. [Impacts of the health crisis on palliative care]. Soins 2021; 66:22-25Lefaucheur AS, Hirsch G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103128 76. [Identifed palliative care beds in the time of COVID-19]. Soins 2021; 66:44- 45Parot-Monpetit A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103135 77. [Day hospital, a link specifc to the patient]. Soins 2021; 66:46-48Rustichelli M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103136 78. Potential role of Nigella sativa supplementation with physical activity in prophylaxis and treatment of COVID-19: a contemporary review. Sport Sci Health 2021:1-6Shirvani H, Rostamkhani F, Arabzadeh E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093778 79. Training for major incidents. Surgery (Oxf) 2021; Porthouse A, Clancy H, Lax P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092879 80. Follow-up strategy with long-term veno-venous extracorporeal membrane oxygenation support for complicated severe acute respiratory distress related to COVID-19 and recovery of the lungs. Turk Gogus Kalp Damar Cerrahisi Derg 2021; 29:252-258Kırali K, Erkılınç A, Erdal Taşçı A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104520 81. Long-Term Proton Pump Inhibitor Use is a Risk Factor for Mortality in Patients Hospitalized for COVID-19. Turk J Med Sci 2021; Yozgat A, Kasapoğlu B, Can G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110723 82. Is there any role of intermittent fasting in the prevention and improving clinical outcomes of COVID-19?: intersection between infammation, mTOR pathway, autophagy and calorie restriction. Virusdisease 2021:1-10Gnoni M, Beas R, Vásquez-Garagatti R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104708 83. Assessment of nitric oxide (NO) potential to mitigate COVID-19 severity. Virusdisease 2021:1-6Srivastava S, Garg I, Hembrom AA, Kumar B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099981

Mental – public health (162 articles)

1. Addressing pediatric mental health using telehealth during COVID-19 and beyond: A narrative review. Acad. Pediatr. 2021; Cunningham NR, Ely SL, Garcia BNB, Bowden J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118499 2. Factors associated with alcohol and tobacco consumption as a coping strategy to deal with the coronavirus disease (COVID-19) pandemic and lockdown in Spain. Addict. Behav. 2021; 121:107003Martínez-Cao C, de la Fuente-Tomás L, Menéndez-Miranda I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34111653 3. Alcohol use among young Australian adults in May-June 2020 during the COVID-19 pandemic: a prospective cohort study. Addiction 2021; Clare PJ, Aiken A, Yuen WS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105838 4. The Impact of COVID-19 on Sexual Behavior and Psychosocial Functioning in a Clinical Sample of Men who have Sex with Men Using HIV Pre-exposure Prophylaxis. AIDS Behav. 2021:1-7Rogers BG, Tao J, Darveau SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114165 5. "Early" and "defnitive" taking charge of subjects positive to SARS-CoV2: the experience of an Italian Local Health Authority. Ann. Ig. 2021; De Polo A, Facchin G, Battistin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113954 6. The reported effects of the COVID-19 pandemic on people with intellectual disability and their carers: a scoping review. Ann. Med. 2021; 53:786-804Doody O, Keenan PM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110258 7. [Feedback from the establishment of a psychiatric regulation line at SAMU 62 in the context of Covid-19]. Ann. Med. Psychol. (Paris) 2021; Rougegrez L, Dupont M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092798 8. Prevalence and correlates of psychological distress in the front-line anti- epidemic medical staff during the COVID-19 outbreak in Wuhan. Ann Palliat Med 2021; Wang H, Yao N, Guo Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34118841 9. Changes in sociocultural attitudes towards appearance, body image, eating attitudes and behaviours, physical activity, and quality of life in students before and during COVID-19 lockdown. Appetite 2021; 166:105452Baceviciene M, Jankauskiene R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107292 10. Suicide prevention in older adults. Asia Pac Psychiatry 2021:e12473de Mendonça Lima CA, De Leo D, Ivbijaro G, Svab I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114355 11. Suicide prevention and COVID-19. Asia Pac Psychiatry 2021:e12482Ivbijaro G, Kolkiewicz L, Goldberg D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34114356 12. Holistic approach supporting mental wellbeing of people in enforced quarantine in South Australia during the COVID-19 pandemic. Aust. N. Z. J. Public Health 2021; D'Onise K, Meena S, Venugopal K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097327 13. The effect of COVID-19 lockdown on psychiatric admissions: role of gender. BJPsych Open 2021; 7:e112Davies M, Hogarth L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099091 14. Associations between the working experiences at frontline of COVID-19 pandemic and mental health of Korean public health doctors. BMC Psychiatry 2021; 21:298Han S, Choi S, Cho SH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34107890 15. Impact of COVID-19 on the mental health of US college students. BMC Psychol 2021; 9:95Lee J, Solomon M, Stead T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103081 16. Prevalence of elder abuse and victim-related risk factors during the COVID-19 pandemic in China. BMC Public Health 2021; 21:1096Du P, Chen Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103014 17. Awareness, knowledge and trust in the Greek authorities towards COVID-19 pandemic: results from the Epirus Health Study cohort. BMC Public Health 2021; 21:1125Kanellopoulou A, Koskeridis F, Markozannes G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118917 18. Readiness and early response to COVID-19: achievements, challenges and lessons learnt in Ethiopia. BMJ Glob Health 2021; 6Lanyero B, Edea ZA, Musa EO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112648 19. Mental health disorders among healthcare workers during the COVID-19 pandemic: a cross-sectional survey from three major hospitals in Kenya. BMJ Open 2021; 11:e050316Shah J, Monroe-Wise A, Talib Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108174 20. The global mental health burden of COVID-19 on critical care staff. Br J Nurs 2021; 30:634-642Ezzat A, Li Y, Holt J, Komorowski M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109816 21. The 'loneliness pandemic': implications for gerontological nursing. Br J Nurs 2021; 30:652-655Laranjeira C. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109813 22. [The COVID-19 battle at CHU Zhongnan and Leishenshan hospital: a summary of the global mobilization in China and refections on the Wuhan experience]. Bull. Acad. Natl. Med. 2021; Xinghuan W, Brugère-Picoux J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092794 23. Calculating the impact of COVID-19 pandemic on child abuse and neglect in the U.S. Child Abuse Negl. 2021; 118:105136Nguyen LH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098378 24. 'The world somehow stopped moving': impact of the COVID-19 pandemic on adolescent psychiatric outpatients and the implementation of teletherapy. Child Adolesc Ment Health 2021; Huscsava MM, Scharinger C, Plener PL, Kothgassner OD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114730 25. Knowledge, attitudes and practices of patients with chronic illnesses during the COVID-19 pandemic: A cross-sectional survey from Pakistan. Chronic Illn 2021:17423953211023961Mahmood MM, Rehman J, Arif B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107795 26. Mental health of children of health workers during the COVID-19 pandemic: A cross-sectional study. Clin. Child Psychol. Psychiatry 2021:13591045211016527Almis H, Han Almis B, Bucak IH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098758 27. Yoga and Naturopathy intervention for reducing anxiety and depression of Covid-19 patients - A pilot study. Clin Epidemiol Glob Health 2021; 11:100800Jenefer Jerrin R, Theebika S, Panneerselvam P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095613 28. Perception, preparedness and response of health care personals towards COVID-19 pandemic in Azad Jammu & Kashmir, Pakistan: A cross sectional interview based study. Clin Epidemiol Glob Health 2021; 11:100783Khan MF, Mahmood M, Hasrat MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095611 29. COVID-19 and its impacts: The situation in Niger republic. Clin Epidemiol Glob Health 2021; 11:100797Nzeribe E, Michael UE, Musa SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095612 30. Caring for Relatives with Dementia in Times of COVID-19: Impact on Caregivers and Care-recipients. Clin. Gerontol. 2021:1-15Losada A, Vara-García C, Romero-Moreno R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096470 31. The relationship between fear of COVID-19 and health anxiety among families with COVID-19 infected: The mediating role of metacognitions, intolerance of uncertainty and emotion regulation. Clin. Psychol. Psychother. 2021; Akbari M, Spada MM, Nikčević AV, Zamani E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34110670 32. Lockdowns, lives and livelihoods: the impact of COVID-19 and public health responses to confict affected populations - a remote qualitative study in Baidoa and Mogadishu, Somalia. Conf Health 2021; 15:47Braam DH, Srinivasan S, Church L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118985 33. Patient and Family Engagement During Challenging Times: What Works and What Does Not? Cureus 2021; 13:e14814Abid MH, Abid MM, Shahid R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094768 34. Stay at home! When personality profles infuence mental health and creativity during the COVID-19 lockdown. Curr. Psychol. 2021:1-12Michinov E, Michinov N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092985 35. Prevalence and psychosocial risk factors of nonsuicidal self-injury among adolescents during the COVID-19 outbreak. Curr. Psychol. 2021:1-10Tang WC, Lin MP, You J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092987 36. Cross-national comparison of psychosocial well-being and diabetes outcomes in adults with type 1 diabetes during the COVID-19 pandemic in US, Brazil, and Iran. Diabetol. Metab. Syndr. 2021; 13:63Abdoli S, Silveira M, Doosti-Irani M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116721 37. COVID-19 Pandemic Increased Anxiety Among Patients with Infammatory Bowel Disease: A Patient Survey in a Tertiary Referral Center. Dig. Dis. Sci. 2021:1-6Stone ML, Feng M, Forster EM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34115232 38. Potentialities and challenges of digital health in psychiatry in Kashmir, India. Digit Health 2021; 7:20552076211019908Shoib S, Arafat SY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104469 39. Changes in physical activity and basic psychological needs related to mental health among people with physical disability during the Covid-19 pandemic in Norway. Disabil Health J 2021:101126Bentzen M, Brurok B, Roeleveld K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099419 40. Factors Related to Self-Reported Distress Experienced by Physicians During Their First COVID-19 Triage Decisions. Disaster Med Public Health Prep 2021:1- 20Chou FL, Abramson D, DiMaggio C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096486 41. Effect of the COVID-19 on perceptions of health, anticipated need for health services, and cost of healthcare. Disaster Med Public Health Prep 2021:1- 28Rekhter N, Ermasova N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099075 42. Academic and emotional effects of online learning during the COVID-19 pandemic on engineering students. Educ Inf Technol (Dordr) 2021:1-28Baltà- Salvador R, Olmedo-Torre N, Peña M, Renta-Davids AI. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108843 43. Network analysis of PTSD in college students across different areas after the COVID-19 epidemic. Eur J Psychotraumatol 2021; 12:1920203Sun R, Qi J, Huang J, Zhou X. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104353 44. Can we expect a rise in suicide rates after the Covid-19 pandemic outbreak? Eur. Neuropsychopharmacol. 2021; 52:1-2Pompili M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120055 45. How is COVID-19 Affecting Patients with Obsessive-Compulsive Disorder? A longitudinal study on the initial phase of the pandemic in a Spanish cohort. Eur. Psychiatry 2021:1-27Alonso P, Bertolín S, Segalàs J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100343 46. Anorexia nervosa: COVID-19 pandemic period (Review). Exp. Ther. Med. 2021; 22:804Dumitrașcu MC, Șandru F, Carsote M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093760 47. Perceived Stress of Quarantine and Isolation During COVID-19 Pandemic: A Global Survey. Front Psychiatry 2021; 12:656664. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113270 48. Design of a Mobile Application and Evaluation of Its Effects on Psychological Parameters of Covid-19 Inpatients: A Protocol for a Randomized Controlled Trial. Front Psychiatry 2021; 12:612384Aalaei S, Khoshrounejad F, Saleh LA, Amini M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108892 49. Coping Strategies and Psychopathological Responses Among Medical and Non-medical Professionals - a Cross-Sectional Online Survey. Front Psychiatry 2021; 12:663224Ciułkowicz M, Maciaszek J, Misiak B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093277 50. Is Higher Subjective Fear Predictive of Post-Traumatic Stress Symptoms in a Sample of the Chinese General Public? Front Psychiatry 2021; 12:560602Guo X, Liu T, Xing C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093250 51. Virtual Online Home-Based Treatment During the COVID-19 Pandemic for Ultra-Orthodox Young Women With Eating Disorders. Front Psychiatry 2021; 12:654589Latzer Y, Herman E, Ashkenazi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108896 52. Corrigendum: Association Between Current Physical Activity and Current Perceived Anxiety and Mood in the Initial Phase of COVID-19 Confnement. Front Psychiatry 2021; 12:694760López-Bueno R, Calatayud J, Ezzatvar Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093291 53. Mental Health and Psychosocial Support During COVID-19: A Review of Health Guidelines in Sub-Saharan Africa. Front Psychiatry 2021; 12:571342Molebatsi K, Musindo O, Ntlantsana V, Wambua GN. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093251 54. Immediate Psychological Responses, Stress Factors, and Coping Behaviors in Military Health-Care Professionals During the COVID-19 Pandemic in Tunisia. Front Psychiatry 2021; 12:622830Slama H, El Kef H, Taamallah K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093258 55. The Association Between Social Support, COVID-19 Exposure, and Medical Students' Mental Health. Front Psychiatry 2021; 12:555893Yin Y, Yang X, Gao L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108891 56. Prevalence of Post-traumatic Stress Symptoms and Its Associations With Quality of Life, Demographic and Clinical Characteristics in COVID-19 Survivors During the Post-COVID-19 Era. Front Psychiatry 2021; 12:665507Yuan Y, Liu ZH, Zhao YJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093279 57. Music Therapy During COVID-19: Changes to the Practice, Use of Technology, and What to Carry Forward in the Future. Front. Psychol. 2021; 12:647790Agres KR, Foubert K, Sridhar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093330 58. Mental Health Consequences of Adversity in Australia: National Bushfres Associated With Increased Depressive Symptoms, While COVID-19 Pandemic Associated With Increased Symptoms of Anxiety. Front. Psychol. 2021; 12:635158Arjmand HA, Seabrook E, Bakker D, Rickard N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093316 59. Anxiety and Social Support as Predictors of Student Academic Motivation During the COVID-19. Front. Psychol. 2021; 12:644338Camacho A, Correia N, Zaccoletti S, Daniel JR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108910 60. Home Confnement in Previously Active Older Adults: A Cross-Sectional Analysis of Physical Fitness and Physical Activity Behavior and Their Relationship With Depressive Symptoms. Front. Psychol. 2021; 12:643832Carvalho J, Borges-Machado F, Pizarro AN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093325 61. Infuence of Resilience and Optimism on Distress and Intention to Self-Isolate: Contrasting Lower and Higher COVID-19 Illness Risk Samples From an Extended Health Belief Model. Front. Psychol. 2021; 12:662395Cervera-Torres S, Ruiz-Fernández S, Godbersen H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34108919 62. Death Concerns, Beneft-Finding, and Well-Being During the COVID-19 Pandemic. Front. Psychol. 2021; 12:648609Cox CR, Swets JA, Gully B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093336 63. Effects of the Brain Wave Modulation Technique Administered Online on Stress, Anxiety, Global Distress, and Affect During the First Wave of the COVID-19 Pandemic: A Randomized Clinical Trial. Front. Psychol. 2021; 12:635877Cozzolino M, Celia G, Girelli L, Limone P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093317 64. Gender and Entrepreneurship in Pandemic Time: What Demands and What Resources? An Exploratory Study. Front. Psychol. 2021; 12:668875De Simone S, Pileri J, Rapp-Ricciardi M, Barbieri B. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093367 65. Masking Emotions: Face Masks Impair How We Read Emotions. Front. Psychol. 2021; 12:669432Gori M, Schiatti L, Amadeo MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113297 66. Music in Mood Regulation and Coping Orientations in Response to COVID-19 Lockdown Measures Within the United Kingdom. Front. Psychol. 2021; 12:647879Henry N, Kayser D, Egermann H. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093331 67. Corrigendum: Self-Perception of Changes in Routines in Adults and Older Adults Associated to Social Distancing Due to COVID-19-A Study in São Paulo, Brazil. Front. Psychol. 2021; 12:684729Machado-Lima A, Alonso AC, Gozzo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093376 68. Predictors of COVID-19 Preventive Behavior Adoption Intention in Malaysia. Front. Psychol. 2021; 12:616749Mat Dawi N, Namazi H, Maresova P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093307 69. Corrigendum: The Use of Online Training Tools in Competition Cyclists During COVID-19 Confnement in Spain. Front. Psychol. 2021; 12:684946Moreno-Tenas A, León-Zarceño E, Serrano-Rosa MA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093377 70. Gamifcation as Online Teaching Strategy During COVID-19: A Mini-Review. Front. Psychol. 2021; 12:648552Nieto-Escamez FA, Roldán-Tapia MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093334 71. Forced Social Isolation and Mental Health: A Study on 1,006 Italians Under COVID-19 Lockdown. Front. Psychol. 2021; 12:663799Pancani L, Marinucci M, Aureli N, Riva P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093358 72. Techno Trend Awareness and Its Attitude Towards Social Connectedness and Mitigating Factors of COVID-19. Front. Psychol. 2021; 12:637395Pandey V, Misra N, Greeshma R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113286 73. Prevalence of Risk Factors Associated With Mental Health Symptoms Among the Outpatient Psychiatric Patients and Their Family Members in China During the Coronavirus Disease 2019 Pandemic. Front. Psychol. 2021; 12:622339Qiu Y, Huang J, Sun J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113277 74. How Having a Clear Why Can Help Us Cope With Almost Anything: Meaningful Well-Being and the COVID-19 Pandemic in México. Front. Psychol. 2021; 12:648069Quiroga-Garza A, Cepeda-Lopez AC, Villarreal Zambrano S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093332 75. Music Listening in Times of COVID-19 Outbreak: A Brazilian Study. Front. Psychol. 2021; 12:647473Ribeiro FS, Lessa JPA, Delmolin G, Santos FH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093328 76. Culture Related Factors May Shape Coping During Pandemics. Front. Psychol. 2021; 12:634078Shekriladze I, Javakhishvili N, Chkhaidze N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093315 77. Major Stressors and Coping Strategies of Internal Migrant Workers During the COVID-19 Pandemic: A Qualitative Exploration. Front. Psychol. 2021; 12:648334Srivastava A, Arya YK, Joshi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093333 78. "It's Like a Kick in the Teeth": The Emergence of Novel Predictors of Burnout in Frontline Workers During Covid-19. Front. Psychol. 2021; 12:645504Sumner RC, Kinsella EL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113288 79. Does Participative Leadership Matters in Employees' Outcomes During COVID-19? Role of Leader Behavioral Integrity. Front. Psychol. 2021; 12:646442Usman M, Ghani U, Cheng J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093327 80. Stress-Related Growth in Adolescents Returning to School After COVID-19 School Closure. Front. Psychol. 2021; 12:643443Waters L, Allen KA, Arslan G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093323 81. From Information Exposure to Protective Behaviors: Investigating the Underlying Mechanism in COVID-19 Outbreak Using Social Amplifcation Theory and Extended Parallel Process Model. Front. Psychol. 2021; 12:631116Zhao S, Wu X. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113280 82. COVID-19 Patient Psychological Pain Factors. Front. Psychol. 2021; 12:649895Zhengkai N, Yajing S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093337 83. Corrigendum: Anxiety and Depression Among People Under the Nationwide Partial Lockdown in Vietnam. Front Public Health 2021; 9:692085Le HT, Lai AJX, Sun J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109151 84. Perception Toward Exposure Risk of COVID-19 Among Health Workers in Vietnam: Status and Correlated Factors. Front Public Health 2021; 9:589317Le XTT, Nguyen QT, Onyango B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113595 85. Changes in Mental Health of Women Undergoing Assisted Reproductive Technology Treatment During the COVID-19 Pandemic Outbreak in Xi'an, China. Front Public Health 2021; 9:645421Qu P, Zhao D, Jia P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113596 86. Determinants of Social Distancing Among South Africans From 12 Days Into the COVID-19 Lockdown: A Cross Sectional Study. Front Public Health 2021; 9:632619Sewpaul R, Mabaso M, Dukhi N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109143 87. The Effect of COVID-19 and Related Lockdown Phases on Young Peoples' Worries and Emotions: Novel Data From India. Front Public Health 2021; 9:645183Shukla M, Pandey R, Singh T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34095054 88. Rapid Evidence Assessment of Mental Health Outcomes of Pandemics for Health Care Workers: Implications for the Covid-19 Pandemic. Front Public Health 2021; 9:629236Waring S, Giles S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34095049 89. Factors Infuencing Mental Health Among Chinese Medical and Non-medical Students in the Early Stage of the COVID-19 Pandemic. Front Public Health 2021; 9:603331Xiong P, Ming WK, Zhang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095044 90. Investigation of awareness and anxiety levels of pregnant women during pandemic process. Ginekol. Pol. 2021; Palalioglu RM, Karadeniz O, Aytok GI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105744 91. COVID-19 crisis and increased risks of elder abuse in caregiving spaces. Glob Public Health 2021:1-5Arthur-Holmes F, Gyasi RM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115568 92. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland. Harm Reduct J 2021; 18:64Parkes T, Carver H, Masterton W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118942 93. Weather, mental health, and mobility during the frst wave of the COVID-19 pandemic. Health Econ. 2021; Burdett A, Davillas A, Etheridge B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114722 94. Anxiety and depression among Kosovar university students during the initial phase of outbreak and lockdown of COVID-19 pandemic. Health Psychol Behav Med 2021; 9:239-250Arënliu A, Bërxulli D, Perolli-Shehu B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104559 95. Risk Communication and Institutional Racism: The Protective Health Effect of Refugee-Led Community Organizations. Health Secur 2021; Pimentel Walker AP, Sanga N, Gonzalez Benson O, Yoshihama M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096802 96. Knowledge, Attitudes, and Practices Regarding COVID-19 prevention among Vietnamese Healthcare Workers in 2020. Health Serv Insights 2021; 14:11786329211019225Tien TQ, Tuyet-Hanh TT, Linh TNQ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103939 97. Covid-19 Preparedness and Response Capability: A Case Study of the Hanoi Primary Healthcare System. Health Serv Insights 2021; 14:11786329211019224Van Hoang M, Tran AT, Vu TT, Duong TK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103938 98. Exploring the association between mental health and subjective sleep quality during the COVID-19 pandemic among Bangladeshi university students. Heliyon 2021; 7:e07082Ahammed B, Jahan N, Seddeque A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095577 99. Psychological impacts of COVID-19 and satisfaction from online classes: disturbance in daily routine and prevalence of depression, stress, and anxiety among students of Pakistan. Heliyon 2021; 7:e07030Khawar MB, Abbasi MH, Hussain S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095563 100. An investigation of psychological responses to COVID-19 in Irish healthcare workers: longitudinal quantitative and nested qualitative study. HRB Open Res 2021; 4:15Fortune DG, Richards HL, Wormald A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109298 101. Prevalence of Depression and Associated Factors Among Quarantined Individuals During the COVID-19 Pandemic in Tigrai Treatment and Quarantine Centers, Tigrai, Ethiopia, 2020: A Cross-Sectional Study. Infect Drug Resist 2021; 14:2113-2119Hagezom HM, Gebrehiwet AB, Haftom Goytom M, Alemseged EA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113138 102. Effect of the COVID-19 pandemic on the mental health, daily and occupational activities of otolaryngologists and allergists in Colombia: a national study. Int Forum Allergy Rhinol 2021; Pérez-Herrera LC, Moreno-López S, Peñaranda D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101370 103. Anxiety Levels Amid the COVID-19 Lockdown in Saudi Arabia. Int. J. Gen. Med. 2021; 14:2161-2170Albagmi FM, AlNujaidi HY, Al Shawan DS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103971 104. Rapid Scoping Review on the Topic of Ensuring Social Protection and Basic Services to Inform the United Nations Framework for the Immediate Socioeconomic Response to COVID-19. Int J Health Serv 2021:207314211024896Highet M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096801 105. Interest Consistency Can Buffer the Effect of COVID-19 Fear on Psychological Distress. Int J Ment Health Addict 2021:1-12Masuyama A, Kubo T, Sugawara D, Yuta C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093094 106. Gambling and COVID-19: Initial Findings from a UK Sample. Int J Ment Health Addict 2021:1-12Sharman S, Roberts A, Bowden-Jones H, Strang J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104123 107. Undergraduate nursing students' resilience, challenges, and supports during corona virus pandemic. Int. J. Ment. Health Nurs. 2021; Hamadeh Kerbage S, Garvey L, Willetts G, Olasoji M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109714 108. The impact of Covid-19-related distancing on the well-being of nursing home residents and their family members: a qualitative study. Int J Nurs Stud Adv 2021; 3:100031Paananen J, Rannikko J, Harju M, Pirhonen J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095858 109. Impact of the COVID-19 pandemic on stress, resilience and depression in health professionals: a cross-sectional study. Int Nurs Rev 2021; Manzanares I, Sevilla Guerra S, Lombraña Mencía M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34097305 110. Trapped Between Two Pandemics: Domestic Violence Cases Under COVID-19 Pandemic Lockdown: A Scoping Review. Int. Q. Community Health Educ. 2021:272684x211022121Uzobo E, Ayinmoro AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102910 111. Subjective Well-Being of Adolescents in Luxembourg, Germany, and Brazil During the COVID-19 Pandemic. J. Adolesc. Health 2021; Engel de Abreu PMJ, Neumann S, Wealer C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092475 112. Perceived Changes in Mood and Anxiety Among Male Youth During the COVID-19 Pandemic: Findings From a Mixed-Methods Study. J. Adolesc. Health 2021; Tetreault E, Teferra AA, Keller-Hamilton B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112599 113. Is the COVID-19 pandemic a risk factor for suicide attempts in adolescent girls? J. Affect. Disord. 2021; 292:139-141Gracia R, Pamias M, Mortier P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119869 114. Anxiety during the Pandemic: Racial and ethnic differences in the trajectory of fear. J. Affect. Disord. 2021; 292:58-66Jacobs M, Burch AE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102549 115. Association between perceived stress and depression among medical students during the outbreak of COVID-19: The mediating role of insomnia. J. Affect. Disord. 2021; 292:89-94Liu Z, Liu R, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107425 116. Impact of Sex on COVID-19 Media Exposure, Anxiety, Perceived Risk, and Severity in Middle-Aged and Older Adults. J. Aging Health 2021:8982643211025383Curtis AF, Rodgers M, Miller MB, McCrae CS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114480 117. Mental Health of People with Dementia During COVID-19 Pandemic: What Have We Learned from the First Wave? J. Alzheimers Dis. 2021; Borg C, Rouch I, Pongan E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092637 118. Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care. J. Alzheimers Dis. 2021; Toniolo S, Scarioni M, Di Lorenzo F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092646 119. The Transition of Academic Mental Health Clinics to Telehealth During the COVID-19 Pandemic. J. Am. Acad. Child Adolesc. Psychiatry 2021; Folk JB, Schiel MA, Oblath R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119633 120. Social Isolation and Self-Reported Cognitive Decline Among Older Adults in Japan: A Longitudinal Study in the COVID-19 Pandemic. J. Am. Med. Dir. Assoc. 2021; Noguchi T, Kubo Y, Hayashi T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34107288 121. Belief and adherence to COVID 19-lockdown restrictions in patients with asthma versus other chronic diseases: results from a cross-sectional survey nested in the ComPaRe e-cohort, in France. J. Asthma 2021:1-11Taillé C, Roche N, Tesson F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111369 122. Mental Health Outcomes Associated with COVID-19 Pandemic in a Group of Health Care Professionals. J. Behav. Health Serv. Res. 2021:1-10Ziarko M, Jasielska A, Stanisławska-Kubiak M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34097206 123. Access to care and worsening eating disorder symptomatology in youth during the COVID-19 pandemic. J Eat Disord 2021; 9:69Spigel R, Lin JA, Milliren CE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112255 124. Review of epidemic, containment strategies, clinical management, and economic evaluation of COVID-19 pandemic. J Formos Med Assoc 2021; Chen CL, Lai CC, Luh DL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116896 125. Preparedness for containing COVID-19 outbreak in mass religious gathering with non-pharmaceutical interventions (NPIs). J Formos Med Assoc 2021; Hsu CY, Chen YM, Su CW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119393 126. Effectiveness of non-pharmaceutical interventions and vaccine for containing the spread of COVID-19: Three illustrations before and after vaccination periods. J Formos Med Assoc 2021; Lin TY, Liao SH, Lai CC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112587 127. The Impact of COVID-19 and Quarantine on Suicidality in Geriatric Inpatients-A Case Report. J. Geriatr. Psychiatry Neurol. 2021:8919887211023588Hophing M, Zimmerman-Winslow KJ, Basu A, Jacob T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109868 128. Comparing Macro Infuences on Individuals' Initial Coping and Response to COVID-19 in Canada and USA. J Hum Rights Soc Work 2021:1-9Wang D, Krase K, Clarke-Jones A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095456 129. Will achieving herd immunity be a road to success to end the COVID-19 pandemic? J Infect 2021; Kwok KO, McNeil EB, Tsoi MTF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118274 130. The healthier healthcare management models for COVID-19. J Infect Public Health 2021; 14:927-937Mishra A, Basumallick S, Lu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119847 131. Supporting Medical Student Mental Health during COVID-19: Strategies Implemented for an Accelerated Curriculum Medical Campus. J Med Educ Curric Dev 2021; 8:23821205211006392Chandratre S, Knight C, Dodson L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095501 132. Knowledge, attitude and practice towards COVID-19 among individuals with associated comorbidities. J. Med. Life 2021; 14:225-237Saeed S, Awasthi AA, Nandi D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104246 133. Perception of COVID-19 Prevention Methods Effcacy and Intention to Use Among Patients with Chronic Disease in Dessie Town, Northeast Ethiopia: A Multicentered Cross-sectional Study. J Multidiscip Healthc 2021; 14:1325- 1339Dires A, Gedamu S, Getachew Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113120 134. Assessing Primary Care Contributions to Behavioral Health: A Cross-sectional Study Using Medical Expenditure Panel Survey. J. Prim. Care Community Health 2021; 12:21501327211023871Jetty A, Petterson S, Westfall JM, Jabbarpour Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109860 135. Perceived Adequacy of Tangible Support during Stay-at-Home Orders in Chicago and New York. J. Prim. Care Community Health 2021; 12:21501327211024411O'Conor R, Opsasnick L, Pack A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109874 136. The interplay of stress and electrocortical reactivity to reward in the prospective prediction of depression symptoms during COVID-19. J. Psychiatr. Res. 2021; 140:124-131Feurer C, Granros M, Calentino AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111702 137. Change in humor and sarcasm use based on anxiety and depression symptom severity during the COVID-19 pandemic. J. Psychiatr. Res. 2021; 140:95- 100Rothermich K, Ogunlana A, Jaworska N. http://www.ncbi.nlm.nih.gov/pubmed/? term=34102518 138. The Relationship Between COVID-19 Confnement, Psychological Adjustment, and Sexual Functioning, in a Sample of Portuguese Men and Women. J. Sex. Med. 2021; Carvalho J, Campos P, Carrito M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116985 139. Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to fexibilities and sustaining reforms. J. Subst. Abuse Treat. 2021; 132:108514Treitler PC, Bowden CF, Lloyd J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098210 140. What does the “corona” situation do to the sleep of our children? Monatsschr. Kinderheilkd. 2021; 169:496-497Kerbl R. 141. Fear of COVID-19, problems accessing medical appointments, and subjective experience of disease progression, predict anxiety and depression reactions in patients with Multiple Sclerosis. Mult Scler Relat Disord 2021; 53:103070Broche-Pérez Y, Jiménez-Morales RM, Monasterio-Ramos LO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119745 142. Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled. Nat Sci Sleep 2021; 13:703-712Guo J, Yang L, Xu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104023 143. Psychiatric Emergencies During the Covid-19 Pandemic: A 6-Month Observational Study. Neuropsychiatr. Dis. Treat. 2021; 17:1763-1778Di Lorenzo R, Frattini N, Dragone D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113107 144. [Experiences of families of autistic children during a period of lockdown: Exploratory study]. Neuropsychiatr. Enfance Adolesc. 2021; Chamak B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092836 145. Resilience of frontline nurses during COVID pandemic in China: A qualitative study. Nurs Health Sci 2021; Huang F, Lin M, Sun W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110071 146. Integrating primary care and public health to enhance response to a pandemic. Prim. Health Care Res. Dev. 2021; 22:e27Kinder K, Bazemore A, Taylor M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109936 147. Transition of Mental Health Service Delivery to Telepsychiatry in Response to COVID-19: A Literature Review. Psychiatr. Q. 2021:1-17Li H, Glecia A, Kent- Wilkinson A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101075 148. How are OCD Patients and Family Members Dealing with the Waxing and Waning Pattern of the COVID-19 Pandemic? Results of a Longitudinal Observational Study. Psychiatr. Q. 2021:1-15Tandt HL, Debruyckere I, Leyman L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097247 149. Suicidal ideation among university students during the COVID-19 pandemic: Identifying at-risk subgroups. Psychiatry Res 2021; 302:114034Gratz KL, Mann AJD, Tull MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098158 150. Infuential factors of general anxiety disorder among Iranian pregnant women during the second peak of COVID-19 pandemic. Psychol Health Med 2021:1- 7Maleki A, Ashtari M, Molaie P, Yousefu S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34107805 151. Mental Disorders of Bangladeshi Students During the COVID-19 Pandemic: A Systematic Review. Psychol. Res. Behav. Manag. 2021; 14:645-654Al Mamun F, Hosen I, Misti JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104010 152. Implications of the COVID-19 Pandemic on the Mental Health and Professional Psychomotor Skills of Dental Students. Psychol. Res. Behav. Manag. 2021; 14:675-685Alrashed FA, Sattar K, Habib SR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113184 153. Ethical Leadership and Organizational Citizenship Behavior: Mediation of Trust and Psychological Well-Being. Psychol. Res. Behav. Manag. 2021; 14:655- 664Huang N, Qiu S, Yang S, Deng R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104011 154. Suicide and Suicidal Behaviors in the Context of COVID-19 Pandemic in Bangladesh: A Systematic Review. Psychol. Res. Behav. Manag. 2021; 14:695- 704Mamun MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113185 155. Low Anti-Mullerian Hormone Levels Are Associated with the Severity of Anxiety Experienced by Healthcare Professionals During the COVID-19 Pandemic. Reprod. Sci. 2021:1-6Yeğin GF, Desdicioğlu R, Seçen E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101147 156. [Not Available]. Rev Colomb Psiquiatr 2021; Pedraz-Petrozzi B, Krüger-Malpartida H, Arevalo-Flores M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108741 157. [Not Available]. Rev Colomb Psiquiatr 2021; Zapata-Ospina JP, Patiño-Lugo DF, Vélez CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108740 158. Impact of COVID-19 pandemic on mental health and health behaviors in Swedish adolescents. Scand J Public Health 2021:14034948211021724Chen Y, Osika W, Henriksson G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100665 159. The impact of the COVID-19 pandemic on nighttime room entries and sleep disruptions for pediatric patients. Sleep Med. 2021; 84:76-81Riehm JM, Arora VM, Tatineni S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119840 160. Can Personality Traits Predict Depression during the COVID-19 Pandemic? Soc Justice Res 2021:1-17Nudelman G, Kamble SV, Otto K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092913 161. Maternal low-intensity psychosocial telemental interventions in response to COVID-19 in Qatar: study protocol for a randomized controlled trial. Trials 2021; 22:382Naja S, Elyamani R, Chehab M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099007 162. Higher education students' behaviour and mental health during Covid-19 lockdown: a pilot study. Z Gesundh Wiss 2021:1-7Mishra L, Kumar NP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094814

Meta-analyses - systematic reviews (29articles) 1. The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis. Ann. Med. 2021; 53:874-884Wu KS, Lin PC, Chen YS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096808 2. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br. J. Clin. Pharmacol. 2021; Asiimwe IG, Pushpakom S, Turner RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101232 3. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the Era of vaccination: A systematic review and meta-analysis. Clin Microbiol Infect 2021; Kayı İ, Madran B, Keske Ş et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116205 4. Global REnal Involvement of CORonavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis of Incidence, Risk Factors, and Clinical Outcomes. Front Med (Lausanne) 2021; 8:678200Chan KW, Yu KY, Lee PW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113640 5. Use of aspirin in reduction of mortality of COVID-19 patients: A metanalysis. Int J Clin Pract 2021:e14515Srivastava R, Kumar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118111 6. COVID-19 associated brain/spinal cord lesions and leptomeningeal enhancement: A meta-analysis of the relationship to CSF SARS-CoV-2. J. Neuroimaging 2021; Lewis A, Jain R, Frontera J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105198 7. Coronary heart disease and COVID-19: A meta-analysis. Med Clin (Engl Ed) 2021; 156:547-554Liang C, Zhang W, Li S, Qin G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109276 8. Sofosbuvir with daclatasvir and the outcomes of patients with COVID-19: a systematic review and meta-analysis with GRADE assessment. Postgrad. Med. J. 2021; Zein A, Sulistiyana CS, Raffaello WM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103373 9. [Relationship between BCG vaccination and increased mortality from COVID- 19. An ecological fallacy?]. Rev. Med. Inst. Mex. Seguro Soc. 2020; 58:78- 79Villasís-Keever M, Miranda-Novales MG. http://www.ncbi.nlm.nih.gov/pubmed/? term=34101549

Mortality (32 articles)

1. Infammatory Response Leads to Neuronal Death in Human Post-Mortem Cerebral Cortex in Patients with COVID-19. ACS Chem Neurosci 2021; 12:2143- 2150Boroujeni ME, Simani L, Bluyssen HAR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100287 2. Dying from cancer with COVID-19: age, sex, socio-economic status, and comorbidities. Acta Oncol. 2021:1-6Strang P, Hedman C, Adlitzer H, Schultz T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101521 3. Evaluation of Modifed ATRIA Risk Score in Predicting Mortality in Hospitalized Patients with COVID-19. Am. J. Med. Sci. 2021; Aciksari G, Cetinkal G, Kocak M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107275 4. Community end-of-life care during COVID-19: Findings of a UK primary care survey. BJGP Open 2021; Mitchell S, Oliver P, Gardiner C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117014 5. Designing COVID-19 mortality predictions to advance clinical outcomes: Evidence from the Department of Veterans Affairs. BMJ Health Care Inform 2021; 28Makridis CA, Strebel T, Marconi V, Alterovitz G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108143 6. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review. Eur. J. Med. Res. 2021; 26:51SeyedAlinaghi S, Mirzapour P, Dadras O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103090 7. Lung Ultrasound Score as a Predictor of Mortality in Patients With COVID-19. Front Cardiovasc Med 2021; 8:633539Sun Z, Zhang Z, Liu J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113658 8. Clinical Signifcance of Plasma D-Dimer in COVID-19 Mortality. Front Med (Lausanne) 2021; 8:638097Li Y, Deng Y, Ye L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113629 9. High Infection Fatality Rate Among Elderly and Risk Factors Associated With Infection Fatality Rate and Asymptomatic Infections of COVID-19 Cases in Hong Kong. Front Med (Lausanne) 2021; 8:678347Tao J, Zhang X, Musa SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109200 10. End of Life Decision-Making Challenges in a Latino Patient with COVID-19: Facing Barriers. Gerontol Geriatr Med 2021; 7:23337214211021726Huayanay I, Pantoja C, Chang C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104688 11. Increased procoagulant platelet levels are predictive of death in COVID-19. Geroscience 2021:1-11Khattab MH, Prodan CI, Vincent AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109507 12. Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area - a population-based registry study. Infect Dis (Lond) 2021:1-11Forsblom E, Silén S, Kortela E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100692 13. The Boundaries Between Survival and Non-Survival at COVID-19: Experience of Tertiary Care Pandemic Hospital. Int J Clin Pract 2021:e14461Arslan Y, Dogan D, Ocal N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107117 14. Association between risk of VTE and mortality in patients with COVID-19. Int J Infect Dis 2021; Chen S, Zheng T, Wang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107325 15. Probabilistic forecasts of COVID-19 deaths with the progression rate from pneumonia to ARDS: An open-data-based global study. J Formos Med Assoc 2021; Chang WJ, Chen YC, Hsu CY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34116895 16. In-hospital Mortality in SARS-CoV-2 stratifed by serum 25-Hydroxy-Vitamin D levels: A Retrospective Study. J Med Virol 2021; Al-Jarallah M, Rajan R, Dashti R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101207 17. Demographic and territorial characteristics of COVID-19 cases and excess mortality in the European Union during the frst wave. J Popul Res (Canberra) 2021:1-24Goujon A, Natale F, Ghio D, Conte A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093083 18. A dignifed death: management of dead bodies during COVID-19. J Public Health (Oxf) 2021; Corpuz JCG. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096608 19. Closed but Not Protected: Excess Deaths Among the Amish and Mennonites During the COVID-19 Pandemic. J Relig Health 2021:1-15Stein RE, Corcoran KE, Colyer CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117598 20. Epidemiological, imaging, laboratory, and clinical characteristics and factors related to mortality in patients with COVID-19: a single-center study. Osong Public Health Res Perspect 2021; Azarkar Z, Salehiniya H, Kazemi T, Abbaszadeh H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102047 21. SARS-CoV‑2 incidental fndings among Hamburg deaths: an epidemiological monitoring during the dynamic infection event in spring 2020. Rechtsmedizin 2021; Klein A, Langenwalder F, Heinrich F et al. 22. Patients' treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections. Respir Res 2021; 22:168Budweiser S, Baş Ş, Jörres RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098967 23. Steady state Kalman flter design for cases and deaths prediction of Covid-19 in Greece. Results Phys 2021; 26:104391Assimakis N, Adam M, Ktena A, Manasis C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104629 24. [Continuous deep sedation until death for COVID-19 patients]. Soins 2021; 66:30-33Amar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103130 25. [Palliative care and COVID-19, a creative challenge]. Soins 2021; 66:37- 38Amouroux-Gorsse V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103132 26. [Infuence of COVID-19 on issues relating to end of life and the support of patients]. Soins 2021; 66:26-29Aubry R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103129 27. [When care means being present for the other]. Soins 2021; 66:39-40Benduduh K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103133 28. [Student nurses faced with the palliative care approach]. Soins 2021; 66:51Hérisson B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103138 29. [Supporting end-of-life at home during a pandemic]. Soins 2021; 66:49- 50Lecointre B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103137 30. [Impacts of the health crisis on palliative care]. Soins 2021; 66:22-25Lefaucheur AS, Hirsch G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103128 31. [Identifed palliative care beds in the time of COVID-19]. Soins 2021; 66:44- 45Parot-Monpetit A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103135 32. Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19. Thromb Res 2021; 204:13- 15Stanne TM, Pedersen A, Gisslén M, Jern C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102452

Online – IT – Apps (104 articles)

1. Addressing pediatric mental health using telehealth during COVID-19 and beyond: A narrative review. Acad. Pediatr. 2021; Cunningham NR, Ely SL, Garcia BNB, Bowden J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118499 2. Simulated Patient Environment: A Training Tool for Healthcare Professionals in COVID-19 Era. Adv Med Educ Pract 2021; 12:579-585M VB, Arumugam MK, Debnath DJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104036 3. The patient's perspective of remote respiratory assessments during the COVID-19 pandemic. Amyotroph Lateral Scler Frontotemporal Degener 2021:1- 5Tattersall R, Carty S, Meldrum D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092157 4. Geospatial analysis of misinformation in COVID-19 related tweets. Appl Geogr 2021; 133:102473Forati AM, Ghose R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34103772 5. Deep Insight: Convolutional Neural Network and its Applications for COVID-19 Prognosis. Biomed. Signal Process. Control 2021:102814Khanday NY, Sof SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093724 6. Web-based, rapid and contactless management of ambulatory patients for SARS-CoV-2-testing. BMC Infect. Dis. 2021; 21:535Stemler J, Cornely OA, Noack- Schönborn T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098882 7. Distance education during COVID 19: an Italian survey on the university teachers' perspectives and their emotional conditions. BMC Med. Educ. 2021; 21:335Casacchia M, Cifone MG, Giusti L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107926 8. The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China. BMC Ophthalmol. 2021; 21:258Guo Z, Ma N, Wu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112134 9. Going beyond access to health information: a pandemic call to action. BMJ Glob Health 2021; 6Bhaumik S, Chatterjee P. http://www.ncbi.nlm.nih.gov/pubmed/? term=34112649 10. A telepresence robot in the room of a COVID-19 patient can provide virtual family presence. Can J Anaesth 2021:1-2Lociciro A, Guillon A, Bodet-Contentin L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105064 11. 'The world somehow stopped moving': impact of the COVID-19 pandemic on adolescent psychiatric outpatients and the implementation of teletherapy. Child Adolesc Ment Health 2021; Huscsava MM, Scharinger C, Plener PL, Kothgassner OD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114730 12. Delivering Transdiagnostic Treatment Over Telehealth During the COVID-19 Pandemic: Application of the Unifed Protocol. Cogn. Behav. Pract. 2021; Cassiello-Robbins C, Zachary Rosenthal M, Ammirati RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108830 13. Perceptions of blame on social media during the coronavirus pandemic. Comput. Human Behav. 2021:106895Choli M, Kuss DJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103785 14. A Hybrid Virtual Fracture Clinic is Safe and Effcacious in the COVID-19 Era: Stay at Home and Save Lives. Cureus 2021; 13:e14849Sharma A, Butt MI, Ajayi B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104593 15. Effectiveness of Video-Based Online Training for Health Care Workers to Prevent COVID-19 Infection: An Experience at a Tertiary Care Level Institute, Uttarakhand, India. Cureus 2021; 13:e14785Sharma R, Mohanty A, Singh V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094747 16. Remote screening of diabetic retinopathy using ultra-widefeld retinal imaging. Diabetes Res Clin Pract 2021:108902Kato A, Fujishima K, Takami K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102247 17. Potentialities and challenges of digital health in psychiatry in Kashmir, India. Digit Health 2021; 7:20552076211019908Shoib S, Arafat SY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104469 18. The Infuence of Social Media use on Practice of Covid-19 Preventive Measures Among Ethiopian Residents: An Online Cross-Sectional Study. Disaster Med Public Health Prep 2021:1-18Sadore AA, Handiso DW, Wontamo TE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099090 19. Initial Development of a National Survey on Remote Learning in Early Childhood During COVID-19: Establishing Content Validity and Reporting Successes and Barriers. Early Child Educ J 2021:1-13McKenna M, Soto-Boykin X, Cheng K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092995 20. Academic and emotional effects of online learning during the COVID-19 pandemic on engineering students. Educ Inf Technol (Dordr) 2021:1-28Baltà- Salvador R, Olmedo-Torre N, Peña M, Renta-Davids AI. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108843 21. Adoption of online proctored examinations by university students during COVID-19: Innovation diffusion study. Educ Inf Technol (Dordr) 2021:1-20Raman R, B S, G V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093065 22. The survey about live broadcast teaching in Chinese middle schools during the COVID-19 Pandemic. Educ Inf Technol (Dordr) 2021:1-15Yu L, Lan M, Xie M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108845 23. Telephone-based assessment of multiple sclerosis patients at Ain Shams University Hospital in the coronavirus disease 2019 pandemic. Egypt J Neurol Psychiatr Neurosurg 2021; 57:66Abdel Hafeez MA, Zamzam DA, Swelam MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093002 24. Challenges of higher education related to e-learning in developing countries during COVID-19 spread: a review of the perspectives of students, instructors, policymakers, and ICT experts. Environ. Sci. Pollut. Res. Int. 2021:1-7Zarei S, Mohammadi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100207 25. Clinical examination practices and perceptions in the era of COVID-19. Expert Rev. Respir. Med. 2021:1-5Kyriakoulis KG, Poulakou G, Nitsotolis T, Syrigos KN. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109904 26. Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data. Front Genet 2021; 12:636441Sardar R, Sharma A, Gupta D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093642 27. Satisfaction of Telehealth in Patients With Established Neuromuscular Disorders. Front. Neurol. 2021; 12:667813Hooshmand S, Cho J, Singh S, Govindarajan R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093416 28. Adolescent Vision Health During the Outbreak of COVID-19: Association Between Digital Screen Use and Myopia Progression. Front Pediatr 2021; 9:662984Liu J, Li B, Sun Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113588 29. Design of a Mobile Application and Evaluation of Its Effects on Psychological Parameters of Covid-19 Inpatients: A Protocol for a Randomized Controlled Trial. Front Psychiatry 2021; 12:612384Aalaei S, Khoshrounejad F, Saleh LA, Amini M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108892 30. Problematic Use of Internet-Related Activities and Perceived Weight Stigma in Schoolchildren: A Longitudinal Study Across Different Epidemic Periods of COVID-19 in China. Front Psychiatry 2021; 12:675839Fung XCC, Siu AMH, Potenza MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108898 31. Virtual Online Home-Based Treatment During the COVID-19 Pandemic for Ultra-Orthodox Young Women With Eating Disorders. Front Psychiatry 2021; 12:654589Latzer Y, Herman E, Ashkenazi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108896 32. Music Therapy During COVID-19: Changes to the Practice, Use of Technology, and What to Carry Forward in the Future. Front. Psychol. 2021; 12:647790Agres KR, Foubert K, Sridhar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093330 33. Effects of the Brain Wave Modulation Technique Administered Online on Stress, Anxiety, Global Distress, and Affect During the First Wave of the COVID-19 Pandemic: A Randomized Clinical Trial. Front. Psychol. 2021; 12:635877Cozzolino M, Celia G, Girelli L, Limone P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093317 34. Corrigendum: The Use of Online Training Tools in Competition Cyclists During COVID-19 Confnement in Spain. Front. Psychol. 2021; 12:684946Moreno-Tenas A, León-Zarceño E, Serrano-Rosa MA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093377 35. Gamifcation as Online Teaching Strategy During COVID-19: A Mini-Review. Front. Psychol. 2021; 12:648552Nieto-Escamez FA, Roldán-Tapia MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093334 36. Livestream Experiments: The Role of COVID-19, Agency, Presence, and Social Context in Facilitating Social Connectedness. Front. Psychol. 2021; 12:647929Onderdijk KE, Swarbrick D, Van Kerrebroeck B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108911 37. Techno Trend Awareness and Its Attitude Towards Social Connectedness and Mitigating Factors of COVID-19. Front. Psychol. 2021; 12:637395Pandey V, Misra N, Greeshma R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113286 38. Reliability of Google Trends: Analysis of the Limits and Potential of Web Infoveillance During COVID-19 Pandemic and for Future Research. Front Res Metr Anal 2021; 6:670226Rovetta A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113751 39. Modelling the Impact of Robotics on Infectious Spread Among Healthcare Workers. Front Robot AI 2021; 8:652685Vicente R, Mohamed Y, Eguíluz VM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113657 40. Telehealth amid the COVID19 pandemic: perception among Asian, Native Hawaiian and Pacifc Islander cancer patients. Future Oncol 2021; Meno M, Abe J, Fukui J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102878 41. E-Mentoring Female Underrepresented Public Health Student Researchers: Supporting a More Diverse Postpandemic Workforce. Health Secur 2021; Mahayosnand PP, Zanders L, Sabra ZM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34097467 42. Using SNSs for early detection of disease outbreak in developing countries: evidence from COVID-19 pandemic in Nigeria. Heliyon 2021; 7:e07184Adebisi T, Aregbesola A, Asamu F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099986 43. Social media and COVID-19 misinformation: how ignorant Facebook users are? Heliyon 2021; 7:e07144Al-Zaman MS. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113736 44. Closer to or further from the new normal? business approach through social media analysis. Heliyon 2021; 7:e07106Iglesias-Sánchez PP, Jambrino-Maldonado C, de Las Heras-Pedrosa C, Fernandez-Díaz E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113731 45. Psychological impacts of COVID-19 and satisfaction from online classes: disturbance in daily routine and prevalence of depression, stress, and anxiety among students of Pakistan. Heliyon 2021; 7:e07030Khawar MB, Abbasi MH, Hussain S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095563 46. Tele-Otolaryngology at a Tertiary Care Center in North India During COVID-19 Pandemic Lockdown: A Validated Patient Feedback Questionnaire Based Study. Indian J Otolaryngol Head Neck Surg 2021:1-14Rathod R, Arora K, Chettuvati K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104634 47. Impact of social media on public fear, adoption of precautionary behaviors, and compliance with health regulations during COVID-19 pandemic. Int. J. Environ. Health Res. 2021:1-13Yassin A, AlOmari M, Al-Azzam S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097535 48. Health Sentinel: A mobile crowdsourcing platform for self-reported surveys provides early detection of COVID-19 clusters in San Luis Potosí, Mexico. Int. J. Med. Inform. 2021; 153:104508Ruiz-Correa S, López-Revilla R, Díaz-Barriga F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098316 49. Sexual healthcare professionals' views on the rapid provision of remote services at the beginning of COVID-19 pandemic: A mixed-methods study. Int. J. STD AIDS 2021:9564624211023018Lunt A, Llewellyn C, Bayley J, Nadarzynski T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106016 50. Dissemination and Acceptance of COVID-19 Misinformation in Iran: A Qualitative Study. Int. Q. Community Health Educ. 2021:272684x211022155Taghipour F, Ashraf-Rizi H, Soleymani MR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098804 51. Telemedicine experiences at a pediatric endocrinology clinic during the COVID-19 pandemic. Ir. J. Med. Sci. 2021:1-6Denkboy Ongen Y, Eren E, Sahin KC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100191 52. Telephone consultations to manage paediatric outpatient clinics during the COVID-19 pandemic: a service evaluation. Ir. J. Med. Sci. 2021:1-7Edwards LM, Parry M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100192 53. Impact of Sex on COVID-19 Media Exposure, Anxiety, Perceived Risk, and Severity in Middle-Aged and Older Adults. J. Aging Health 2021:8982643211025383Curtis AF, Rodgers M, Miller MB, McCrae CS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114480 54. The Transition of Academic Mental Health Clinics to Telehealth During the COVID-19 Pandemic. J. Am. Acad. Child Adolesc. Psychiatry 2021; Folk JB, Schiel MA, Oblath R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119633 55. Artifcial Intelligence and technology in COVID Era: A narrative review. J. Anaesthesiol. Clin. Pharmacol. 2021; 37:28-34Ahuja V, Nair LV. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103818 56. Big data insight on global mobility during the Covid-19 pandemic lockdown. J Big Data 2021; 8:78Sadowski A, Galar Z, Walasek R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094812 57. Building Back Better: Applying Lessons from the COVID-19 Pandemic to Expand Critical Information Access. J. Emerg. Med. 2021; Schwartz HEM, Stark NR, Sowa CS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108121 58. Sudden shift to remote genetic counseling during the COVID-19 pandemic: Experiences of genetics professionals in Italy. J Genet Couns 2021; Turchetti D, Battistuzzi L, Bertonazzi B, Godino L. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096134 59. Truths and fakes in the smell terminology during the COVID-19 outbreak. J Intern Med 2021; Arana-Fernández B, Santamaría-Gadea A, Mariño-Sánchez F, Mullol J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110054 60. Low-barrier buprenorphine during the COVID-19 pandemic: A rapid transition to on-demand telemedicine with wide-ranging effects. J. Subst. Abuse Treat. 2021; 131:108444Buchheit BM, Wheelock H, Lee A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098299 61. Perceived Usefulness of Telehealth Among Rural Medical Providers: Barriers to Use and Associations with Provider Confdence. J Technol Behav Sci 2021:1- 5Terry DL, Buntoro SP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109271 62. Protocol for a Nationwide Internet-based Health Survey of Workers During the COVID-19 Pandemic in 2020. J uoeh 2021; 43:217-225Fujino Y, Ishimaru T, Eguchi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092766 63. Exploration of Immersive Virtual Reality in Teaching Veterinary Orthopedics. J. Vet. Med. Educ. 2021:e20210009McCaw K, West A, Duncan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102095 64. Building Primary-School Children's Resilience through a Web-Based Interactive Learning Environment: Quasi-Experimental Pre-Post Study. JMIR Pediatr Parent 2021; 4:e27958Nicolaidou I, Stavrou E, Leonidou G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106080 65. Developing Modern System in Healthcare to Detect Covid 19 Based on Internet of Things. Mater Today Proc 2021; Ismael MH, Maolood AT. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104630 66. Development of a Virtual Journal Club in Anatomy: a Responsive Pandemic Pedagogy. Med Sci Educ 2021:1-8Keet KA, Baatjes KJ, Venter RG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094692 67. Exploring the STEP-uP to practice: A survey of UK Lead Midwives for Education views of the STudent midwife Extended Practice Placement during the frst wave of the COVID-19 pandemic. Midwifery 2021; 101:103048Cooke A, Hancock A, White H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111806 68. Surveilling and Tracking COVID-19 Patients Using a Portable Quantum Dot Smartphone Device. Nano Lett 2021; Zhang Y, Malekjahani A, Udugama BN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110166 69. COVID-19: an Alarm to Move Faster towards "Smart Hospitals". Online J Public Health Inform 2021; 13:e7Tabatabaei SM, Kasrineh MR, Sharifzadeh N, Soodejani MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113422 70. Utility of Emergency Medical Dispatch (EMD) Telephone Screening in Identifying COVID-19 Positive Patients. Prehosp. Emerg. Care 2021:1- 14McCann-Pineo M, Li T, Barbara P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34115573 71. [The contribution of teleconsultation and isolation of symptomatic cases in control of the COVID-19 outbreak a military base]. Rev. Epidemiol. Sante Publique 2021; Allonneau A, Villeneuve JP, Sempere H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119362 72. Virtual reality relaxation for the general population: a systematic review. Soc. Psychiatry Psychiatr. Epidemiol. 2021:1-21Riches S, Azevedo L, Bird L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120220 73. Picture fuzzy set-based decision-making approach using Dempster-Shafer theory of evidence and grey relation analysis and its application in COVID-19 medicine selection. Soft comput 2021:1-15Si A, Das S, Kar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108847 74. Patient Satisfaction with Telehealth During COVID-19: Experience in a Rural County on the United States-Mexico Border. Telemed J E Health 2021; Phenicie R, Acosta Wright R, Holzberg J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096790 75. Telehealth in Pediatric Surgical Subspecialties: Rapid Adoption in the Setting of COVID-19. Telemed J E Health 2021; Schmidtberg LC, Grindle C, Hersh DS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101508 76. Kidney transplant recipient perspectives on telehealth during the COVID-19 pandemic. Transpl Int 2021; Huuskes BM, Scholes-Robertson N, Guha C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115918 77. Maternal low-intensity psychosocial telemental interventions in response to COVID-19 in Qatar: study protocol for a randomized controlled trial. Trials 2021; 22:382Naja S, Elyamani R, Chehab M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099007

Other – Miscellaneous (78 articles)

1. Alcohol consumption during the COVID-19 pandemic in Europe: a large-scale cross-sectional study in 21 countries. Addiction 2021; Kilian C, Rehm J, Allebeck P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109685 2. Program Adaptations to Provide Harm Reduction Services During the COVID- 19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S. AIDS Behav. 2021:1-12Frost MC, Sweek EW, Austin EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110506 3. Distribution of spreading viruses during COVID-19 pandemic: Effect of mitigation strategies. Am. J. Infect. Control 2021; Kıymet E, Böncüoğlu E, Şahinkaya Ş et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116082 4. Endangered mountain gorillas and COVID-19: One health lessons for prevention and preparedness during a global pandemic. Am. J. Primatol. 2021:e23291Gilardi K, Nziza J, Ssebide B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110030 5. Understanding the changing role of global public health in biodiversity conservation. Ambio 2021:1-9Smith W. http://www.ncbi.nlm.nih.gov/pubmed/? term=34115346 6. COVID-19 and sunlight: Impact on SARS-CoV-2 transmissibility, morbidity, and mortality. Ann Med Surg (Lond) 2021; 66:102419Sharun K, Tiwari R, Dhama K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094531 7. Drivers and trajectories of China's renewable energy consumption. Ann Oper Res 2021:1-19Chen J, Xu C, Wu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092839 8. Air pollution and cardiovascular disease: Can the Australian bushfres and global COVID-19 pandemic of 2020 convince us to change our ways? Bioessays 2021:e2100046Wolhuter K, Arora M, Kovacic JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106476 9. High food insecurity in Latinx families and associated COVID-19 infection in the Greater Bay Area, California. BMC Nutr 2021; 7:23Escobar M, Mendez AD, Encinas MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112257 10. Increased household secondary attacks rates with Variant of Concern SARS- CoV-2 index cases. Clin Infect Dis 2021; Buchan SA, Tibebu S, Daneman N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105720 11. Infuence of the confnement that occurred in Spain due to the SARS-CoV-2 virus outbreak on adherence to the Mediterranean diet. Clin Investig Arterioscler 2021; Carbayo Herencia JA, Rosich N, Panisello Royo JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092432 12. The politics of testing positive: an autoethnography of media (mis)representations at the 'start' and 'end' of different pandemics. Cult Health Sex 2021:1-15Morris M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114520 13. Deciding between moral priorities and COVID-19 avoiding behaviors: A moral foundations vignette study. Curr. Psychol. 2021:1-17Ekici H, Yücel E, Cesur S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099957 14. The infuence of organizational death on work priorities and the moderating role of attachment internal working models. Curr. Psychol. 2021:1-15Yaakobi E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092988 15. Food Insecurity and Affecting Factors in Households with Children During the Covid-19 Pandemic: A Cross-Sectional Study. Disaster Med Public Health Prep 2021:1-20Bulucu Büyüksoy GD, Çatıker A, Özdil K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096489 16. War on waste: Challenges and experiences in COVID-19 waste management. Disaster Med Public Health Prep 2021:1-13Gowda NR, Siddharth V, Inquillabi K, Sharma DK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096492 17. Impact assessment on water quality in the polluted stretch using a cluster analysis during pre- and COVID-19 lockdown of Tawi river basin, Jammu, North India: an environment resiliency. Energy Ecol Environ 2021:1-12Kour G, Kothari R, Dhar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095454 18. Assessment of air pollution status during COVID-19 lockdown (March-May 2020) over Bangalore City in India. Environ. Monit. Assess. 2021; 193:395Gouda KC, Singh P, P N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105059 19. Intra-city variability of fne particulate matter during COVID-19 lockdown: A case study from Park City, Utah. Environ. Res. 2021:111471Mendoza D, Benney TM, Bares R, Crosman ET. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102162 20. Ethics Guidance for Environmental Scientists Engaged in Surveillance of Wastewater for SARS-CoV-2. Environ. Sci. Technol. 2021; Hrudey SE, Silva DS, Shelley J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101444 21. Detecting epidemiological relevance of adenoid hypertrophy, rhinosinusitis, and allergic rhinitis through an Internet search. Eur Arch Otorhinolaryngol 2021:1-7Yang Y, Li X, Ma Q et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104981 22. Disease and Disapproval: COVID-19 Concern is Related to Greater Moral Condemnation. Evol Psychol 2021; 19:14747049211021524Henderson RK, Schnall S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112018 23. Nurture, Pleasure and Read and Resist!: Abolition Feminist Methodology for a Collective Recovery? Fem Leg Stud 2021:1-12Adams F, Emmerich F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092938 24. iOntoBioethics: A Framework for the Agile Development of Bioethics Ontologies in Pandemics, Applied to COVID-19. Front Med (Lausanne) 2021; 8:619978Odeh M, Kharbat FF, Yousef R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34095160 25. Encapsulated Food Products as a Strategy to Strengthen Immunity Against COVID-19. Front Nutr 2021; 8:673174Tripathy S, Verma DK, Thakur M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095193 26. Work Resumption Rate and Migrant Workers' Income During the COVID-19 Pandemic. Front Public Health 2021; 9:678934Li J, Chu B, Chai N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095076 27. Empirical Examination on the Drivers of the U.S. Equity Returns in the During the COVID-19 Crisis. Front Public Health 2021; 9:679475Wang Q, Bai M, Huang M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095078 28. On the Environmental Determinants of COVID-19 Seasonality. Geohealth 2021; 5:e2021GH000413Choi YW, Tuel A, Eltahir EAB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095688 29. Risk Communication and Institutional Racism: The Protective Health Effect of Refugee-Led Community Organizations. Health Secur 2021; 19:S89-s94Pimentel Walker AP, Sanga N, Benson OG, Yoshihama M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096802 30. Risk Communication and Institutional Racism: The Protective Health Effect of Refugee-Led Community Organizations. Health Secur 2021; Pimentel Walker AP, Sanga N, Gonzalez Benson O, Yoshihama M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096802 31. US Immigration Policies Pose Threat to Health Security During COVID-19 Pandemic. Health Secur 2021; Ross HM, Desiderio S, St Mars T, Rangel P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096788 32. Access to Harm Reduction Treatment Among Formerly Incarcerated Individuals During the COVID-19 Era. Health Secur 2021; 19:S95-s101Rowell- Cunsolo TL, Bellerose M, Hart C. http://www.ncbi.nlm.nih.gov/pubmed/? term=34101494 33. Symbolic annihilation of Syrian refugees by Turkish news media during the COVID-19 pandemic. Int J Equity Health 2021; 20:137Yücel A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116671 34. Looking around the corner: COVID-19 shocks and market dynamics in US medical tourism. Int. J. Health Plann. Manage. 2021; Stackpole I, Ziemba E, Johnson T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096092 35. U.S.-Imposed Economic Sanctions on Iran in the COVID-19 Crisis From the Human Rights Perspective. Int J Health Serv 2021:207314211024912Karimi A, Turkamani HS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106781 36. COVID-19 outbreaks at shelters for women victims of gender-based violence from Ecuador. Int J Infect Dis 2021; Vallejo-Janeta AP, Morales-Jadan D, Freire- Paspuel B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119677 37. Commercial Sex Work During Novel Coronavirus (SARS-CoV-2) Era in the Niger Delta Region: Relationships Between Knowledge, Preventive Practice, and Transmission Potential. Int J Womens Health 2021; 13:509-523Avwioro G, Egwunyenga A, Adjekuko C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113178 38. Where Do We Go After Surviving the Virus? Cross-Country Documentary Analysis of the Social Consequences Faced by COVID-19 Survivors. Int. Q. Community Health Educ. 2021:272684x211022176Owusu AFS, Abdullah A, Pinto GH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102924 39. Big data insight on global mobility during the Covid-19 pandemic lockdown. J Big Data 2021; 8:78Sadowski A, Galar Z, Walasek R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094812 40. A Relational Refection on Pandemic Nationalism. J Chin Polit Sci 2021:1- 25Yeophantong P, Shih CY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092991 41. Improving the Perception of Patient-Centered Wellness in a Virtual Population During the COVID-19 Pandemic. J Dr Nurs Pract 2021; Myers S, Kennedy C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108200 42. The impact of COVID-19 on households´ income in the EU. J Econ Inequal 2021:1-19Almeida V, Barrios S, Christl M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093098 43. Review of epidemic, containment strategies, clinical management, and economic evaluation of COVID-19 pandemic. J Formos Med Assoc 2021; Chen CL, Lai CC, Luh DL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116896 44. HEALTH STATUS AND LIFESTYLE HABITS OF VULNERABLE, COMMUNITY- DWELLING OLDER PEOPLE DURING THE COVID-19 LOCKDOWN. J Frailty Aging 2021; 10:286-289Machón M, Mateo-Abad M, Vrotsou K, Vergara I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105714 45. Increased disinfection byproducts in the air resulting from intensifed disinfection during the COVID-19 pandemic. J. Hazard. Mater. 2021; 418:126249Lou J, Wang W, Lu H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34119971 46. Biological removal of benzalkonium chlorides from wastewater by immobilized cells of Pseudomonas sp. BIOMIG1 in an up-fow packed bed reactor. J. Hazard. Mater. 2021; 418:126210Sakarya FK, Haznedaroglu BZ, Tezel U. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102365 47. Moral judgment is important in COVID-19 pandemic. J Infect Dev Ctries 2021; 15:615-617Abualait T, Bashir S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34106882 48. Political stigma of communicable diseases in complex emergencies. J Infect Dev Ctries 2021; 15:747-748Bellizzi S, Bassat Q, Pichierri G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106901 49. Fortieth anniversary refections on the early days of HIV and the current era. J Int AIDS Soc 2021; 24:e25757Mayer KH. http://www.ncbi.nlm.nih.gov/pubmed/? term=34097346 50. COVID-19 conscience tracing: mapping the moral distances of coronavirus. J. Med. Ethics 2021; Shaw D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103367 51. A Comparison of Zika Virus and COVID-19: Clinical Overview and Public Health Messaging. J Midwifery Womens Health 2021; McBroom K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096682 52. Developing a Multilevel Scale to Assess Retention of Workers with Disabilities. J Occup Rehabil 2021:1-9Krisi M, Eckhaus E, Nagar R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106379 53. Electronic Cigarette Use Is Not Associated with COVID-19 Diagnosis. J. Prim. Care Community Health 2021; 12:21501327211024391Jose T, Croghan IT, Hays JT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109870 54. #ChurchInAction: more than a hashtag, it is an activism. J Public Health (Oxf) 2021; Macaraan WER. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095955 55. Changing landscapes of death and burial practices: public health response in time of COVID-19 pandemic. J Public Health (Oxf) 2021; 43:e267-e268Sarmiento PJD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102747 56. An Investigation of Associations Between Race, Ethnicity, and Past Experiences of Discrimination with Medical Mistrust and COVID-19 Protective Strategies. J Racial Ethn Health Disparities 2021:1-13Smith AC, Woerner J, Perera R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117633 57. COVID-19 Medical-Religious Partnerships: Implementation of a Just-In-Time COVID-19 Training in Catholic Schools. J Relig Health 2021:1-9Galiatsatos P, Soybel A, Bryan J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105027 58. Determining quarantine length and testing frequency for international border opening. J Travel Med 2021; Dickens BL, Koo JR, Lim JT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104959 59. Comparing the laws of England, Wales and Italy Relating to the Unilateral Modifcation for the Terms of Operational Contract during the COVID-19 Pandemic. Liverp Law Rev 2021:1-19Sharar B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108775 60. Budgies and bugs: our homegrown contribution to pandemics. Med. J. Aust. 2021; Kaplan RM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096071 61. Quarantine during COVID-19 outbreak: Adherence to the Mediterranean diet among the Cypriot population. Nutrition 2021; 90:111313Kyprianidou M, Christophi CA, Giannakou K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119718 62. Coastal vulnerability analysis to support strategies for tackling COVID-19 infection. Ocean Coast Manag 2021; 211:105731Armenio E, Mossa M, Petrillo AF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092937 63. Socio-demographic disparities in the eating behaviour of Malaysian children during the COVID-19 lockdown. Osong Public Health Res Perspect 2021; Joseph Louis SP, Tyug TS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102050 64. COVID-19 pandemic: impacts on the achievements of Sustainable Development Goals in Africa. Pan Afr. Med. J. 2021; 38:251Odey GO, Alawad AGA, Atieno OS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104299 65. Senior Editor. Pharm. Ztg. 2021; 166:3Dingermann PT. 66. COVID-19 and Health Care Leaders: How Could Emotional Intelligence Be a Helpful Resource during a Pandemic? Phys Ther 2021; Rossettini G, Conti C, Suardelli M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101807 67. Paid sick leave benefts among essential frontline workers serving people experiencing homelessness in Canada during the COVID-19 pandemic. Public Health 2021; 195:142-144Kerman N, Ecker J, Tiderington E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111803 68. Case Discussion on 'Return-to-Play' for the Athlete Following COVID-19 Infection. R I Med J (2013) 2021; 104:8-12Moulson N, Wasfy M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106098 69. Measurement report of the change of PM(2.5) composition during the COVID- 19 lockdown in urban Xi'an: Enhanced secondary formation and oxidation. Sci Total Environ 2021; 791:148126Duan J, Huang RJ, Chang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119790 70. A scenario-based approach for urban water management in the context of the COVID-19 pandemic and a case study for the Tabriz metropolitan area, Iran. Sci Total Environ 2021; 790:148272Feizizadeh B, Omarzadeh D, Ronagh Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111779 71. Temporal transition of racial/ethnic disparities in COVID-19 outcomes in 3108 counties of the United States: Three phases from January to December 2020. Sci Total Environ 2021; 791:148167Kim H, Zanobetti A, Bell ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118681 72. COVID-19 pandemic in Africa: Is it time for water, sanitation and hygiene to climb up the ladder of global priorities? Sci Total Environ 2021; 791:148252Marcos-Garcia P, Carmona-Moreno C, López-Puga J, Ruiz-Ruano García AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116497 73. Impacts of the COVID-19 epidemic on merchant ship activity and pollution emissions in Shanghai port waters. Sci Total Environ 2021; 790:148198Shi K, Weng J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098281 74. Moderate to vigorous physical activity and sedentary behavior changes in self-isolating adults during the COVID-19 pandemic in Brazil: a cross-sectional survey exploring correlates. Sport Sci Health 2021:1-9Schuch FB, Bulzing RA, Meyer J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108999 75. Lessons learned about virtual cancer care and distress screening in the time of COVID-19. Support. Care Cancer 2021:1-6Bultz BD, Watson L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114098 76. Second-hand smoke surveillance and COVID-19: a missed opportunity. Tob. Control 2021; Klein JD, Resnick EA, Chamberlin ME, Kress EA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117098 77. Safety of air travel during the ongoing COVID-19 pandemic. Travel Med Infect Dis 2021; 43:102103Bhuvan KC, Shrestha R, Leggat PA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111566 78. Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s). Virusdisease 2021:1-10Mohanty S, Paul S, Ahmad Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109260

Pathology (3 articles)

1. Comparison of renal histopathology and gene expression profles between severe COVID-19 and bacterial sepsis in critically ill patients. Crit Care 2021; 25:202Volbeda M, Jou-Valencia D, van den Heuvel MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112226 2. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology. J. Pathol. 2021; 254:303-306Herrington CS, Poulsom R, Koeppen H, Coates PJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097314 3. Nanobiocide Based-Silver Nanomaterials Upon Coronaviruses: Approaches for Preventing Viral Infections. Nanoscale Res Lett 2021; 16:100Khoshnevisan K, Maleki H, Baharifar H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095961

Protection (34 articles)

1. Sterilization and sanitizing of 3D-printed personal protective equipment using polypropylene and a Single Wall design. 3D Print Med 2021; 7:16Luchini K, Sloan SNB, Mauro R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115246 2. Acoustic Effect of Face Mask Design and Material Choice. Acoust. Aust. 2021:1- 8Balamurali BT, Enyi T, Clarke CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099950 3. Keep your distance! Measuring staff physical distancing during the Sars-Cov- 2 pandemic using a real-time locating system. Am J Emerg Med 2021; 49:110- 113Barrick L, Overmann KM, LaBare J, Wu DTY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098329 4. Protocol for percutaneous tracheostomy and prevention of COVID-19 transmission. Am. J. Otolaryngol. 2021; 42:103090Avalos N, Grego K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098456 5. A Cross-Sectional Study on Knowledge, Attitude, and Practices of Donning and Doffng of Personal Protective Equipment: An Institutional Survey of Health-Care Staff during the COVID-19 Pandemic. Anesth Essays Res 2020; 14:370-375Garg K, Grewal A, Mahajan R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092844 6. Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study. Ann Intensive Care 2021; 11:92Ferreira JC, Ho YL, Besen B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097145 7. Effect of the Photocatalyst under Visible Light Irradiation in SARS-CoV-2 Stability on an Abiotic Surface. Biocontrol Sci 2021; 26:119-125Uema M, Yonemitsu K, Momose Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092715 8. 3D Printed frames to enable reuse and improve the ft of N95 and KN95 respirators. BMC Biomed Eng 2021; 3:10McAvoy M, Bui AN, Hansen C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099062 9. Handwashing revisited in dental practice during the COVID-19 outbreak. Dent Med Probl 2021; Ait-Ou-Amar S, Berrazzouk S, Ennibi O. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101392 10. COVID-19: Protecting Healthcare Workers in South Korea. Disaster Med Public Health Prep 2021:1-10Jeon Y, Kim Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096485 11. COVID-19 infection is related to differences in the use of personal protective equipment by orthopaedic specialist trainees caring for hip fracture patients during the second surge of COVID-19 in the North West of England. Eur. J. Orthop. Surg. Traumatol. 2021:1-5Mastan S, Malik RA, Charalambous CP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110468 12. Masking Emotions: Face Masks Impair How We Read Emotions. Front. Psychol. 2021; 12:669432Gori M, Schiatti L, Amadeo MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113297 13. Emerging Science, Personal Protective Equipment Guidance, and Resource Scarcity: Inaction and Inequity for Workers in Essential Industries. Health Secur 2021; Lowe AE, Dineen KK, Herstein JJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107779 14. Modeling the viral load dependence of residence times of virus-laden droplets from COVID-19-infected subjects in indoor environments. Indoor Air 2021; Srinivasan A, Krishan J, Bathula S, Mayya YS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118165 15. The complıance of emergency healthcare personnel wıth ısolatıon precautıons durıng the COVID-19 pandemıc: A cross-sectıonal questıonnaıre study. Int J Clin Pract 2021:e14492Özlü İ, Karaman Özlü Z, Tekin E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115907 16. Use of personal protective equipment (PPE) during COVID-19 pandemic: A letter to the editor on "Envisioning the UN Sustainable Development Goals (SDGs) through the lens of clean water sanitation, life below water, and life on land in Fiji". Int J Surg 2021:105995Chand AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118439 17. Importance of nose wires in face masks in reply to: "Diagnostic and management considerations for "maskne" in the era of COVID-19". J Am Acad Dermatol 2021; Kassamali B, Kus KJ, Min MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102251 18. Design elements in face masks can provide an effective ft to prevent droplet spread in reply to "Importance of nose wires in face masks". J Am Acad Dermatol 2021; Teo WL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102250 19. Admissions of COVID-positive patients to US nursing homes with personal protective equipment or staffng shortages. J Am Geriatr Soc 2021; Gibson DM, Greene J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101162 20. An assessment of the impact of recommended anesthesia work area cleaning procedures on intraoperative SARS-CoV-2 contamination, a case-series analysis. J. Clin. Anesth. 2021; 73:110350Loftus RW, Dexter F, Evans LC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098391 21. Hospital-onset COVID-19 infection surveillance systems: A systematic review. J Hosp Infect 2021; Abbas M, Zhu NJ, Mookerjee S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098049 22. Healthcare workers acquired COVID-19 disease from patients? An investigation by phylogenomics. J Hosp Infect 2021; Chun-Wai Wong R, Lee MK, Kit-Hang Siu G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098050 23. Non-Sterile to Sterile Compounding: An Unconventional Response During the COVID-19 Pandemic. J. Pharm. Pract. 2021:8971900211017861Belisle CD, Anger K, Kanaan D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098782 24. Effects of Medical Masks on Voice Assessment During the COVID-19 Pandemic. J. Voice 2021; Lin Y, Cheng L, Wang Q, Xu W. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116888 25. Portable HEPA Purifers to Eliminate Airborne SARS-CoV-2: A Systematic Review. Otolaryngol Head Neck Surg 2021:1945998211022636Liu DT, Philips KM, Speth MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098798 26. What factors underlie attitudes regarding protective mask use during the COVID-19 pandemic? Pers. Individ. Dif. 2021; 181:111038Mallinas SR, Maner JK, Ashby Plant E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092834 27. Decontamination of respirators amid shortages due to SARS-CoV-2. Photochem Photobiol Sci 2021:1-11Thaper R, Fagen B, Oh J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118013 28. Challenging the engineering design process for the development of facial masks in the constraint of the COVID-19 pandemic. Procedia CIRP 2021; 100:660-665Formentini G, Rodríguez NB, Favi C, Marconi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094845 29. Infection prevention measures for patients undergoing hemodialysis during the COVID-19 pandemic in Japan: a nationwide questionnaire survey. Ren Replace Ther 2021; 7:27Sugawara Y, Iwagami M, Kikuchi K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094590 30. Government Intervention and the Price of KF94 Masks in the Covid-19 Era. Risk Manag. Healthc. Policy 2021; 14:2377-2383Ahn DY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113192 31. Investigation of droplets released during digestive endoscopy using a high- speed camera (with video): a pilot study. Surg. Endosc. 2021:1-5Lee DS, Jeong JB, Kim JW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115216 32. Perceptions of the Health Care Workers about the Guideline Implemented for Safe Surgical Practice during COVID-19 Pandemic in a University Teaching Hospital. Surg J (N Y) 2021; 7:e73-e82Iyer S, Subramaniam S, Thankappan K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104719 33. Indoors ventilation in times of confnement by SARS-CoV-2 epidemic: A comparative approach between Spain and Italy. Sustain Cities Soc 2021; 72:103051Lepore E, Aguilera Benito P, Piña Ramírez C, Viccione G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099968 34. Study of Recycling Potential of FFP2 Face Masks and Characterization of the Plastic Mix-Material Obtained. A Way of Reducing Waste in Times of Covid-19. Waste Biomass Valorization 2021:1-10Crespo C, Ibarz G, Sáenz C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093901

Pulmonary disease (21 articles)

1. The patient's perspective of remote respiratory assessments during the COVID-19 pandemic. Amyotroph Lateral Scler Frontotemporal Degener 2021:1- 5Tattersall R, Carty S, Meldrum D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092157 2. Lobar expression of SARS-CoV-2 pneumonia. BMJ Case Rep. 2021; 14Mendes Pedro D, Cunha M, Marques T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34112635 3. SARS-CoV-2 infection with pneumonia and stroke. Brain Hemorrhages 2021; Hassan M, Syed F, Mustafa F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34095787 4. Arterial oxygen saturation and hypoxemia in hemodialysis patients with COVID-19. Clin Kidney J 2021; 14:1222-1228Preciado P, Tapia Silva LM, Ye X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094520 5. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients. Crit Care 2021; 25:199Li Bassi G, Suen JY, Dalton HJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108029 6. COVID-19 Associated Spontaneous Pneumothorax and Pneumopericardium: A Case Report. Cureus 2021; 13:e14861Bistre J, Douedi S, Alshami A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113499 7. Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax. Epidemiol Infect 2021; 149:e137Guven BB, Erturk T, Kompe Ö, Ersoy A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099076 8. High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis. Front. Oncol. 2021; 11:644575Wang Q, Li L, Qu T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094930 9. Pediatric Pulmonary Function Testing in COVID-19 Pandemic and Beyond. A Position Statement From the Hellenic Pediatric Respiratory Society. Front Pediatr 2021; 9:673322Fouzas S, Gidaris D, Karantaglis N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095031 10. Case Report: COVID-19 Pneumonia Following Left Pneumonectomy for Lung Cancer Complicated by Empyema and Bronchopleural Fistula. Front Surg 2021; 8:679757Testori A, Giudici VM, Alloisio M, Cioff U. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095211 11. Does COVID-19 pneumonia signify secondary organizing pneumonia?: A narrative review comparing the similarities between these two distinct entities. Heart Lung 2021; 50:667-674Chong WH, Saha BK, Chopra A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098237 12. Post covid 19 pulmonary fbrosis. Is it real threat? Indian J. Tuberc. 2021; 68:330-333Rai DK, Sharma P, Kumar R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099197 13. Subpleural Curvilinear Shadows Associated with COVID-19. Intern Med 2021; Fujita J, Nakamura H, Miyagi K, Tateyama M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092732 14. Chemokines and Eicosanoids Fuel the Hyperinfammation Within the Lungs of Patients with Severe COVID-19. J Allergy Clin Immunol 2021; Zaid Y, Doré É, Dubuc I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111453 15. Asthma in the era of SARS CoV-2 virus. J. Asthma 2021:1-10Bakakos A, Krompa A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112029 16. Belief and adherence to COVID 19-lockdown restrictions in patients with asthma versus other chronic diseases: results from a cross-sectional survey nested in the ComPaRe e-cohort, in France. J. Asthma 2021:1-11Taillé C, Roche N, Tesson F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111369 17. Immuno-fbrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2. JCI Insight 2021; Chun HJ, Coutavas E, Pine AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111030 18. Yield of Severe Acute Respiratory Syndrome Coronavirus 2 Lower Respiratory Tract Testing After a Negative Nasopharyngeal Test Among Hospitalized Persons Under Investigation for Coronavirus Disease 2019. Open Forum Infect Dis 2021; 8:ofab257Egbuonu K, Hyle EP, Hurtado RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113690 19. Incidence of pneumomediastinum in COVID-19: A single-center comparison between 1st and 2nd wave. Respir Investig 2021; Tacconi F, Rogliani P, Leonardis F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108126 20. Successful endobronchial occlusion in empyema with broncho-pleural fstula secondary to COVID-19 pneumonia: a case report and literature review. Respirol Case Rep 2021; 9:e00785Nakano T, Kawada M, Minami K, Kaneda H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094570 21. Bronchoscopy during the COVID-19 pandemic: A survey study. Turk Gogus Kalp Damar Cerrahisi Derg 2021; 29:183-190Çağlayan B, Karataş F, İliaz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104512 Renal disease (21 articles)

1. Real-world risk evaluation of remdesivir in patients with an estimated glomerular fltration rate of less than 30 mL/min. Am. J. Health Syst. Pharm. 2021; Schieber TJ, Bennett N, Aragon L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34107027 2. COVID-19 Infection and Acute Kidney Injury: Cause or Complication? Blood Purif. 2021:1-4Cassia MA, Casazza R, Napodano P, Cozzolino M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107484 3. Vaccines and Disease Relapses in Children with Nephrotic Syndrome. Clin J Am Soc Nephrol 2021; 16:937-938Angeletti A, Bruschi M, Bianchin S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117084 4. Arterial oxygen saturation and hypoxemia in hemodialysis patients with COVID-19. Clin Kidney J 2021; 14:1222-1228Preciado P, Tapia Silva LM, Ye X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094520 5. Comparison of renal histopathology and gene expression profles between severe COVID-19 and bacterial sepsis in critically ill patients. Crit Care 2021; 25:202Volbeda M, Jou-Valencia D, van den Heuvel MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112226 6. Global REnal Involvement of CORonavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis of Incidence, Risk Factors, and Clinical Outcomes. Front Med (Lausanne) 2021; 8:678200Chan KW, Yu KY, Lee PW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113640 7. Viral Nephropathies, Adding SARS-CoV-2 to the List. Int. J. Nephrol. Renovasc. Dis. 2021; 14:157-164Pramod S, Kheetan M, Ogu I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113150 8. [Coronavirus disease 2019 pandemic from a nephrological perspective]. Internist (Berl.) 2021:1-6Hoxha E, Suling A, Turner JE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106294 9. Association of Kidney Disease With Outcomes in COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. J Am Heart Assoc 2021; 10:e020910Rao A, Ranka S, Ayers C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107743 10. Epidemiology and Outcomes of COVID-19 in Home Dialysis Patients Compared with In-Center Dialysis Patients. J Am Soc Nephrol 2021; Hsu CM, Weiner DE, Aweh G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108232 11. Self-identifed Race and COVID-19-Associated Acute Kidney Injury and Infammation: a Retrospective Cohort Study of Hospitalized Inner-City COVID- 19 Patients. J Gen Intern Med 2021:1-10Charoenngam N, Ilori TO, Holick MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100227 12. Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19. J Nephrol 2021:1-12Vogel MJ, Mustroph J, Staudner ST et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34110585 13. COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy- Proven Kidney Disease. Kidney Blood Press. Res. 2021:1-8Román JL, García- Carro C, Agraz I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098555 14. Comparison of COVID-19 versus infuenza on the incidence, features, and recovery from acute kidney injury in hospitalized United States Veterans. Kidney Int 2021; Birkelo BC, Parr SK, Perkins AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111501 15. Relapse of IgG4 related nephritis following mRNA Covid vaccine. Kidney Int 2021; Masset C, Kervella D, Kandel-Aznar C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116086 16. Relapse of Minimal Change Disease Following the Astra-Zeneca COVID-19 Vaccine. Kidney Int 2021; Morlidge C, El-Kateb S, Jeevaratnam P, Thompson B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119512 17. Acute kidney injury in hospitalized patients with COVID-19: A Portuguese cohort. Nefrologia 2021; Gameiro J, Fonseca JA, Oliveira J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112531 18. Infection prevention measures for patients undergoing hemodialysis during the COVID-19 pandemic in Japan: a nationwide questionnaire survey. Ren Replace Ther 2021; 7:27Sugawara Y, Iwagami M, Kikuchi K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094590 19. The perspectives of dialysis patients about the Covid-19 pandemic and differences between the modalities. Ther. Apher. Dial. 2021; Oruc A, Aktas N, Dogan I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105251 20. Kidney transplantation from a SARS-CoV-2-positive donor for the recipients with immunity after COVID-19. Transpl Infect Dis 2021:e13666Puodziukaite L, Serpytis M, Kundrotaite A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34097791 21. Kidney transplant recipient perspectives on telehealth during the COVID-19 pandemic. Transpl Int 2021; Huuskes BM, Scholes-Robertson N, Guha C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115918

Reviews (40 articles)

1. Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review. Aging Clin. Exp. Res. 2021:1-11Raisi-Estabragh Z, Martineau AR, Curtis EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118024 2. Preparing Intensive Care Unit in Resource-Constraint Setting Amid COVID-19 Pandemic: Our Experience and Review. Anesth Essays Res 2020; 14:366- 369Kajal K, Naik BN, Singh A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092843 3. Understanding the cycles of COVID-19 incidence: Principal Component Analysis and interaction of biological and socio-economic factors. Ann Med Surg (Lond) 2021; 66:102437Duarte P, Riveros-Perez E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094532 4. Origin, Pathogenesis, Diagnosis and Treatment Options for SARS-CoV-2: A Review. Biologia (Bratisl) 2021:1-19Sajjad H, Majeed M, Imtiaz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092799 5. Which ethical values underpin England's National Health Service reset of paediatric and maternity services following COVID-19: a rapid review. BMJ Open 2021; 11:e049214Chiumento A, Baines P, Redhead C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103322 6. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications? Cardiovasc. Drugs Ther. 2021:1-14Castro P, Palomo M, Moreno-Castaño AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097193 7. COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 2021; Pesce M, Agostoni P, Bøtker HE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117887 8. Mechanisms of myocardial injury in COVID-19. Clin Chem 2021; Bularga A, Chapman AR, Mills NL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117871 9. COVID-19 and Male Sexual Functioning: A report of 3 Recovered Cases and Literature Review. Clin. Med. Insights Case Rep. 2021; 14:11795476211020593Salama N, Blgozah S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104031 10. Cutaneous manifestations related to the COVID-19 pandemic: a review article. Cutan. Ocul. Toxicol. 2021; 40:168-174Molaee H, Allahyari F, Emadi SN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097555 11. Mechanical thrombectomy (MT) for acute ischemic stroke (AIS) in COVID-19 pandemic: a systematic review. Egypt J Neurol Psychiatr Neurosurg 2021; 57:67Kurnianto A, Tugasworo D, Andhitara Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093003 12. Melatonin in Early Treatment for COVID-19: A Narrative Review of Current Evidence and Possible Effcacy. Endocr. Pract. 2021; Cross KM, Landis DM, Sehgal L, Payne JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119679 13. Advanced packaging for distribution and storage of COVID-19 vaccines: a review. Environ. Chem. Lett. 2021:1-12Ramakanth D, Singh S, Maji PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104127 14. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Heart J Qual Care Clin Outcomes 2021; Harrison SL, Buckley BJR, Rivera-Caravaca JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107535 15. Persistent visual dysfunction following PRES due to COVID-19: Case series and literature review. Eur. J. Neurol. 2021; Hixon AM, Thaker AA, Pelak VS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115917 16. Effcacy and safety of Dihydroorotate dehydrogenase (DHODH) inhibitors "Lefunomide" and "Terifunomide" in Covid-19: A narrative review. Eur. J. Pharmacol. 2021:174233Kaur H, Sarma P, Bhattacharyya A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111397 17. Management of diabetes in elderly patients during the COVID-19 pandemic: current and future perspectives. Expert Rev. Endocrinol. Metab. 2021:1-9Rajpal A, Sayyed Kassem L, Aron DC. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096441 18. Recent Advances in Potential Drug Therapies Combating COVID-19 and Related Coronaviruses-A Perspective. Food Chem. Toxicol. 2021; 154:112333Nile SH, Nile A, Jalde S, Kai G. http://www.ncbi.nlm.nih.gov/pubmed/? term=34118347 19. Gamifcation as Online Teaching Strategy During COVID-19: A Mini-Review. Front. Psychol. 2021; 12:648552Nieto-Escamez FA, Roldán-Tapia MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093334 20. The Long-Term Presence of SARS-CoV-2 on Cold-Chain Food Packaging Surfaces Indicates a New COVID-19 Winter Outbreak: A Mini Review. Front Public Health 2021; 9:650493Chi Y, Wang Q, Chen G, Zheng S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095057 21. The role of ethics in science: a systematic literature review from the frst wave of COVID-19. Health Technol (Berl) 2021:1-9Maccaro A, Piaggio D, Pagliara S, Pecchia L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104626 22. Does COVID-19 pneumonia signify secondary organizing pneumonia?: A narrative review comparing the similarities between these two distinct entities. Heart Lung 2021; 50:667-674Chong WH, Saha BK, Chopra A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098237 23. After Action Reviews of COVID-19 response: Case study of a large tertiary care hospital in Italy. Int. J. Health Plann. Manage. 2021; Sebastiano S, Eleonora B, Camilla Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096091 24. After Action Reviews of COVID-19 response: Case study of a large tertiary care hospital in Italy. Int. J. Health Plann. Manage. 2021; Sorbello S, Bossi E, Zandalasini C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096091 25. Artifcial Intelligence and technology in COVID Era: A narrative review. J. Anaesthesiol. Clin. Pharmacol. 2021; 37:28-34Ahuja V, Nair LV. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103818 26. Intracerebral hemorrhage in COVID-19: A narrative review. J. Clin. Neurosci. 2021; 89:271-278Margos NP, Meintanopoulos AS, Filioglou D, Ellul J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119280 27. Hospital-onset COVID-19 infection surveillance systems: A systematic review. J Hosp Infect 2021; Abbas M, Zhu NJ, Mookerjee S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098049 28. Kawasaki like illness due to COVID-19: a review of the literature. J Infect Dev Ctries 2021; 15:630-638Fang Y, Aravamudan VM, Sridharan GK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106885 29. Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review. J Infect Public Health 2021; 14:910-921Goyal M, Tewatia N, Vashisht H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119845 30. Interferon-alpha position in combating with COVID-19: A systematic review. J Med Virol 2021; Nakhlband A, Fakhari A, Azizi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101851 31. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology. J. Pathol. 2021; 254:303-306Herrington CS, Poulsom R, Koeppen H, Coates PJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097314 32. ?Mini-review:_Guillain Barrè syndrome and myelitis associated with SARS- CoV-2 infection_? Neurosci. Lett. 2021:136040Canavero I, Ravaglia S, Valentino F, Micieli G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118307 33. Transition of Mental Health Service Delivery to Telepsychiatry in Response to COVID-19: A Literature Review. Psychiatr. Q. 2021:1-17Li H, Glecia A, Kent- Wilkinson A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101075 34. Suicide and Suicidal Behaviors in the Context of COVID-19 Pandemic in Bangladesh: A Systematic Review. Psychol. Res. Behav. Manag. 2021; 14:695- 704Mamun MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113185 35. Upper respiratory tract and otolaryngological manifestations of coronavirus disease 2019 (COVID-19): A systemic review. SAGE Open Med 2021; 9:20503121211016965Al-Swiahb JN, Motiwala MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094558 36. Virtual reality relaxation for the general population: a systematic review. Soc. Psychiatry Psychiatr. Epidemiol. 2021:1-21Riches S, Azevedo L, Bird L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120220 37. Increased pulmonary embolism in patients with COVID-19: a case series and literature review. Trop Dis Travel Med Vaccines 2021; 7:16Hesam-Shariati S, Fatehi P, Abouzaripour M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34118995 38. A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come? Virol J 2021; 18:120Shakaib B, Zohra T, Ikram A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34098986 39. Understanding the SARS-CoV-2 virus to mitigate current and future pandemic(s). Virusdisease 2021:1-10Mohanty S, Paul S, Ahmad Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109260 40. [Colchicine: old medication with new benefts : Use in rheumatology and beyond]. Z. Rheumatol. 2021:1-10Boyadzhieva Z, Ruffer N, Krusche M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097101

Risk factors (75 articles)

1. Dying from cancer with COVID-19: age, sex, socio-economic status, and comorbidities. Acta Oncol. 2021:1-6Strang P, Hedman C, Adlitzer H, Schultz T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101521 2. The key role of the level of ACE2 gene expression in SARS-CoV-2 infection. Aging (Albany NY) 2021; 13Lecarpentier Y, Vallée A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115612 3. Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review. Aging Clin. Exp. Res. 2021:1-11Raisi-Estabragh Z, Martineau AR, Curtis EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118024 4. Severe COVID-19 in Alzheimer's disease: APOE4's fault again? Alzheimers Res. Ther. 2021; 13:111Xiong N, Schiller MR, Li J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118974 5. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. Am. J. Hum. Genet. 2021; Kosmicki JA, Horowitz JE, Banerjee N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115965 6. Evaluation of Modifed ATRIA Risk Score in Predicting Mortality in Hospitalized Patients with COVID-19. Am. J. Med. Sci. 2021; Aciksari G, Cetinkal G, Kocak M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107275 7. COVID-19 morbidity and severity in patients with age-related macular degeneration: a Korean nationwide cohort study. Am. J. Ophthalmol. 2021:11881Yang JM, Moon SY, Lee JY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34102151 8. History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis 2021; Panagides V, Vincent F, Weizman O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099379 9. Coronavirus disease vaccination in heart failure: No time to waste. Arch Cardiovasc Dis 2021; Roncalli J, Roubille F, Lamblin N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099378 10. IL-6 and Other Biomarkers associated with Poor Prognosis in a Cohort of Hospitalized Patients with COVID-19 in Madrid. Biomark. Insights 2021; 16:11772719211013363Donoso-Navarro E, Arribas Gómez I, Bernabeu-Andreu FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103886 11. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England. BMC Health Serv. Res. 2021; 21:566Leclerc QJ, Fuller NM, Keogh RH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107928 12. Associated risk factors with disease severity and antiviral drug therapy in patients with COVID-19. BMC Infect. Dis. 2021; 21:549Gong X, Kang S, Guo X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112084 13. Designing COVID-19 mortality predictions to advance clinical outcomes: Evidence from the Department of Veterans Affairs. BMJ Health Care Inform 2021; 28Makridis CA, Strebel T, Marconi V, Alterovitz G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108143 14. Beyond probiotic legend: ESSAP gut microbiota health score to delineate COVID-19 severity. Br. J. Nutr. 2021:1-34Hegazy MA, Ashoush OA, Hegazy MT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096487 15. Characteristics and outcomes of cancer patients with covid-19 at a safety-net hospital. Cancer Treat Res Commun 2021; 28:100418Ozer M, Goksu SY, Mahdi M, Gandhi N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118790 16. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders. Cell. Mol. Neurobiol. 2021:1-9Stefano GB, Kream RM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117968 17. Obesity as a Risk Factor for Severe Illness From COVID-19 in the Pediatric Population. Cureus 2021; 13:e14825Agarwal A, Karim F, Fernandez Bowman A, Antonetti CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094778 18. Prognostic Factors in Hospitalized COVID-19 Patients at the Start of the Pandemic in Colombia: A Retrospective Cohort Study. Cureus 2021; 13:e14865Nuñez-Ramos JA, Forero Illera E, Quintero Barrios JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113503 19. The roles of vitamin D in increasing the body's immunity and reducing injuries due to viral infections: With an emphasis on its possible role in SARS-CoV-2 (COVID-19). Curr. Pharm. Des. 2021; Aleebrahim-Dehkordi E, Deravi N, Yaghoobpoor S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102962 20. Heart rate variability moderates the effects of COVID-19-related stress and family adversity on emotional problems in adolescents: Testing models of differential susceptibility and diathesis stress. Dev. Psychopathol. 2021:1- 12Miller JG, Chahal R, Kirshenbaum JS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34099071 21. The usefulness of Shock Index and Modifed Shock Index in predicting outcome of COVID-19 patients. Disaster Med Public Health Prep 2021:1-16Kurt E, Bahadirli S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099089 22. The infuence of selection bias on identifying an association between allergy medication use and SARS-CoV-2 infection. EClinicalMedicine 2021:100936Thompson LA, Gurka MJ, Filipp SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104879 23. Detecting epidemiological relevance of adenoid hypertrophy, rhinosinusitis, and allergic rhinitis through an Internet search. Eur Arch Otorhinolaryngol 2021:1-7Yang Y, Li X, Ma Q et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34104981 24. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review. Eur. J. Med. Res. 2021; 26:51SeyedAlinaghi S, Mirzapour P, Dadras O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103090 25. Chest radiograph characteristics in COVID-19 infection and their association with survival. Eur J Radiol Open 2021; 8:100360Colman J, Zamfr G, Sheehan F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095358 26. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity. Faseb j 2021; 35:e21713Suresh V, Mohanty V, Avula K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105201 27. Lung Ultrasound Score as a Predictor of Mortality in Patients With COVID-19. Front Cardiovasc Med 2021; 8:633539Sun Z, Zhang Z, Liu J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113658 28. Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data. Front Genet 2021; 12:636441Sardar R, Sharma A, Gupta D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093642 29. Clinical Signifcance of Plasma D-Dimer in COVID-19 Mortality. Front Med (Lausanne) 2021; 8:638097Li Y, Deng Y, Ye L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113629 30. Development and Validation of a Predictive Model for Severe COVID-19: A Case-Control Study in China. Front Med (Lausanne) 2021; 8:663145Meng Z, Wang M, Zhao Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113636 31. High Infection Fatality Rate Among Elderly and Risk Factors Associated With Infection Fatality Rate and Asymptomatic Infections of COVID-19 Cases in Hong Kong. Front Med (Lausanne) 2021; 8:678347Tao J, Zhang X, Musa SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109200 32. High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis. Front. Oncol. 2021; 11:644575Wang Q, Li L, Qu T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094930 33. Can Vitamin D Defciency Increase the Susceptibility to COVID-19? Front. Physiol. 2021; 12:630956Maha Q, Talal M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093219 34. Alteration of Autonomic Nervous System Is Associated With Severity and Outcomes in Patients With COVID-19. Front. Physiol. 2021; 12:630038Pan Y, Yu Z, Yuan Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093217 35. On the Environmental Determinants of COVID-19 Seasonality. Geohealth 2021; 5:e2021GH000413Choi YW, Tuel A, Eltahir EAB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095688 36. Increased procoagulant platelet levels are predictive of death in COVID-19. Geroscience 2021:1-11Khattab MH, Prodan CI, Vincent AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109507 37. Lung ultrasound score as a tool to monitor disease progression and detect ventilator-associated pneumonia during COVID-19-associated ARDS. Heart Lung 2021; 50:700-705Dargent A, Chatelain E, Si-Mohamed S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107394 38. Diabetes and susceptibility to infections: implication for COVID-19. Immunology 2021; van Niekerk G, van der Merwe M, Engelbrecht AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115881 39. Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area - a population-based registry study. Infect Dis (Lond) 2021:1-11Forsblom E, Silén S, Kortela E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100692 40. Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2. Infect Dis Ther 2021:1- 15Zheng F, Chen R, Yao R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34110618 41. Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity. Int Immunopharmacol 2021; 98:107825Cuesta-Llavona E, Gómez J, Albaiceta GM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116286 42. The Boundaries Between Survival and Non-Survival at COVID-19: Experience of Tertiary Care Pandemic Hospital. Int J Clin Pract 2021:e14461Arslan Y, Dogan D, Ocal N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107117 43. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Int J Clin Pract 2021:e14462Lu Q, Zhu Z, Tan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107113 44. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med 2021:1-5Başcı S, Ata N, Altuntaş F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110562 45. A Cross-Sectional Analysis of Demographic and Behavioral Risk Factors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Among a Sample of U.S. College Students. J. Adolesc. Health 2021; Kianersi S, Ludema C, Macy JT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112598 46. Association of Kidney Disease With Outcomes in COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. J Am Heart Assoc 2021; 10:e020910Rao A, Ranka S, Ayers C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107743 47. COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico. J. Clin. Immunol. 2021:1-16Castano-Jaramillo LM, Yamazaki-Nakashimada MA, O'Farrill-Romanillos PM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114122 48. Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control Study. J. Clin. Med. Res. 2021; 13:258-267Acharya R, Poudel D, Bowers R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104277 49. Preadmission predictors of severe COVID-19 in patients with diabetes mellitus. J. Diabetes Complications 2021:107967Shukla AP, Tchang BG, Lam T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099384 50. Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department. J. Emerg. Med. 2021; Stauning MA, Altintas I, Kallemose T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092446 51. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies. J Immunother Cancer 2021; 9Goldman JD, Robinson PC, Uldrick TS, Ljungman P. http://www.ncbi.nlm.nih.gov/pubmed/? term=34117116 52. An observed association between conjunctivitis and severity of COVID-19. J Infect 2021; Loffredo L, Oliva A, Paraninf A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118275 53. Large variations in disease severity, death and ICU admission of 2993 patients infected with SARS-CoV-2: The potential impact of genetic vulnerability. J Infect Public Health 2021; 14:886-891Farajallah HM, AlSuwaidi SK, AlSuwaidi SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118740 54. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio and Their Role as Predictors of Disease Severity of Coronavirus Disease 2019 (COVID- 19). J Lab Physicians 2021; 13:58-63Jain R, Gopal A, Pathak BK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103879 55. In-hospital Mortality in SARS-CoV-2 stratifed by serum 25-Hydroxy-Vitamin D levels: A Retrospective Study. J Med Virol 2021; Al-Jarallah M, Rajan R, Dashti R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101207 56. 7-ketocholesterol: effects on viral infections and hypothetical contribution in COVID-19. J. Steroid Biochem. Mol. Biol. 2021; 212:105939Ghzaiel I, Sassi K, Zarrouk A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118414 57. Racial Disparities in Ischemic Stroke Among Patients with COVID-19 in the United States. J. Stroke Cerebrovasc. Dis. 2021; 30:105877Lekoubou A, Pelton M, Ba DM, Ssentongo P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102552 58. Reduced retinal vessel density in COVID-19 patients and elevated D-dimer levels during the acute phase of the infection. Med Clin (Engl Ed) 2021; 156:541- 546Guemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109275 59. Addressing Racial/Ethnic Equity in Access to COVID-19 Testing Through Drive-Thru And Walk-In Testing Sites in Chicago. Med Res Arch 2021; 9Kim SJ, Watson K, Khare N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109272 60. The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurol Sci 2021:1-7Moghadasi AN, Mirmosayyeb O, Barzegar M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34100130 61. RLIM: a recursive and latent infection model for the prediction of US COVID-19 infections and turning points. Nonlinear Dyn 2021:1-14Yu X, Lu L, Shen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092919 62. High Prevalence of SARS-CoV-2 Genetic Variation and D614G Mutation in Pediatric Patients With COVID-19. Open Forum Infect Dis 2021; 8:ofaa551Pandey U, Yee R, Shen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095334 63. The association between ethnicity, socioeconomic deprivation and receipt of hospital-based palliative care for people with Covid-19: A dual centre service evaluation. Palliat. Med. 2021:2692163211022959Bajwah S, Edmonds P, Yorganci E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098811 64. COVID-19 and Smoking: A Position Paper by the DGP Taskforce for Smoking Cessation. Pneumologie 2021; Raspe M, Bals R, Hering T et al. 65. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrinology 2021; 131:105295Kappelmann N, Dantzer R, Khandaker GM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119855 66. A County-Level Analysis of Socioeconomic and Clinical Predictors of COVID- 19 Incidence and Case-Fatality Rates in Georgia, March-September 2020. Public Health Rep. 2021:333549211023267Berman AE, Miller DD, Rahn DW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111358 67. Risk and resilience of vulnerable families in Hong Kong under the impact of COVID-19: an ecological resilience perspective. Soc. Psychiatry Psychiatr. Epidemiol. 2021:1-12Zhuang X, Lau YY, Chan WMH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100978 68. Variation and correlation between ultraviolet index and tropospheric ozone during COVID-19 lockdown over megacities of India. Stoch. Environ. Res. Risk Assess. 2021:1-19Bera B, Bhattacharjee S, Shit PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093082 69. Indoors ventilation in times of confnement by SARS-CoV-2 epidemic: A comparative approach between Spain and Italy. Sustain Cities Soc 2021; 72:103051Lepore E, Aguilera Benito P, Piña Ramírez C, Viccione G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099968 70. Establishment of a Clinical Nomogram Model to Predict the Progression of COVID-19 to Severe Disease. Ther. Clin. Risk Manag. 2021; 17:553-561Tu C, Wang G, Geng Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103920 71. Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19. Thromb Res 2021; 204:13- 15Stanne TM, Pedersen A, Gisslén M, Jern C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102452 72. Role of ABO blood system in COVID-19: Findings from a southern Italian study. Transfus. Med. 2021; Negro P, Congedo M, Zizza A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114287 73. Long-Term Proton Pump Inhibitor Use is a Risk Factor for Mortality in Patients Hospitalized for COVID-19. Turk J Med Sci 2021; Yozgat A, Kasapoğlu B, Can G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110723 74. Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-19. Viral Immunol 2021; Avendaño-Félix M, Ochoa-Ramírez LA, Ramos-Payán R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34115949 75. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study. Virol J 2021; 18:126Yin SW, Zhou Z, Wang JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118952

Safety (24 articles)

1. Real-world risk evaluation of remdesivir in patients with an estimated glomerular fltration rate of less than 30 mL/min. Am. J. Health Syst. Pharm. 2021; Schieber TJ, Bennett N, Aragon L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34107027 2. Application of the "immunization islands" model to improve quality, ef fciency and safet y of a COVID-19 mass vaccination site. Ann. Ig. 2021; Signorelli C, Odone A, Gianfredi V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113956 3. Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic infammatory conditions and immunosuppressive therapy in a monocentric cohort'. Ann. Rheum. Dis. 2021; Veenstra J, Wang J, McKinnon-Maksimowicz K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112654 4. Getting the COVID-19 vaccine as a transplant patient. BMJ Evid Based Med 2021; Mittelman M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103389 5. Myocarditis after SARS-CoV-2 Vaccination: A Vaccine-induced Reaction? Can J Cardiol 2021; D'Angelo T, Cattaf A, Carerj ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118375 6. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. Chin. Med. 2021; 16:44An X, Duan L, Zhang YH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099015 7. Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clin Imaging 2021; 79:201-203Kim B, Park Y, Kim EK, Lee SH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116295 8. Transient akathisia after the SARS-Cov-2 vaccine. Clin Park Relat Disord 2021; 4:100098Salinas MR, Dieppa M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113842 9. Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration. Cureus 2021; 13:e14853Idogun PO, Ward MC, Teklie Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113494 10. Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Rev Vaccines 2021:1-6Esba LCA, Al Jeraisy M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092166 11. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says. Front. Immunol. 2021; 12:669010Chen G, Li X, Sun M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093567 12. Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality? Intern Emerg Med 2021:1-3Pasin F, Calabrese A, Pelagatti L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100214 13. Anaphylaxis is a rare reaction in COVID-19 vaccination. J Biol Regul Homeost Agents 2021; 35Bellomo RG, Gallenga CE, Caraffa A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105336 14. Autoimmune hepatitis following sars-cov-2 VACCINE: MAY not be a casualty. J Hepatol 2021; Rocco A, Sgamato C, Compare D, Nardone G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116081 15. Do coronavirus vaccine challenge trials have a distinctive generalisability problem? J. Med. Ethics 2021; Eyal N, Gerhard T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099541 16. Interferon-alpha position in combating with COVID-19: A systematic review. J Med Virol 2021; Nakhlband A, Fakhari A, Azizi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101851 17. Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J. Stroke Cerebrovasc. Dis. 2021; 30:105906Dias L, Soares-Dos-Reis R, Meira J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111775 18. Relapse of IgG4 related nephritis following mRNA Covid vaccine. Kidney Int 2021; Masset C, Kervella D, Kandel-Aznar C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116086 19. Relapse of Minimal Change Disease Following the Astra-Zeneca COVID-19 Vaccine. Kidney Int 2021; Morlidge C, El-Kateb S, Jeevaratnam P, Thompson B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119512 20. The frst known case of vaccine-induced thrombotic thrombocytopenia in Australia. Med. J. Aust. 2021; Hocking J, Chunilal SD, Chen VM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117641 21. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologia (Engl Ed) 2021. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112621 22. Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment. SAGE Open Med Case Rep 2021; 9:2050313x211016991Sottilotta G, Mangano C, Basile R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104443 23. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation. Saudi J. Gastroenterol. 2021; Alqahtani SA, Barry M, Memish Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100388 24. Myocarditis following COVID-19 mRNA vaccination. Vaccine 2021; Abu Mouch S, Roguin A, Hellou E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092429

Treatment options

1. Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain. Adv Ther 2021:1-13Soriano A, Montejano R, Sanz-Moreno J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118007 2. Vitamin D and coronavirus disease 2019 (COVID-19): rapid evidence review. Aging Clin. Exp. Res. 2021:1-11Raisi-Estabragh Z, Martineau AR, Curtis EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118024 3. How Chinese Herbal Medicine Prevents Epidemics: From Ancient Pestilences to COVID-19 Pandemic. Am J Chin Med 2021:1-28Wu XQ, Zhang WN, Hao MZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107860 4. Real-world risk evaluation of remdesivir in patients with an estimated glomerular fltration rate of less than 30 mL/min. Am. J. Health Syst. Pharm. 2021; Schieber TJ, Bennett N, Aragon L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34107027 5. Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports. Ann Med Surg (Lond) 2021; 66:102444Thabrani A, Hadi WS, Thobari JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34094533 6. Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals. Ann. Rheum. Dis. 2021; Melikhov O, Kruglova T, Lytkina K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099486 7. What do secreted phospholipases A(2) have to offer in combat against different viruses up to SARS-CoV-2? Biochimie 2021; 189:40-50Pungerčar J, Bihl F, Lambeau G, Križaj I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097986 8. Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation. Biomed J 2021; Tang WF, Tsai HP, Chang YH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119448 9. Associated risk factors with disease severity and antiviral drug therapy in patients with COVID-19. BMC Infect. Dis. 2021; 21:549Gong X, Kang S, Guo X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112084 10. DeepR2cov: deep representation learning on heterogeneous drug networks to discover anti-infammatory agents for COVID-19. Brief. Bioinform. 2021; Wang X, Xin B, Tan W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117734 11. JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations. Cardiovasc Endocrinol Metab 2021; 10:80-88Menshawey R, Menshawey E, Alserr AHK, Abdelmassih AF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109302 12. Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study. Clin Infect Dis 2021; Benfeld T, Bodilsen J, Brieghel C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111274 13. Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial. EClinicalMedicine 2021:100926Ali S, Uddin SM, Shalim E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109306 14. Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries. EClinicalMedicine 2021:100931Rejeki MS, Sarnadi N, Wihastuti R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104878 15. Melatonin in Early Treatment for COVID-19: A Narrative Review of Current Evidence and Possible Effcacy. Endocr. Pract. 2021; Cross KM, Landis DM, Sehgal L, Payne JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119679 16. Improved SARS-CoV-2 M(pro) inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies. Eur. J. Med. Chem. 2021; 222:113584Vuong W, Fischer C, Khan MB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118724 17. Effcacy and safety of Dihydroorotate dehydrogenase (DHODH) inhibitors "Lefunomide" and "Terifunomide" in Covid-19: A narrative review. Eur. J. Pharmacol. 2021:174233Kaur H, Sarma P, Bhattacharyya A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111397 18. Recent Advances in Potential Drug Therapies Combating COVID-19 and Related Coronaviruses-A Perspective. Food Chem. Toxicol. 2021; 154:112333Nile SH, Nile A, Jalde S, Kai G. http://www.ncbi.nlm.nih.gov/pubmed/? term=34118347 19. Nasopharyngeal Type-I Interferon for Immediately Available Prophylaxis Against Emerging Respiratory Viral Infections. Front. Immunol. 2021; 12:660298Lee AC, Jeong Y, Lee S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34093548 20. Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19? Front. Immunol. 2021; 12:670955Rossi GA, Sacco O, Capizzi A, Mastromarino P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093569 21. The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19. Front Mol Biosci 2021; 8:666054Li H, Li J, Xiao W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109213 22. A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients. Front. Pharmacol. 2021; 12:666348Bousquet-Mélou A, Lespine A, Sutra JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093195 23. Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: a review. Futur J Pharm Sci 2021; 7:113Sharanya CS, Sabu A, Haridas M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34095323 24. Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery. Future Virol. 2021; Mohebbi A, Askari FS, Sammak AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099962 25. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 infammasome activation and pulmonary infammation. Immunity 2021; Xian H, Liu Y, Rundberg Nilsson A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34115964 26. Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides. Int. J. Biol. Macromol. 2021; 184:297-312Dhanjal JK, Kumar V, Garg S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118289 27. Impact of intermediate to high-doses of methylprednisolone on mortality rate in patients with COVID-19 pneumonia-induced severe systemic infammation. Int J Clin Pract 2021:e14479Climente-Martí M, Ruiz-Millo O, López-Cruz I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107137 28. Calcifediol treatment and COVID-19-related outcomes. J. Clin. Endocrinol. Metab. 2021; Nogues X, Ovejero D, Pineda-Moncusí M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097036 29. Active components in Ephedra sinica Stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: potent COVID-19 therapeutic agents. J. Ethnopharmacol. 2021; 278:114303Mei J, Zhou Y, Yang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102269 30. Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review. J Infect Public Health 2021; 14:910-921Goyal M, Tewatia N, Vashisht H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119845 31. Another new application of heparin in COVID-19: more than anticoagulation and antiviral. J. Investig. Med. 2021; Yu X. http://www.ncbi.nlm.nih.gov/pubmed/? term=34112704 32. Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania. J Investig Med High Impact Case Rep 2021; 9:23247096211019557Suresh K, Figart M, Formeck S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105382 33. Interferon-alpha position in combating with COVID-19: A systematic review. J Med Virol 2021; Nakhlband A, Fakhari A, Azizi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101851 34. Macrophage biomimetic nanocarriers for anti-infammation and targeted antiviral treatment in COVID-19. J Nanobiotechnology 2021; 19:173Tan Q, He L, Meng X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112203 35. Use of Intravenous Vitamin C in Critically Ill Patients With COVID-19 Infection. J. Pharm. Pract. 2021:8971900211015052Li M, Ching TH, Hipple C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098784 36. In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors. J Tradit Complement Med 2021; Singh R, Bhardwaj VK, Sharma J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099976 37. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS- CoV-2 pneumonia. Med Clin (Barc) 2021; Suna K, Melahat U, Murat Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103164 38. Decorin as a possible strategy for the amelioration of COVID-19. Med. Hypotheses 2021; 152:110612Allawadhi P, Singh V, Khurana I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098463 39. mRNA Targeting, Transport and Local Translation in Eukaryotic Cells: From the Classical View to a Diversity of New Concepts. Mol. Biol. 2021:1- 31Lashkevich KA, Dmitriev SE. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092811 40. Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study. Mol. Divers. 2021:1-14Vivek- Ananth RP, Krishnaswamy S, Samal A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34117992 41. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis. Mol. Divers. 2021:1-16Wang J, Ge W, Peng X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105049 42. Virtual screening, ADMET profling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and favonoids against COVID-19 main protease (M(pro)). Nat Prod Res 2021:1-7Abdul-Hammed M, Adedotun IO, Olajide M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107799 43. Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2). Nutrition 2021; 89:111340Fan L, Zhu X, Zheng Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116393 44. Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19. Open Biol 2021; 11:210069Cheema PS, Nandi D, Nag A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102081 45. In Silico Evaluation of Cyclophilin Inhibitors as Potential Treatment for SARS- CoV-2. Open Forum Infect Dis 2021; 8:ofab189Laurie K, Holcomb D, Kames J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109257 46. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild- to-moderate COVID19-associated acute respiratory distress syndrome. Pharmacol. Rep. 2021:1-10Taher A, Lashgari M, Sedighi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114174 47. Therapeutic targets of natural products for the management of cardiovascular symptoms of coronavirus disease 2019. Phytother. Res. 2021; Mohammadi Pour P, Farzaei MH, Soleiman Dehkordi E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34110678 48. Sofosbuvir with daclatasvir and the outcomes of patients with COVID-19: a systematic review and meta-analysis with GRADE assessment. Postgrad. Med. J. 2021; Zein A, Sulistiyana CS, Raffaello WM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103373 49. Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure. Respir. Med. 2021; 185:106477Damiani M, Gandini L, Landi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102594 50. Patients' treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections. Respir Res 2021; 22:168Budweiser S, Baş Ş, Jörres RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34098967 51. Picture fuzzy set-based decision-making approach using Dempster-Shafer theory of evidence and grey relation analysis and its application in COVID-19 medicine selection. Soft comput 2021:1-15Si A, Das S, Kar S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108847 52. Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial. Stem Cells Transl Med 2021; Dilogo IH, Aditianingsih D, Sugiarto A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34102020 53. Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection. Ther. Adv. Endocrinol. Metab. 2021; 12:20420188211010105Salciccia S, Del Giudice F, Eisenberg ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104394 54. How we secured a COVID-19 convalescent plasma procurement scheme in Japan. Transfusion 2021; Terada M, Kutsuna S, Togano T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096059 55. [Colchicine: old medication with new benefts : Use in rheumatology and beyond]. Z. Rheumatol. 2021:1-10Boyadzhieva Z, Ruffer N, Krusche M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34097101

Trials (12 articles)

1. Sociodemographic factors associated with acceptance of COVID-19 vaccine and clinical trials in Uganda: a cross-sectional study in western Uganda. BMC Public Health 2021; 21:1106Echoru I, Ajambo PD, Keirania E, Bukenya EEM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112143 2. Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial. EClinicalMedicine 2021:100926Ali S, Uddin SM, Shalim E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109306 3. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021. Emerg Infect Dis 2021; 27Tober-Lau P, Schwarz T, Hillus D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102098 4. SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility. F S Rep 2021; Morris RS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095871 5. Design of a Mobile Application and Evaluation of Its Effects on Psychological Parameters of Covid-19 Inpatients: A Protocol for a Randomized Controlled Trial. Front Psychiatry 2021; 12:612384Aalaei S, Khoshrounejad F, Saleh LA, Amini M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108892 6. The Effect Of Chronic DOAC Treatment On Clinical Outcomes Of Hospitalized Patients With COVID-19. Int J Clin Pract 2021:e14467Aslan B, Akyüz A, Işık F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107130 7. Impact of intermediate to high-doses of methylprednisolone on mortality rate in patients with COVID-19 pneumonia-induced severe systemic infammation. Int J Clin Pract 2021:e14479Climente-Martí M, Ruiz-Millo O, López-Cruz I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107137 8. Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study. J. Cardiovasc. Magn. Reson. 2021; 23:77Gorecka M, McCann GP, Berry C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34112195 9. Do coronavirus vaccine challenge trials have a distinctive generalisability problem? J. Med. Ethics 2021; Eyal N, Gerhard T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099541 10. Development of a Coronavirus Disease 2019 (COVID-19) Application Ontology for the Accrual to Clinical Trials (ACT) network. JAMIA Open 2021; 4:ooab036Visweswaran S, Samayamuthu MJ, Morris M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113801 11. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild- to-moderate COVID19-associated acute respiratory distress syndrome. Pharmacol. Rep. 2021:1-10Taher A, Lashgari M, Sedighi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114174 12. Anticipated impact of stem cell and other cellular medicine clinical trials for COVID-19. Regen. Med. 2021; Kim M, Knoepfer PS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114493

Vaccines (82 articles)

1. Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization. AAPS PharmSciTech 2021; 22:172Khehra N, Padda I, Jaferi U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100150 2. Validation Checklist for Massive Vaccination Cente. Ann. Ig. 2021; Capolongo S, Brambilla A, Girardi A, Signorelli C. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113951 3. Application of the "immunization islands" model to improve quality, ef fciency and safet y of a COVID-19 mass vaccination site. Ann. Ig. 2021; Signorelli C, Odone A, Gianfredi V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113956 4. A mathematical programming approach for equitable COVID-19 vaccine distribution in developing countries. Ann Oper Res 2021:1-34Tavana M, Govindan K, Nasr AK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099948 5. Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic infammatory conditions and immunosuppressive therapy in a monocentric cohort'. Ann. Rheum. Dis. 2021; Veenstra J, Wang J, McKinnon-Maksimowicz K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112654 6. Vaccination against COVID-19: a challenge in CLL. Blood 2021; 137:3153- 3154Eichhorst B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34110406 7. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers. BMC Infect. Dis. 2021; 21:544Jackson-Thompson BM, Goguet E, Laing ED et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107889 8. Sociodemographic factors associated with acceptance of COVID-19 vaccine and clinical trials in Uganda: a cross-sectional study in western Uganda. BMC Public Health 2021; 21:1106Echoru I, Ajambo PD, Keirania E, Bukenya EEM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112143 9. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health 2021; 21:1129Syed Alwi SAR, Rafdah E, Zurraini A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118897 10. Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China. BMC Public Health 2021; 21:1103Zhou Y, Zhang J, Wu W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107930 11. Getting the COVID-19 vaccine as a transplant patient. BMJ Evid Based Med 2021; Mittelman M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103389 12. Which ethical values underpin England's National Health Service reset of paediatric and maternity services following COVID-19: a rapid review. BMJ Open 2021; 11:e049214Chiumento A, Baines P, Redhead C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103322 13. Understanding vaccine hesitancy: the evidence. Br. J. Community Nurs. 2021; 26:278-282While A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105372 14. Myocarditis after SARS-CoV-2 Vaccination: A Vaccine-induced Reaction? Can J Cardiol 2021; D'Angelo T, Cattaf A, Carerj ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118375 15. Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Clin Imaging 2021; 79:201-203Kim B, Park Y, Kim EK, Lee SH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116295 16. Vaccines and Disease Relapses in Children with Nephrotic Syndrome. Clin J Am Soc Nephrol 2021; 16:937-938Angeletti A, Bruschi M, Bianchin S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117084 17. Socioeconomic disparities and COVID-19 vaccination acceptance: a nationwide ecologic study. Clin Microbiol Infect 2021; Caspi G, Dayan A, Eshal Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111591 18. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the Era of vaccination: A systematic review and meta-analysis. Clin Microbiol Infect 2021; Kayı İ, Madran B, Keske Ş et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116205 19. Transient akathisia after the SARS-Cov-2 vaccine. Clin Park Relat Disord 2021; 4:100098Salinas MR, Dieppa M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34113842 20. Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration. Cureus 2021; 13:e14853Idogun PO, Ward MC, Teklie Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113494 21. Two birds with one stone?: Fewer SARS-CoV-2 infections after fu vaccination. Deutsche Apotheker Zeitung 2021; 161Jungmayr P. 22. COVID-19: Perspectives on vaccination and therapy. An update of the strategies. Deutsche Apotheker Zeitung 2021; 161Stahl V. 23. COVID-19: Compulsory vaccination for workers in the medical feld? Deutsche Medizinische Wochenschrift 2021; Bothe K. 24. The Importance of Pharmacy Partnerships in Effective COVID-19 Vaccine Distribution. Disaster Med Public Health Prep 2021:1-11Pammal RS, Kreinces JB, Pohlman KL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099082 25. The UK approach to COVID-19 vaccination: why was it so different? Drugs Context 2021; 10English PM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104199 26. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine. EClinicalMedicine 2021:100928Pellini R, Venuti A, Pimpinelli F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109307 27. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerg Infect Dis 2021; 27Schwarz T, Tober-Lau P, Hillus D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102097 28. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021. Emerg Infect Dis 2021; 27Tober-Lau P, Schwarz T, Hillus D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102098 29. Advanced packaging for distribution and storage of COVID-19 vaccines: a review. Environ. Chem. Lett. 2021:1-12Ramakanth D, Singh S, Maji PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104127 30. Race, ethnicity and COVID-19 vaccination: a qualitative study of UK healthcare staff. Ethn. Health 2021:1-20Woodhead C, Onwumere J, Rhead R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092149 31. COVID-19 vaccination may cause FDG uptake beyond axillary area. Eur J Hybrid Imaging 2021; 5:11Fleury V, Maucherat B, Rusu D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095746 32. Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Rev Vaccines 2021:1-6Esba LCA, Al Jeraisy M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34092166 33. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says. Front. Immunol. 2021; 12:669010Chen G, Li X, Sun M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093567 34. Will Healthcare Workers Accept a COVID-19 Vaccine When It Becomes Available? A Cross-Sectional Study in China. Front Public Health 2021; 9:664905Sun Y, Chen X, Cao M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34095068 35. Forty days of regulatory emergency use authorisation of COVID-19 vaccines: Interfacing effcacy, hesitancy and SDG target 3.8. Glob Public Health 2021:1- 22Nhamo G, Sibanda M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105432 36. Vaccination and the Prevention of Communicable Diseases in Healthcare Settings: Lessons from the Covid-19 Pandemic. Health Serv Insights 2021; 14:11786329211019221Voyer BG, Provencher C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103937 37. The pivotal roles of the host immune response in the fne-tuning the infection and the development of the vaccines for SARS-CoV-2. Hum Vaccin Immunother 2021:1-13Alturaiki W, Mubarak A, Al Jurayyan A, Hemida MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114940 38. A rational strategy to support approved COVID-19 vaccines prioritization. Hum Vaccin Immunother 2021:1-4Burgos-Salcedo J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114939 39. COVID-19 vaccine hesitancy: a survey in a population highly compliant to common vaccinations. Hum Vaccin Immunother 2021:1-7Fedele F, Aria M, Esposito V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096836 40. Temporary vaccination clinic for COVID-19 in Zhuhai, China. Hum Vaccin Immunother 2021:1-3Jin H, Chu J, Zhao W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114926 41. SARS-CoV-2: Unique Challenges of the Virus and Vaccines. Immunol. Invest. 2021:1-8Mahmoodpoor A, Sanaie S, Samadi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109900 42. Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19? Indian J. Tuberc. 2021; 68:401-404Gong W, Wu X. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099209 43. A forecast of maternal deaths with and without vaccination of pregnant women against COVID-19 in Mexico. Int J Gynaecol Obstet 2021; Lumbreras- Marquez MI, Fields KG, Campos-Zamora M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118064 44. Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality? Intern Emerg Med 2021:1-3Pasin F, Calabrese A, Pelagatti L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100214 45. Anaphylaxis is a rare reaction in COVID-19 vaccination. J Biol Regul Homeost Agents 2021; 35Bellomo RG, Gallenga CE, Caraffa A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34105336 46. Effectiveness of non-pharmaceutical interventions and vaccine for containing the spread of COVID-19: Three illustrations before and after vaccination periods. J Formos Med Assoc 2021; Lin TY, Liao SH, Lai CC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112587 47. Economic evaluation for mass vaccination against COVID-19. J Formos Med Assoc 2021; Wang WC, Fann JC, Chang RE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108119 48. Autoimmune hepatitis following sars-cov-2 VACCINE: MAY not be a casualty. J Hepatol 2021; Rocco A, Sgamato C, Compare D, Nardone G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116081 49. Heterologous immunization with Covishield and Pfzer vaccines against SARS-CoV-2 elicits a robust humoral immune response. J Infect Dev Ctries 2021; 15:653-656Ostadgavahi AT, Booth R, Sisson G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34106888 50. COVID-19 mRNA vaccination generates greater IgG levels in women compared to men. J Infect Dis 2021; Demonbreun AR, Sancilio A, Velez ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117873 51. Voluntary COVID-19 vaccination of children: a social responsibility. J. Med. Ethics 2021; Brusa M, Barilan YM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34117126 52. Do coronavirus vaccine challenge trials have a distinctive generalisability problem? J. Med. Ethics 2021; Eyal N, Gerhard T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099541 53. Justice in COVID-19 vaccine prioritisation: rethinking the approach. J. Med. Ethics 2021; Rhodes R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108257 54. Willingness of Ethiopian Population to Receive COVID-19 Vaccine. J Multidiscip Healthc 2021; 14:1233-1243Belsti Y, Gela YY, Akalu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093019 55. COVID-19 vaccination certifcate (CVC) for ASEAN: the way forward? J Public Health (Oxf) 2021; Corpuz JCG. http://www.ncbi.nlm.nih.gov/pubmed/? term=34109396 56. Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. J. Stroke Cerebrovasc. Dis. 2021; 30:105906Dias L, Soares-Dos-Reis R, Meira J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111775 57. Relapse of IgG4 related nephritis following mRNA Covid vaccine. Kidney Int 2021; Masset C, Kervella D, Kandel-Aznar C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116086 58. Relapse of Minimal Change Disease Following the Astra-Zeneca COVID-19 Vaccine. Kidney Int 2021; Morlidge C, El-Kateb S, Jeevaratnam P, Thompson B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119512 59. The frst known case of vaccine-induced thrombotic thrombocytopenia in Australia. Med. J. Aust. 2021; Hocking J, Chunilal SD, Chen VM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117641 60. Medico-legal considerations of mandatory COVID-19 vaccination for high risk workers. Med. J. Aust. 2021; Kevat DA, Panaccio DC, Pang SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34117640 61. In brief: Pfzer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old. Med. Lett. Drugs Ther. 2021; 63:81. http://www.ncbi.nlm.nih.gov/pubmed/?term=34101717 62. Attitude towards vaccination against SARS-CoV-2: Survey among employees in hospitals before and after the start of vaccinations in German hospitals. Medizinische Klinik - Intensivmedizin und Notfallmedizin 2021; 116:421- 430Janssens U, Kluge S, Marx G et al. 63. COVID-19 vaccination willingness among people with multiple sclerosis. Mult Scler J Exp Transl Clin 2021; 7:20552173211017159Xiang XM, Hollen C, Yang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104472 64. Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination. Neurologia (Engl Ed) 2021. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112621 65. [SARS-CoV-2 infection and COVID‒19 in Gaucher disease: indications for vaccination]. Orv. Hetil. 2021; 162:938-942Maródi L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34120104 66. A conceptual approach to the rationale for SARS-CoV-2 vaccine allocation prioritisation. Pathog Glob Health 2021:1-4Kohns Vasconcelos M, Marazia C, Koniordou M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107233 67. The trade-off between mobility and vaccination for COVID-19 control: a metapopulation modelling approach. R Soc Open Sci 2021; 8:202240Saldaña F, Velasco-Hernández JX. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109037 68. [Relationship between BCG vaccination and increased mortality from COVID- 19. An ecological fallacy?]. Rev. Med. Inst. Mex. Seguro Soc. 2020; 58:78- 79Villasís-Keever M, Miranda-Novales MG. http://www.ncbi.nlm.nih.gov/pubmed/? term=34101549 69. Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune- mediated diseases: a controlled study among hospital workers and elderly. Rheumatol. Int. 2021:1-12Seyahi E, Bakhdiyarli G, Oztas M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34109466 70. Attitude and acceptance of Covid-19 vaccine amongst medical and dental fraternity - a questionnaire survey. Rocz. Panstw. Zakl. Hig. 2021; 72:185- 191Kaur A, Kaur G, Kashyap A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34114775 71. COVID-19 pandemic decision support system for a population defense strategy and vaccination effectiveness. Saf Sci 2021; 142:105370Varotsos CA, Krapivin VF, Xue Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108816 72. Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation. Saudi J. Gastroenterol. 2021; Alqahtani SA, Barry M, Memish Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34100388 73. Willingness of Middle Eastern Public to Receive COVID-19 Vaccines. Saudi Pharm J 2021; Abu-Farha R, Mukattash T, Itani R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093059 74. [Vaccination of healthcare workers against COVID-19]. Soins 2021; 66:10- 13Maroudy D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34103125 75. Author response to: Correspondence to humoral immune response to COVID- 19 mRNA vaccine in patients with multiple sclerosis treated with high-effcacy disease-modifying therapies. Ther. Adv. Neurol. Disord. 2021; 14:17562864211020082Achiron A, Mandel M, Dreyer-Alster S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104221 76. Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-effcacy disease-modifying therapies. Ther. Adv. Neurol. Disord. 2021; 14:17562864211019567Piquet AL, Corboy JR, Vollmer TL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104219 77. COVID-19 vaccines: A perspective from social pharmacology. Therapie 2021; Montastruc JL, Lafaurie M, de Canecaude C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119317 78. Myocarditis following COVID-19 mRNA vaccination. Vaccine 2021; Abu Mouch S, Roguin A, Hellou E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34092429 79. Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general. Vaccine 2021; Kessels R, Luyten J, Tubeuf S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119349 80. Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization. Vaccine 2021; Patel MK, Bergeri I, Bresee JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34119350 81. Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada. Vaccine 2021; Piché-Renaud PP, Ji C, Farrar DS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34108076 82. [COVID-19 - The vaccine miracle must include strictness and caution]. Virologie (Montrouge) 2021; Agut H. http://www.ncbi.nlm.nih.gov/pubmed/? term=34112629

Women – pregnancy (19 articles)

1. Giving birth during the COVID-19 pandemic, perspectives from a sample of the United States birthing persons during the frst wave: March-June 2020. Birth 2021; Breman RB, Neerland C, Bradley D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114262 2. COVID-19 and Male Sexual Functioning: A report of 3 Recovered Cases and Literature Review. Clin. Med. Insights Case Rep. 2021; 14:11795476211020593Salama N, Blgozah S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34104031 3. Alcohol and substance use in pregnancy during the COVID-19 pandemic. Drug Alcohol Depend. 2021; 225:108760Kar P, Tomfohr-Madsen L, Giesbrecht G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34102507 4. SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility. F S Rep 2021; Morris RS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34095871 5. Changes in Mental Health of Women Undergoing Assisted Reproductive Technology Treatment During the COVID-19 Pandemic Outbreak in Xi'an, China. Front Public Health 2021; 9:645421Qu P, Zhao D, Jia P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34113596 6. E-Mentoring Female Underrepresented Public Health Student Researchers: Supporting a More Diverse Postpandemic Workforce. Health Secur 2021; Mahayosnand PP, Zanders L, Sabra ZM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34097467 7. The psychological impact of the COVID-19 pandemic on fertility care: a qualitative systematic review. Hum. Fertil. (Camb.) 2021:1-8Kirubarajan A, Patel P, Tsang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114919 8. A forecast of maternal deaths with and without vaccination of pregnant women against COVID-19 in Mexico. Int J Gynaecol Obstet 2021; Lumbreras- Marquez MI, Fields KG, Campos-Zamora M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118064 9. SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies-a narrative review. J Infect Public Health 2021; 14:863-875Kumar R, Yeni CM, Utami NA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34118736 10. Peripartum anesthetic management of women with SARS-CoV-2 infection in eight medical centers across three European countries: prospective cohort observation study. J Matern Fetal Neonatal Med 2021:1-8Ioscovich A, Guasch E, Brogly N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107853 11. Modifed lung ultrasound scoring system to evaluate the feasibility of pregnant women with COVID-19 pneumonia. J Matern Fetal Neonatal Med 2021:1-6Zhang Y, Lyu G, Kang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34096434 12. SARS-CoV-2 in asymptomatic pregnant women in South Brazil: RT-PCR and serological detection. J. Perinat. Med. 2021; Chiste JA, Furuie IN, Nogueira MB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34107573 13. Newborns at risk of Covid-19 - lessons from the last year. J. Perinat. Med. 2021; Shah MD, Saugstad OD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34116585 14. Clinical characteristics, management, and short term outcome of neonates born to mothers with COVID-19 in a tertiary care hospital in India. J. Trop. Pediatr. 2021; Malik S, Surve S, Wade P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34114628 15. Exploring the STEP-uP to practice: A survey of UK Lead Midwives for Education views of the STudent midwife Extended Practice Placement during the frst wave of the COVID-19 pandemic. Midwifery 2021; 101:103048Cooke A, Hancock A, White H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34111806 16. The Indirect Effect of Parental Intolerance of Uncertainty on Perinatal Mental Health via Mindfulness During COVID-19. Mindfulness (N Y) 2021:1-10Sbrilli MD, Haigler K, Laurent HK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34093889 17. Comparative analysis of viral infection outcomes in human seminal fuid from prior viral epidemics and Sars-CoV-2 may offer trends for viral sexual transmissibility and long-term reproductive health implications. Reprod Health 2021; 18:123Pike JFW, Polley EL, Pritchett DY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34112171 18. Maternal low-intensity psychosocial telemental interventions in response to COVID-19 in Qatar: study protocol for a randomized controlled trial. Trials 2021; 22:382Naja S, Elyamani R, Chehab M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34099007 19. Immune system and COVID-19 by sex differences and age. Womens Health (Lond) 2021; 17:17455065211022262Ciarambino T, Para O, Giordano M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34096383

to subscribe click here

mailing address is: [email protected]